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Abstract 
 
Background: 
Exposure to tobacco smoke imposes a heavy morbidity and mortality burden and 
exacerbates health inequalities. Whilst the health and economic benefits of smoke-free 
legislation (SFL) are evident in high income countries (HICs), there is a lack of evidence 
from low- and middle-income countries (LMICs) where implementation and monitoring 
mechanisms are generally weak. 
 
Objectives: 
To examine whether the health benefits of SFL identified in HICs are likely to accrue in 
LMICs and whether any benefits are evenly distributed between socioeconomic status 
(SES) groups. 
 
Methods: 
1) A systematic review was undertaken to examine the impact of SFL on socioeconomic 
inequalities in tobacco-related health outcomes in adults 2) Secondary analyses of the 
Global Adult Tobacco Survey (GATS) data from 15 LMICs was undertaken to examine 
inequalities in second hand smoke (SHS) exposure at work and at home 3) Quasi-
experimental difference-in-differences study design was used to examine whether the 
National Tobacco Control Programme (NTCP) in India was associated with reductions in 
active smoking.  
 
Results: 
1) Evidence from LMICs examining the health impacts of SFL was sparse. 
Comprehensive SFL was associated with pro-equity impacts in smoking associated 
health outcomes in HICs 2) In LMICs, exposure to SHS at workplaces and at homes 
was higher among the low SES groups. Being employed in a smoke-free workplace in 
LMICs was associated with reduced exposure to SHS in the home 3) There was no 
compelling evidence that NTCP reduced bidi and cigarette consumption over and above 
the general reduction that occurred in all districts in India. 
4 
 
Policy implications: 
Poor implementation of SFL in LMICs is associated with substantial forgone health 
benefits, especially in the low SES groups. Strengthening tobacco control is key to 
improve health outcomes and reduce inequalities in LMICs and attainment of the 
Sustainable Development Goals for Health.  
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Chapter 1: Introduction, aims, objectives, and outline of the thesis 
 
1.1. Introduction 
Tobacco smoking and exposure to secondhand smoke (SHS) or passive smoking are 
collectively responsible for 7.2 million annual deaths worldwide while SHS exposure by 
itself is responsible for 0.9 million annual deaths.1 Tobacco smoking and SHS exposure 
collectively, are also the third leading risk factor for non-communicable diseases 
(NCDs), which are responsible for 71% of deaths globally.1 Worldwide, between 1990 
and 2015, morbidity and mortality attributable to tobacco smoking has increased while 
that attributable to SHS exposure has decreased.1 However, low- and middle-income 
countries (LMICs) are likely to continue to face heavy health and economic burden due 
to tobacco smoking as 80% of the world’s smokers reside in these settings.2 Over the 
past decade, cigarette smoking has declined in the European Region, the Region of the 
Americas, the South East Asian Region, and the Western Pacific Region (except China 
where it has notably increased), while it has increased in the Eastern Mediterranean 
Region and the African Region.3  
 
In high income countries (HICs) as well as in LMICs (except among women in some 
countries), there is clear evidence of socioeconomic inequalities in tobacco smoking 
such that smoking is higher among people belonging to low socioeconomic status (SES) 
or the poor.4, 5 Similar inequalities also exist in the case of SHS exposure in HICs.6, 7 
However, evidence from LMICs on inequalities in SHS exposure is lacking. Further, 
tobacco smoking and SHS exposure are causally associated with several diseases such 
as cardiovascular diseases (CVDs), respiratory diseases, and cancers among others.6, 8 
Tobacco smoking and SHS exposure are therefore likely to exacerbate health 
inequalities. The economic costs of tobacco use are also high in HICs as well as in 
LMICs,9-15 further impoverishing millions and contributing to widening socioeconomic 
inequalities.  
 
The first global treaty on tobacco control, Framework Convention on Tobacco Control 
(FCTC) was signed under the auspices of WHO in 2003 and was implemented in 
2004.16 Currently there are 180 Parties (member nations) to the FCTC, which provides 
guidance on demand and supply reduction strategies for tobacco control.17 Reduction in 
tobacco use and implementation of WHO FCTC strategies have been recommended for 
achievement of the global target - 25% relative reduction in premature mortality from 
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NCDs by 2025.18, 19 Similarly, under Goal 3 (Ensure healthy lives and promote well-
being for all at all ages) of the United Nations (UN) Sustainable Development Goals 
(SDGs), reducing tobacco use is recognized as critical for achievement of the global 
target of 33% reduction in premature deaths from NCDs by the year 2030.20 Towards 
that end, Article 8 of WHO FCTC recommends protection of non-smokers from exposure 
to tobacco smoke through implementation of comprehensive smoke-free legislation 
(SFL), which implies 100% smoke-free environment in all indoor public places, indoor 
workplaces, public transport and as appropriate, in other public places (outdoor or quasi-
outdoor), without any exemptions.16 The SFL has evolved gradually from early partial 
laws (1969) to initial local comprehensive law in California (1998) and the first 
comprehensive law in a then LMIC, Uruguay (2006), to the more recent nationwide 
comprehensive law in Brazil (2011).21, 22 Despite being the most widely adopted 
measure for tobacco control, only 18% of the world’s population is covered by 
comprehensive SFL, with low income countries faring the worst.23 Several LMICs 
including India have implemented various tobacco control policies at different levels 
however enforcement is lacking. Section 4 of the Indian national tobacco control law 
imposes a partial ban on smoking in public places, which includes all indoor workplaces 
and public places (but allows designated smoking rooms [DSRs] at airports, hotels with 
more than 30 rooms and restaurants with a seating capacity of more than 30), public 
transport as well as several other places frequented by public including stadiums, bus 
stops, railway stations, and open auditoriums among others.24 The SFL however, 
remains inadequately enforced in India as in several other LMICs,25 as often, no action 
is taken against violations of SFL.  
 
Research evidence, mostly from HICs, shows that comprehensive SFL is effective in 
improving the air quality.26 National SFL has been shown to reduce adverse 
cardiovascular outcomes (Acute Coronary Syndrome (ACS)/Acute Myocardial Infarction 
(AMI)/stroke), asthma, improve lung function, and reduce mortality associated with 
smoking-related illnesses.27 The health benefits are significantly higher in jurisdictions 
implementing comprehensive SFL compared with partial SFL.27 Among adults, SFL has 
also been shown to reduce the prevalence and intensity of smoking, exposure to SHS 
and increase quit rate.21, 28 The implementation of SFL has also been shown to 
significantly reduce preterm births and hospital attendance for childhood asthma,29 as 
well as exposure to SHS.30 Comprehensive SFL has also been shown to have a neutral 
or positive effect on business, economy, and employment, particularly for the hospitality 
sector.31 SFL has also been shown to be highly popular and has the potential to 
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positively alter social norms towards exposing non-smokers to SHS, thereby leading to 
the adoption of voluntary measures such as smoke-free homes and private vehicles.32-37 
However, most of this research is concentrated in HICs. A recent extensive Cochrane 
review showed that only about 2% the research was from LMICs.27  
 
The implementation and enforcement of SFL are weak in several LMICs when 
compared with HICs.23 Barriers for implementation of SFL in the LMIC settings include a 
lack of understanding of the political economy for tobacco control,38 tobacco industry 
interference and the myths propagated by them,21, 31 the lack of required enforcement 
capacity and resources, gaps in knowledge about the harmfulness of tobacco use and 
SHS exposure,39 the lack of political will and a cumbersome policy formulation 
process.40 A major barrier, however, is the lack of data and research on SHS exposure 
and the impact of SFL. There also exist facilitators that could enable implementation and 
enforcement of SFL in LMICs: the huge economic gains resulting from tobacco smoke 
attributable morbidity and mortality averted subsequent to SFL implementation,41 pre-
existing networks of tobacco control advocates, organizations, programmes and laws in 
several LMICs, and the increasing support for SFL and tobacco control in general, 
among the public.21  
 
Overall, SFL has been shown to be associated with considerable health and economic 
benefits mainly in HICs. However, there is a lack of evidence whether similar benefits 
accrue in the LMIC settings where implementation of SFL is poor and monitoring 
mechanisms are weak. The resulting lack of data impedes evaluation of the impact of 
tobacco control policies such as SFL in these settings. As tobacco smoking and SHS 
exposure have the potential to exacerbate health inequalities, it is also important to 
evaluate the impact of such tobacco control policies on inequalities. There is an urgent 
need to undertake focused research in the LMIC settings to generate evidence which 
would facilitate implementation and enforcement of pro-equity tobacco control measures 
such as comprehensive SFL, as observed in the HIC settings.  
 
This thesis uses limited data available in LMICs, including a case study in India, to 
examine whether the health benefits identified in HICs are likely to accrue in LMICs and 
if so, whether these benefits are evenly distributed between SES groups. Specifically, I 
start by conducting a systematic review to examine whether the identified health benefits 
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of SFL accrue equally among adults in low and high SES groups. I then use data from 
the Global Adult Tobacco Survey (GATS) to determine whether implementation of SFL 
in LMICs is likely to produce additional health benefits, especially among women and 
children, by influencing smoking behaviour in the home through a shifting of social 
norms. In a second study using the GATS data, I examine whether exposure to SHS in 
workplaces and at homes in LMICs is socially patterned, such that low SES individuals 
are more likely to be exposed to SHS. Finally, I evaluate whether implementation of the 
National Tobacco Control Programme (NTCP) in India, which sought to strengthen 
implementation and enforcement of tobacco control policies in the country including 
SFL, was associated with reductions in active smoking. This thesis is based, in part, on 
two published research papers,42, 43 and two yet to be published research papers (Nazar 
et al. submitted; Jamaludin et al. yet to be submitted), which comprise chapters 3-5, 
together with additional material (chapters 1, 2 and 6). Overall, my thesis provides 
background information and literature as well as implications of the findings relevant for 
LMICs, however, each section also contains some specific reference to India as the 
country is included as a case study within the thesis. Although research from HICs 
shows beneficial effect of SFL on health and SHS exposure among children, my thesis 
primarily focuses on adults as my research proposal was developed under the category 
“occupational health”, which was the theme of call for proposals under the Wellcome 
Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India 
(PHFI) and a consortium of UK universities in 2012, which funded this study. Further, my 
co-supervisor is a co-author on a study with other researchers which focuses on the 
impact of SFL on perinatal and child health. 
 
1.2. Aims 
 Aim 1: To study the impact of SFL on socioeconomic inequalities in health 
outcomes related to exposure to tobacco smoke. 
 Aim 2: To study the association between SFL and exposure to SHS in the home 
in the LMIC settings. 
 Aim 3: To study socioeconomic inequalities in exposure to SHS at home and in 
the workplace in LMICs.  
 Aim 4: To assess the impact of its National Tobacco Control Programme (NTCP) 
in India on bidi* and cigarette smoking. 
                                                          
* Bidi is made by rolling a dried, rectangular piece of temburni leaf (Diospyros melanoxylon) with 0.15-
0.25 grams of sun-dried, flaked tobacco into a conical shape and securing the roll with a thread.236  
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 Aim 5: To generate research evidence to strengthen implementation and 
enforcement of strong tobacco control policies including comprehensive SFL in 
the LMIC settings.  
 
1.2.1. Objectives 
 Objective 1: To conduct a systematic literature review to assess quantity and 
quality of global research describing the impact of SFL on socioeconomic 
inequalities in health outcomes associated with exposure to tobacco smoke 
among adults.  
 Objective 2: To conduct secondary analyses on cross-sectional GATS (2008-
2011) data from 15 LMICs: 
o Objective 2a: to study the association between being employed in a 
smoke-free workplace and living in a smoke-free home. 
o Objective 2b: to study the extent of SHS exposure at homes and at 
workplaces and the socioeconomic inequalities in SHS exposure therein. 
 Objective 3: To evaluate the impact of the National Tobacco Control Programme 
(NTCP) in India (an LMIC) using repeated cross-sectional National Sample 
Survey Organization (NSSO) Consumer Expenditure Survey (CES) data (1999-
2000; 2004-05; 2011-12) on consumption of bidis and cigarettes at household 
level using the difference-in-differences (DID) analysis. 
 Objective 4: To draw comparisons between the findings of this study with those 
available from the HIC settings and generate policy recommendations to enable 
better implementation and enforcement of comprehensive SFL across LMICs. 
 Objective 5: To generate and compile results from this study in the form of 
research papers (published or yet to be published) and disseminate 
findings/recommendations through conference presentations, seminars, and 
posters.  
 
1.3. Outline of the thesis 
 
Chapter 1: Introduction, aims, objectives, and outline of the thesis 
This chapter gives a brief introduction of the current knowledge about the burden of 
disease and harms due to tobacco smoking and exposure to SHS. The chapter further 
introduces SFL, its evolution and implementation, the benefits of SFL and the 
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barriers/facilitators to implementation and enforcement of SFL in LMIC settings. The 
importance of this research for LMIC settings is introduced followed by a description of 
the aims, objectives, and structure of the thesis. At the end of the chapter, information 
about ethics approval and funding for this study are presented.  
 
Chapter 2: Tobacco smoking, secondhand smoke exposure, and smoke-free legislation 
This chapter describes in detail the background existing literature and the current 
knowledge on tobacco smoking, SHS exposure and SFL from HICs as well as LMICs. 
Topics such as the burden and prevalence of tobacco smoking as well as SHS 
exposure, health and economic adverse consequences of smoking and SHS exposure, 
international tobacco control policies with a specific focus on SFL, history, evolution and 
coverage of SFL, best practices in SFL implementation from LMICs, impact of SFL on 
health and non-health outcomes, and challenges and facilitators to implementation of 
SFL in LMICs are described in detail. The background section of this chapter is followed 
by a rationale and justification for this study. This chapter describes literature and data 
from various sources such as Government and non-governmental reports/publications, 
as well as credible websites (e.g. WHO, UN, Centre for tobacco-free kids, tobacco.org, 
Action on Smoking and Health, and American Non-smokers’ Rights Foundation among 
others) of organizations active in tobacco control, data repositories, epidemiologic 
studies, systematic reviews and meta-analyses.  
 
Chapter 3: Impact of smoke-free legislation on socioeconomic inequalities in health 
outcomes associated with exposure to tobacco smoke among adults 
This chapter presents the results from a systematic review (in the form of a research 
paper) conducted as a part of this study. The review focuses on the study of quality, 
quantity and findings of research from HICs as well as LMICs, which have studied the 
impact of SFL on health outcomes among adults and which also report health outcomes 
by indicators of SES e.g. income/wealth, education, occupation or some other form of 
SES index such as area deprivation. The findings suggest that all the included studies 
were from HICs indicating a need for more research in LMICs on SFL impact evaluation. 
Moreover, studies included in the review which evaluated the impact of comprehensive 
SFL, reported either a neutral or equity positive effect (low SES groups benefitted more 
than the high SES groups) on health outcomes. Partial SFL may not reduce inequalities. 
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We conclude with a recommendation for implementation and enforcement of 
comprehensive SFL to reduce health inequalities.  
 
Chapter 4: Secondhand smoke exposure and the impact of smoke-free legislation on 
protection against exposure to tobacco smoke: Multi-country evidence from Global Adult 
Tobacco Survey  
This chapter initially provides an overview of the Global Tobacco Surveillance System 
and goes on to describe the GATS methodology in detail. Subsequently, the results of 
secondary data analyses using the GATS data from 15 LMICs are presented in the form 
of two research papers, published and disseminated as part of my thesis. The first paper 
describes the association between being employed at smoke-free workplaces and living 
in smoke-free homes in these LMICs and thereby suggests that SFL positively changes 
social norms around exposing others/non-smokers to SHS. The second paper describes 
the extent of SHS exposure at workplaces and at homes in these countries and shows 
associations with socioeconomic indicators, indicating that SHS exposure is significantly 
higher among the less educated and the poor in LMICs, as observed in HICs.  
 
Chapter 5: Evaluation of the impact of National Tobacco Control Programme on bidi and 
cigarette consumption in India  
This chapter initially describes India’s national tobacco control laws, followed by its 
National Tobacco Control Programme (NTCP) and the Consumer Expenditure Survey 
(CES) methodology conducted by the National Sample Survey Organization (NSSO), 
Government of India. This description is followed by the results of a secondary data 
analysis (in the form of a research paper) which was undertaken to study the impact of 
NTCP on household level bidi and cigarette consumption using three years of repeated 
cross-sectional CES data (1999-2000; 2004-05; 2011-12) and a sophisticated 
Difference-in-differences (DID) technique, typically used in econometrics for programme 
impact evaluation. There was no compelling evidence that NTCP reduced bidi and 
cigarette consumption over and above the general reduction that occurred in all districts 
in India. Strengths and weaknesses of the NTCP and policy implications are also 
discussed in this chapter.  
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Chapter 6: Discussion and policy implications 
This chapter presents an overall discussion based on the results of individual 
components of this study. Findings of each research paper are summarised along with 
an overall synthesis. General strengths and limitations, and policy implications of 
findings relevant to implementation and enforcement of comprehensive SFL in the LMIC 
settings are discussed, followed by a conclusion to the thesis.  
 
All references have been listed in Vancouver style in one separate section after the last 
chapter. The appendices provide additional material relevant to this work including 
ethics approval letters, and supplementary material included in published or yet to be 
published research papers.  
 
A total of four research papers (published and yet to be published) are included in this 
thesis. A research paper coversheet is included before each paper which provides 
information about the publication (or planned publication) including copyright 
information, author details, journal, and description of my contribution to the research 
paper (in the case of multi-authored research papers).  
 
1.4. Ethics clearance 
An exemption from ethics review for using anonymous secondary data from the 
nationally representative surveys (GATS and NSSO CES) was provided by the 
Institutional Ethics Committee at Public Health Foundation of India (PHFI) and the 
Research Ethics Committee at the London School of Hygiene and Tropical Medicine 
(LSHTM) (see Appendix A). 
 
1.5. Funding 
This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award 
to the Public Health Foundation of India and a consortium of UK universities. 
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Chapter 2: Tobacco smoking, secondhand smoke exposure, and smoke-free 
legislation  
 
2.1. Background 
 
2.1.1. Prevalence of smoking 
Tobacco smoking and SHS exposure (collectively) is the third leading risk factor for 
global burden of disease (GBD).1 Collectively, tobacco smoking and SHS exposure are 
responsible for 7.2 million annual deaths worldwide (17% of all deaths among men and 
8% of all deaths among women) and 7% of the Disability-Adjusted Life Years (DALYs) 
lost (9% of all DALYs lost among men and 4% among women).1 Tobacco smoking alone 
is responsible for 6.4 million annual deaths worldwide, (of which, 77% are among men 
and 23% are among women) and 6% of the DALYs lost.1 Although the absolute 
numbers of deaths and DALYs lost attributable to smoking have increased between 
1990 and 2015, there has been a relative decline in the age-standardized death rate by 
32% and DALYs lost by 35%.1 
 
Ng et al. studied the prevalence of daily smoking and the number of cigarettes smoked 
per day in 187 countries between 1980 and 2012.44 They report that the age-
standardized prevalence of daily smoking reduced by 25% and 42% among men and 
women respectively over this period, however, due to increases in the population over 
time, there was a 41% increase in the number of men who smoked daily and a 7% 
increase in the number of females who smoked daily. They observed that the decline in 
smoking prevalence was faster before 2006, after which, it slowed down substantially, 
possibly due to increases in the number of smokers in some countries (e.g. China and 
Indonesia) and varying levels of implementation of tobacco control policies across 
countries. The decline was particularly notable in some of the countries (mainly HICs) 
such as Canada, Ireland, Iceland, New Zealand, Mexico, and Norway.44 Apart from this 
study, other sources also confirm that over the past decade, cigarette smoking has 
declined in the European Region, the Region of the Americas, the South East Asian 
Region, and the Western Pacific Region (except China where it has notably increased) 
while it has increased in the Eastern Mediterranean Region and the African Region.3 
Concurrently, there is an upsurge in the burden of death and disease attributable to 
NCDs, which are responsible for 71% of all deaths globally.1 The highest tobacco-
attributable burden of disease is due to NCDs such as CVDs, cancers and chronic 
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pulmonary diseases.1, 45 It is estimated that there are a billion smokers globally and 
every four out of five smokers are from LMICs.2 The burden of disease and death 
attributable to tobacco smoking and the associated NCDs is therefore set to rise further 
in the resource-poor LMICs. Moreover, the WHO estimates that, if uncontrolled, tobacco 
use would lead to a billion deaths in the 21st century.2 
 
Giovino et al. compared the prevalence of tobacco use in 14 LMICs with that in two 
HICs (US and UK) using nationally representative data from 2008 to 2010 (Table 2.1).46 
The authors reported much higher prevalence of smoking and any tobacco use among 
men compared with women in LMICs. The prevalence of smokeless tobacco (SLT) use 
was reported to be highest in Bangladesh and India. Additionally, the authors reported 
that the women were starting to use tobacco at increasingly younger ages so that the 
age of initiation in younger age groups was similar among men and women.46  
 
Table 2.1: Comparison of tobacco use prevalence between low- and middle-income countries (LMICs) and high income 
countries (HICs) 46 
  GATS Countries (LMICs) High income 
countries (HICs) 
  Lowest prevalence Highest prevalence UK US 
Current 
smoking 
Total India (14%) Russia (30.1%) 21.7% 19.9% 
 Males (≥15 years) Brazil (21.6%) Russia (60.2%) 22.8% 24.0% 
 Females (≥15 years) Egypt (0.5%) Poland (24.4%) 20.6% 16.2% 
 
Current SLT 
use 
Total Uruguay (0%) Bangladesh (27.2%) - 1.8% 
 Males (≥15 years) Uruguay (0%) India (32.9%) - 3.5% 
 Females (≥15 years) Uruguay, Ukraine, China 
(0%) 
Bangladesh (27.9%) - 0.2% 
 
Current any 
tobacco use 
Total Mexico (16.0%) Bangladesh (43.3%) 21.7% 21.1% 
 Males (≥15 years) Brazil (22%) Russia (60.6%) 22.8% 26.2% 
 Females (≥15 years) Egypt (0.6%) Bangladesh (28.7%) 20.6% 16.3% 
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Lopez et al. initially described a model for the cigarette epidemic in 1994, which 
described the progress of the epidemic in four stages.47 Stage I (one or two decades) – 
characterised by the low prevalence of smoking, low per capita consumption, and no 
smoking-related death and disease. Stage II (two to three decades) – characterised by 
rapidly rising prevalence and frequency of consumption (higher among males vs. 
females), no SES differences or smoking higher among the rich, and the health effects 
become evident among males towards the end of this stage. Stage III (approximately 
three decades) – characterised by a decline in male smoking, the start of the decline in 
female smoking towards the end of this stage, decline in smoking more evident among 
those with higher education, high death, and disease among males (low among 
females). Stage IV – characterised by a continued slower decline in male and female 
smoking, declining smoking-attributable death and disease among males (rising among 
females) and inequalities in smoking (higher rates among the low SES groups). The 
countries in stage IV of the smoking epidemic are mainly HICs such as the US, UK, 
Australia, and Canada, among others, where socioeconomic inequalities in smoking 
became apparent with declining smoking rates or probably even before that, during 
stage III of the epidemic.47 More recent research evidence shows that in most HICs, 
smoking prevalence is higher among the people belonging to low SES, while on average 
high SES smokers smoke more per day than low SES smokers.4 Mixed evidence of 
socioeconomic inequality in smoking exists in LMICs as most of these countries are in 
stage II or stage III of the epidemic. Hosseinpoor et al. studied the prevalence of 
smoking from 48 LMICs that participated in the World Health Survey and found that the 
smoking prevalence among males was higher among those belonging to low SES in 
most of the countries studied (possibly stage III of the epidemic), while the smoking 
prevalence among females from nine countries was higher among the richest vs. the 
poorest (possibly stage II of the epidemic).5 This indicates that in LMICs tobacco control 
policies need to be strengthened further and targeted as per the country-specific 
situation.  
 
2.1.1.1. Country specific example - India 
In India, tobacco smoking led to 0.7 million deaths (majority of these deaths were among 
males) and 4% of DALYs lost in the year 2015.1 The prevalence of any tobacco use is 
34.6% (among those ≥ 15 years of age) (47.9% among men and 20.3% among women); 
current smoking is 14% (24.3% among men and 2.9% among women); and current SLT 
use is 25.9% (32.9% among men and 18.4% among women).48 Ng et al. suggests that 
between 1980 and 2012, the smoking prevalence among adult Indian men decreased 
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from 34% to 23%, while the adult female smoking prevalence which was 3.2% in 2012 
has virtually remained unchanged since 1980.44 Overall, the smoking prevalence 
decreased from 19% in 1980 to 13% in 2012. The study also suggested that India has 
the second highest number of female smokers in the world (12.1 million) after the US, 
due to high absolute numbers of female smokers in India. When comparing India with 
HICs such as the US and the UK, although there has been an overall decline in adult 
smoking prevalence in India, the decline has been much slower.44 The prevalence 
among females in India has stayed constant since 1980, while there has been a steady 
decrease in the prevalence among females from the US and the UK. The gap in 
prevalence between boys and girls is narrower compared with the adult men and 
women suggesting that young females are increasingly taking up tobacco use in India.48, 
49  
  
2.1.2. Prevalence of secondhand smoke exposure 
SHS, also commonly known as environmental tobacco smoke comprises of the 
mainstream smoke (exhaled by the smoker) and the smoke emanating from the burning 
end of a cigarette.50 Approximately 0.9 million annual deaths (1.6% of all deaths) are 
attributable to SHS exposure globally, of which, 61% deaths occur among women.1 SHS 
exposure is responsible for 1% of the global burden of disease in terms of DALYs lost.1 
Between 1990 and 2015 there has been a significant relative decline in the age-
standardized death rate (by 53%) as well as DALYs lost (by 56%) due to SHS 
exposure.1  
 
In LMICs, the bulk of burden from SHS exposure falls on women and children.46 Figure 
2.1 shows the prevalence of SHS exposure (in past 30 days) among adults at home, at 
workplace and at restaurants in 22 countries (most of them are LMICs) in which the 
Global Adult Tobacco Survey (GATS) was implemented from 2008 to 2013.3 SHS 
exposure at home in several LMICs is typically high, ranging from 4.4% in Panama51 to 
78.4% in Indonesia.3, 52 At workplaces, exposure to SHS is higher among men in these 
LMICs participating in GATS.53 SHS exposure at workplaces ranges from 5.6% in 
Panama to over 60% in China; while the exposure is highest in restaurants where it is 
over 60% in nearly half of these countries.3 In India, 52.3% of adults are exposed to 
SHS at homes and 29% are exposed at public places,48 while 21.9% of children are 
exposed to SHS at home and 36.6% are exposed to SHS outside their homes.49   
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In the US, exposure to SHS among non-smokers has declined steadily over the years 
(from 88% in 1988-1991 to 25% in 2011-2012).7 In the European countries such as 
England and Scotland, there has been a significant decline in SHS exposure, both in 
homes and at workplaces since the introduction of smoke-free laws.54, 55  In HICs, there 
exists sufficient evidence to suggest that SHS exposure is higher among the poor (e.g. 
people with low incomes, blacks vs. whites as well as the blue collar and the service 
workers).6, 7 However, similar evidence is lacking in the context of LMICs in which the 
SFL is often poorly enforced and implemented. Apart from differences in the prevalence 
of tobacco use and trends therein across countries, a major reason for the observed 
differences in SHS exposure between these countries is the difference in the extent to 
which SFL is implemented and enforced.56 
 
2.1.3. Harms due to smoking and secondhand smoke exposure 
As research has shown that SFL reduces smoking as well as SHS exposure among the 
non-smokers,21 it is important to have an understanding of the harms that are caused by 
smoking as well as by exposure to SHS. Evidence on the harmful health effects of 
Figure 2.1: Prevalence of secondhand smoke (SHS) exposure (in past 30 days) among adults at home, at workplace 
and at restaurants in 22 Global Adult Tobacco Survey (GATS) countries (2008-2013)3  
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tobacco smoking began to accumulate after the 1962 Royal College of Physicians report 
observed that cigarette smoking causes lung cancer and bronchitis, and possibly other 
diseases, including coronary heart disease.57 Subsequently, a 1964 US Surgeon 
General’s report causally linked smoking with lung cancer.58 A series of US Surgeon 
General’s reports have been published since then. Causal associations described these 
reports carry additional weight as over the years, these reports have established 
rigorous procedures for compiling and evaluating the global scientific literature. The US 
Surgeon General’s reports critically review the available research evidence for quality 
and strength of association and conservatively establish a summary causal statement 
for each outcome. These causal statements fall into one of the following four levels - 
Level 1: sufficient evidence to infer a causal relationship; Level 2: suggestive but not 
sufficient evidence to infer a causal relationship; Level 3: inadequate evidence to infer a 
causal relationship; Level 4: suggestive of no causal evidence.8 The US Surgeon 
General’s reports published after the initial 1964 report causally linked smoking with 
several other types of cancers, diseases, and conditions affecting the cardiovascular 
system, respiratory system, and reproductive system among others (Figure 2.2). The 
evidence continues to be generated and the latest conditions to be causally associated 
with smoking in the 2014 US Surgeon General’s report include: liver and colorectal 
cancers, age-related macular degeneration, congenital anomalies, tuberculosis, 
diabetes, ectopic pregnancy, erectile dysfunction, rheumatoid arthritis, diminished 
immunity and overall health.8  
 
IARC Monographs use similar methodology of reviewing global evidence to assess the 
strength of evidence for carcinogenicity among humans and experimental animals 
wherein it uses four categories of classification similar to the US Surgeon General’s 
Reports (e.g. Group 1: sufficient evidence of carcinogenicity among humans; Group 2a: 
limited evidence of carcinogenicity in humans but sufficient evidence of carcinogenicity 
among experimental animals; Group 2b: limited evidence of carcinogenicity in humans 
and less than sufficient evidence of carcinogenicity among experimental animals; Group 
3: inadequate evidence of carcinogenicity in humans and inadequate or limited evidence 
of carcinogenicity among experimental animals; Group 4: evidence suggesting lack of 
carcinogenicity among humans and experimental animals.50 In addition to confirming the 
findings of the US Surgeon General’s report, cancers of sinonasal cavities and the 
nasopharynx and mucinous ovarian tumours are suggested by the IARC Monograph to 
be causally associated with smoking.50 The IARC Monograph reviewed studies of bidi 
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smoking separately and concluded: “bidi smoking increases the risk for cancers of the 
oral cavity, oropharynx, hypopharynx, larynx, lung, oesophagus and stomach.” 50 
 
 
SHS contains more than 7000 chemicals including 70 carcinogens and other toxins.8 
Initial evidence on the possible adverse health effects of SHS exposure began to 
emerge in US Surgeon General’s reports from 1972.8 Subsequent reports also included 
other possible adverse health effects of exposure to SHS such as those affecting the 
respiratory system, particularly among children. A causal link between SHS exposure 
and lung cancer among non-smokers was only established after the 1986 US Surgeon 
General’s report, which solely focused on SHS exposure (another report solely focused 
on SHS exposure was published in 2006).6, 59 The 2006 report suggested that SHS 
exposure is causally associated with middle ear infections, respiratory symptoms such 
as coughing, sneezing and shortness of breath, lower respiratory tract infections such as 
bronchitis and pneumonia, and sudden infant death syndrome (SIDS) among children 
(Figure 2.3). Among adults, exposure to SHS was shown to be causally linked with 
coronary heart disease, lung cancer, low birth weight babies, respiratory symptoms and 
stroke.6, 8 Further, evidence is suggestive but not sufficient to infer a causal relationship 
Figure 2.2: Adverse health effects causally associated with tobacco smoking8 
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between exposure to SHS and breast cancer, pre-term delivery, chronic obstructive 
pulmonary disease (COPD), chronic respiratory symptoms, asthma, impaired lung 
function, atherosclerosis, cancer of nasal sinuses, pharynx and larynx among adults; 
and dental caries, neurodevelopmental disorders, asthma, tuberculosis, allergic 
diseases, lymphoma and leukaemia among children.3, 8 The IARC Monograph suggests 
that causal associations exist between SHS exposure and leukaemia, lymphoma and 
hepatoblastoma among children.50  
 
 
 
 
 
 
 
 
 
 
 
 
2.1.3.1. Economic costs of smoking 
Apart from the health harms due to active smoking and SHS exposure, the cost of 
purchasing cigarettes and the healthcare cost of treating related diseases can be 
overwhelming for the smokers, the non-smokers exposed to SHS and the entire nation. 
In the US, lifetime cost of buying cigarettes per smoker has been estimated to be 
between US$ 1.1 million to 2 million, depending on the state of residence.9 On the other 
hand, the total economic cost of tobacco smoking and SHS exposure in the US is US$ 
300 billion and US$ 11 billion per year respectively, including direct healthcare costs and 
indirect costs.10, 11 In the UK, the annual household expenditure on cigarettes in 2014 
was £19.4 billion, while the cost of buying cigarettes per year was estimated to be £3000 
Figure 2.3: Adverse health effects causally associated with exposure to secondhand smoke (SHS)8 
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per year for a heavy smoker.12 The healthcare cost of treating smoking-related diseases 
was estimated to be £2 billion per year to the UK National Health Services.12 This cost 
was £23.3 million for the treatment of diseases related to SHS exposure.13 Similar high 
costs are also observed in LMICs. In India, the cost of purchasing cigarettes has been 
estimated to be INR10 million per smoker who smokes five cigarettes a day for 30 
years.14 The total economic cost of tobacco use in India in 2011 was estimated to be 
US$ 22.4 billion including direct health care costs and indirect costs.15 Tobacco 
consumption has been estimated to push 15 million people into poverty annually in 
India.60 Expenditure on tobacco smoking diverts resources which could otherwise be 
spent on education and other household necessities. Apart from the direct and indirect 
costs, smoking also leads to intangible costs arising due to loss of life, pain, and 
suffering due to smoking-related illness. The global annual intangible cost attributable to 
smoking has been estimated to be US$ 2.1 trillion, higher than most of the other risk 
factors for the global burden of disease.61  
 
2.1.4. International tobacco control policies  
Due to the mounting evidence on the harms of active smoking and exposure to SHS, 
global action to control tobacco has been strengthened in the recent years. The 
Framework Convention on Tobacco Control (FCTC), a treaty negotiated under the 
auspices of WHO at the 56th World Health Assembly (2003), came into force on 
February 27, 2005.16 As of December 2016, there are 168 signatories and 180 Parties 
(ratifying nations) to the WHO FCTC.17 The WHO FCTC provides guidance on 
implementation and enforcement of several evidence-based supply and demand 
reduction measures for tobacco control to the Parties. Each of these measures is 
outlined in a separate article in the WHO FCTC document.16 The WHO FCTC has 
further developed and disseminated detailed and clear guidelines separately for each 
article so as to enable effective implementation and enforcement by each Party. Table 
2.2 lists the key demand and supply reduction measures from the WHO FCTC.  
 
Article 8 of the WHO FCTC urges the ratifying Parties to: a) recognize that exposure to 
tobacco smoke can lead to “death, disease and disability” and b) “adopt and implement 
in areas of existing national jurisdiction as determined by national law and actively 
promote at other jurisdictional levels the adoption and implementation of effective 
legislative, executive, administrative and/or other measures, providing for protection 
from exposure to tobacco smoke in indoor workplaces, public transport, indoor public 
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places and, as appropriate, other public places.”16 Guidelines for implementation of 
Article 8 of the WHO FCTC suggest that even minor exposure to SHS can cause harm; 
only 100% smoke-free environments can provide complete protection from exposure to 
SHS while mechanical ventilation, air filtration systems or designated smoking rooms 
(DSRs) are not effective and should be discouraged.6, 62 The guidelines further require 
that comprehensive SFL should include all indoor workplaces, indoor public places, and 
public transport and as appropriate, other public places, without any exemptions and 
voluntary agreements. In order to ensure compliance, the public needs to be made 
aware by educating them about SFL, its benefits, related myths and penalties resulting 
from a violation of such policies. At the same time designation of an enabled agency or 
a group is essential to ensure effective implementation and enforcement.62  
 
Table 2.2: Demand and supply reduction measures outlined in the WHO Framework Convention on Tobacco Control 
(FCTC) 200316 
Demand reduction measures Supply reduction measures 
Article 6 Price and tax Article 15 Illicit trade of tobacco products 
Article 7 Non-price measures Article 16 Sale to and by minors 
Article 8 Protection from exposure to SHS Article 17 Provision of support for 
economically viable alternative 
activities 
Article 9 Regulation of the contents of tobacco products   
Article 10 Regulation of tobacco product disclosures   
Article 11 Packaging and labelling of tobacco products   
Article 12 Education, communication, awareness and public awareness   
Article 13 Tobacco advertising, promotion, and sponsorship   
Article 14 Tobacco dependence and cessation   
   
 
2.1.4.1. Smoke-free legislation – past and present 
While some activists had been warning about the dangers of smoking even before 1950 
when cigarette smoking gained popularity, the researchers, the medical community, and 
the Governmental agencies started considering protection from tobacco smoke only 
after the US Surgeon General’s 1964 report which causally linked smoking with lung 
cancer.21 As research evidence accumulated thereafter, SFL started to be enacted 
across the globe. Initial SFL tended to be ‘partial’ as either only certain venues/public 
places/workplaces were smoke-free, or there was no physical separation between the 
smoke-free and the smoking zones or the hospitality venues were not covered by such 
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policies. The first comprehensive smoke-free workplace law was introduced in the US 
state of California in 1998 which covered all indoor workplaces (including bars and 
taverns). Moreover, there have been differences between countries in terms of the level 
at which SFL was implemented for e.g. some of the countries introduced national SFL 
(e.g. Ireland, Uruguay, and India) while others implemented a state level or sub-
state/regional level legislation and then expanded it over time (e.g. Australia, the US).21 
Some of the countries have SFL at multiple levels e.g. national and/or state and/or city 
levels (as in Sydney, Melbourne, and New York City).23 The IARC Monograph published 
in the year 2009 which presents comprehensive evidence on the effectiveness of SFL 
provides a detailed historical overview of the evolution of SFL which is briefly 
summarised in Table 2.3. 
 
Table 2.3: Summary of key events in the evolution of smoke-free legislation (SFL)21 
Year Country/State/City Detail of SFL coverage Partial/ 
Comprehensive 
1969 Bulgaria Ban on smoking in workplaces where non-smokers work (except if the 
non-smokers have no objection to smoking). Exception not applicable if 
pregnant or nursing mothers were working there. 
Partial 
1970 Singapore Ban on smoking in movie halls, theatres, public lifts and some buildings.  Partial 
1973 Norway Restriction on smoking in public transport, meeting rooms, workplaces, 
and institutions 
Partial 
Arizona Smoking in libraries, theatres, concert halls and buses restricted to 
designated areas 
Partial 
Connecticut Smoking restricted in restaurants Partial 
1975 Minnesota Smoking restricted in private workplaces, restaurants, meeting rooms and 
public places 
Partial 
1988 Norway Extension of earlier law to restrict smoking in all enclosed public places 
and public transport (but excluded restaurants and bars) 
Partial 
1989 Multiple states in the 
US 
45 states – Restriction of smoking in public places 
17 states – Restriction in private sector workplaces 
Partial 
1990 New Zealand Some smoke-free public places and partial restrictions in hospitality 
venues 
Partial 
1994 California 195 municipalities implemented clean air laws at local/city level Partial 
1998 California California smoke-free workplace law required all indoor workplaces 
in the state to be completely smoke-free (including bars and taverns) 
Comprehensive 
2002 Delaware Smoke-free workplace law Comprehensive 
2003 India Cigarettes and Other Tobacco Products Act (COTPA) 2003 section 4 – 
smoking banned in several public places (exemptions allowed in hospitality 
venues) 
Partial 
New York Smoke-free workplace law Comprehensive 
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2004 Uganda Regulation of smoking in public places Partial 
Ireland Nationwide smoke-free workplace law Comprehensive 
Norway Nationwide smoke-free workplace law Comprehensive 
New Zealand Nationwide smoke-free workplace law Comprehensive 
Maine, Connecticut, 
Massachusetts 
Smoke-free workplace law Comprehensive 
Canada – 3 
provinces and 2 
territories 
Smoke-free workplace law Comprehensive 
2005 Canada – 2 
provinces 
Smoke-free workplace law Comprehensive 
US – 3 additional 
states 
Smoke-free workplace law Comprehensive 
Italy Nationwide smoke-free workplace law Partial 
2006 Uruguay Nationwide smoke-free workplace law Comprehensive 
Scotland Nationwide smoke-free workplace law Comprehensive 
Argentina – 2 
provinces 
Smoke-free workplace law Comprehensive 
US – 4 additional 
states 
Smoke-free workplace law Comprehensive 
Australia – 3 states Smoke-free workplace law Comprehensive 
2007 Lithuania Nationwide smoke-free workplace law Comprehensive 
Iceland Nationwide smoke-free workplace law Comprehensive 
Australia – 3 states Smoke-free workplace law Comprehensive 
Northern Ireland, 
Wales, England 
Nationwide smoke-free workplace law Comprehensive 
US – 5 additional 
states 
Smoke-free workplace law Comprehensive 
Argentina – 1 
province 
Smoke-free workplace law Comprehensive 
2008 India Amendment of COTPA 2003 to strengthen SFL (including all indoor public 
places, workplaces, public transport and some outdoor public places as 
well). DSRs allowed at airports, hotels (more than 30 rooms) and 
restaurants (more than 30 seats) 
Partial 
2011 Brazil Nationwide smoke-free workplace law (all enclosed public places 
including restaurants and bars) 
Comprehensive 
 
Comprehensive SFL was, and continues to be the most widely implemented measure 
among all the tobacco control measures recommended by the WHO; yet, as per the 
WHO MPOWER report (2015), only 18% of the world’s population was covered by 
comprehensive SFL in 2014.23 The MPOWER report classifies existing SFL in a country 
as comprehensive SFL if all its public places (including health care facilities, educational 
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facilities other than universities, universities, government facilities, other indoor 
workplaces and offices, restaurants or facilities that serve mostly food, cafes/pubs/bars 
or facilities that serve mostly beverages and public transport) are completely (100%) 
smoke-free or at least 90% of its population is covered by complete sub-national SFL.23 
In the recent years, most of the progress in enforcement of this policy initiative has been 
observed in the middle income countries (particularly those from the Latin America).63 
With the recent additions of Chile, Jamaica, Madagascar, Russian Federation and 
Suriname, 49 countries in the world are now covered by comprehensive SFL at the 
national or sub-national level.23 Globally, 75% of the countries still have weak or no 
implementation of SFL, notable among these are about 88% of the low income 
countries.23 Figure 2.4 shows the status of implementation of SFL across the globe.  
 
 
 
 
 
 
 
 
 
 
 
 
A global map of smoke-free policies published in 2008 showed that across all the six 
WHO regions, enforcement of SFL was poor in several LMICs.25 Since then, there have 
been several changes in the global SFL scenario. However, typically, implementation 
and enforcement of tobacco control policies have been observed to be poor among 
LMICs compared with HICs. More recently, two LMICs – Uruguay (an upper-middle 
income country before 2013) and Brazil have set the benchmark for all the other LMICs 
to follow by successfully demonstrating a significant reduction in smoking and SHS 
Figure 2.4: Status of implementation of smoke-free legislation (SFL) across the globe in 
201423 
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exposure following implementation of stringent tobacco control policies including a 
comprehensive SFL.  
 
2.1.4.2. Case study: Smoke-free legislation in Uruguay 
Uruguay is the first country in Latin America and the first among all LMICs to have 
implemented a comprehensive SFL from March 1, 2006.21 This was possible only due to 
the high level of political commitment from the then President of Uruguay who was an 
oncologist and was well-aware of the adverse consequences of smoking and exposure 
to tobacco smoke. The introduction of the comprehensive legislation was a stepwise 
process in Uruguay – initially, only the hospitals were required to be 100% smoke-free 
(2004), followed by addition of all public offices (2005) and then all indoor workplaces 
and public places (2006).64 An apex group, the National Commission on Tobacco 
Control was set up to look after and guide all the aspects of tobacco control, which 
consisted of members from the Government as well as the civil society, and which was 
very active in tobacco control in Uruguay. This group also established links with the 
University of Waterloo’s Tobacco Control Policy evaluation project (ITC project) which 
provided information about the prevalence of tobacco use and also conducted an 
evaluation of the tobacco control policy in Uruguay.65 The enforcement of SFL is 
implemented by the Government (Ministry of Health) while the citizens act as watchdogs 
and facilitate the implementation. Violations of the SFL are subject to heavy penalties, 
imprisonment, and closure of the hospitality venue in question. Therefore, there is a high 
level of compliance with SFL in the hospitality venues (90%) and at workplaces (70-
80%) in Uruguay.66  
 
The media was utilised effectively throughout this campaign. In order to address the 
issue of compliance following implementation, raise awareness about the policy and 
create a social norm for smoke-free air, the Government launched the ‘One Million 
Thanks’ campaign wherein over a million signatures were collected thanking the 
smokers for not smoking in public places.64 The nationwide campaign was launched by 
the President himself. Another campaign was ‘Smoke-free Uruguay’ which was 
launched on the World No Tobacco Day in 2006 to launch a logo for smoke-free 
environment.64 Various strategies such as posters, brochures, and radio/television spots 
were used in this campaign.  
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Research evidence from Uruguay has shown that the SFL has a high level of support 
from the general public. An opinion poll conducted nine months after implementation of 
the policy showed that 95% of the participants supported 100% smoke-free 
environments including 92% of the smokers.64 Uruguay also implemented a number of 
other evidence-based tobacco control measures along with the SFL from 2005. Between 
2005 and 2011, the prevalence of smoking in Uruguay reduced by 3.3% and the number 
of cigarettes smoked per person reduced by 4.4% per year.66 Between 1998 and 2012, 
the prevalence of smoking in Uruguay reduced from almost 50% to 20%.66 
Comprehensive SFL in Uruguay has been shown to be more effective than weaker 
policies (e.g. in some Mexican cities) in reducing exposure to SHS.67 Two studies 
conducted after implementation of the SFL in Uruguay have shown that AMI admissions 
in hospitals reduced by 22% and 17% after 2 years and 4 years respectively.68, 69 
 
2.1.4.3. Case study: Smoke-free legislation in Brazil 
Brazil is the world’s largest country to have a comprehensive SFL since December 15, 
2011, when the then President of Brazil signed it into law.70 Brazil strengthened its SFL 
along with other tobacco control measures progressively. DSRs were allowed at certain 
collective places in 1996, all aircraft and public transport went smoke-free in 2000, and 
all indoor workplaces and public places went 100% smoke-free in 2011.71 Three national 
agencies played an important role in the tobacco control policy formulation, 
strengthening, implementation and enforcement since 1999 in Brazil: an inter-ministerial 
National Commission for Tobacco Control, the National Agency for Sanitary Surveillance 
(ANVISA) (governs product and content regulation) and the Ministry of Finance (governs 
taxation).22 Evidence of the effect of tobacco control policies on smoking prevalence and 
their attributable fractions have been estimated through research conducted in Brazil. As 
a result of the periodic strengthening of its tobacco control policies including the SFL, 
adult smoking prevalence in Brazil has been declining steadily since 1989.72, 73 Between 
1989 and 2008, adult smoking prevalence reduced by half from 35% to 18.5%, which 
prevented over 0.4 million premature deaths.72, 73 The SimSmoke (simulation) model 
predicted that among all the tobacco control policies implemented in Brazil, tobacco 
price rise was responsible for most of the reduction in smoking (46%), while the next 
largest measures were SFL and marketing restrictions (14% reduction through each).74 
Thus, SFL, in conjunction with other strong tobacco control measures such as price 
increases, restriction on tobacco advertising, promotion and sponsorship, strong and 
large pictorial health warnings on tobacco packs, tobacco cessation facilities and 
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tobacco product regulation have the potential to greatly reduce smoking in LMICs such 
as Brazil, when they are effectively implemented and enforced.  
 
2.1.5. Benefits of smoke-free legislation 
Evidence, mostly from HICs, demonstrates that comprehensive smoke-free laws are 
effective in improving air quality and population health, reducing the prevalence and 
intensity of smoking and exposure to SHS, and increasing the quit rates. In HICs, SFL 
has also been shown to be beneficial to the business and economy contrary to the 
tobacco industry claims of losses following implementation of SFL. As more and more 
LMICs implement SFL, the evidence is gradually emerging from these countries 
although rigorous, high-quality pre- and post-intervention evaluation studies are often 
lacking.  
 
2.1.5.1. Impact on air quality and secondhand smoke exposure 
Semple et al. studied the concentrations of particulate matter less than a diameter of 2.5 
micrometres (PM2.5) (a good marker of SHS in indoor places where there are no other 
sources of combustion) in bars of England, Wales and Scotland before and up to 12 
months after implementation of comprehensive SFL.75 They observed that in all of these 
countries, there was a significant reduction in the PM2.5 concentrations post-
implementation of the law, in the order of 84%-93%.75 Similar improvements in the air 
quality have been observed in studies undertaken in New York,76 Ireland,77 and 
Ontario.78 Pre- and post-implementation evaluation of the SFL implemented in 2007 in 
Israeli bars, pubs and cafes suggested that post-implementation, there was a significant 
34% reduction in the PM2.5 concentration, a 10% decline in the number of smoking 
patrons in these venues and an increase in the number of non-smoking venues.79 A 
similar pre- and post- SFL evaluation conducted in 21 hospitality venues of Cyprus has 
shown that within 2-4 months of implementation of the smoke-free law, the particulate 
matter in hospitality venues reduced significantly by 98%.80 
 
Another study was conducted in 2011 at nine busy airports across the US (five allowed 
smoking in the DSRs at airports and four were completely smoke-free) which involved 
measurement of the PM2.5 concentrations at different locations in these airports.81 
Results of the study showed that DSRs at airports where smoking was allowed, had 16 
times higher mean concentrations of PM2.5 compared with the non-smoking areas of 
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these airports and 23 times higher compared with the airports that were completely 
smoke-free.81 Moreover, PM2.5 concentrations in the areas immediately adjacent to 
DSRs of airports that allowed smoking were four times higher than the average levels in 
non-smoking areas of these airports and five times higher than the average levels in 
non-smoking airports.81 These results suggest that separate DSRs and ventilation 
systems are not effective in removing the tobacco smoke which gets dissipated to the 
non-smoking areas of these venues, resulting in high concentrations of the harmful 
particulate matter throughout the venue. Only 100% smoke-free air would offer complete 
protection against SHS exposure to the non-smokers.  
 
A study was conducted in Uruguay, which assessed changes in air nicotine 
concentrations at public places and workplaces, to evaluate the impact of 
comprehensive SFL introduced in the country in 2006.82 It was observed that a year 
after the introduction of comprehensive SFL, there was 91% reduction in air nicotine 
concentration across the sampled venues (compared with concentrations in 2002), with 
greatest reductions observed in schools and airports, followed by hospitals, government 
buildings, and restaurants/bars.82 Another study conducted in Sao Paulo, Brazil 
assessed changes in carbon monoxide (CO) levels (in the environmental air and in the 
air exhaled by hospitality venue workers) in its hospitality venues to study the effect of a 
state level SFL introduced in 2009.83  Significant reductions were observed in CO levels 
from pre- to post-ban in indoor areas (4.57 to 1.35 ppm), semi-open areas (3.79 to 1.16 
ppm), smoking employees (15.78 to 11.50 ppm) as well as non-smoking employees 
(6.88 to 3.50 ppm).83 There are studies from other LMICs such as Turkey,84 India,85 and 
Argentina,86 which report changes in the air quality following SFL implementation but 
seem to suffer from methodological issues and lack of rigour. Hence, the results need to 
be interpreted with caution. 
 
Smoke-free laws have also been shown to reduce exposure to SHS among the general 
public (including children) and especially among the hospitality industry workers. Studies 
have assessed the hospitality industry workers for self-reported or measured respiratory 
symptoms and cotinine levels (in saliva, urine, serum or hair) as markers of exposure to 
SHS.87 In a pre-post SFL evaluation study conducted with 77 asthmatic and non-
asthmatic bar workers in Scotland, it was shown that within one and two months of 
implementation of the smoke-free law, there were significant reductions in respiratory 
symptoms (coughing, wheezing, shortness of breath and phlegm) and sensory 
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symptoms (eye and throat irritation, sneezing, runny and itchy nose) by 26% and 32% 
respectively.88 Significantly improved lung function, reduced serum cotinine and 
improved quality of life (among asthmatics) were also observed following 
implementation of the SFL.88 Similar improvements in respiratory symptoms, lung 
function and reduction in cotinine levels have been observed among the hospitality 
industry workers in other studies undertaken in Ireland77 and California89 after the 
implementation of SFL. 
 
Two studies conducted with adult participants and primary school children after the 
implementation of Scotland’s SFL in 2006 suggested that within one year after the law 
went into effect, there was a 39% reduction in SHS exposure in both groups (determined 
by salivary cotinine concentrations).30, 90 Moreover, it was observed that the fall was 
greater in participants who lived either in homes with low or no SHS exposure. 
Participants also noted the greater reduction in SHS exposure at restaurants/cafes, 
pubs (among adults), public transport and workplaces (among adults). Similar 
reductions in SHS exposure following implementation of the SFL have been observed in 
other countries such as Spain,91 New Zealand,92 and the US.93 Among LMICs, a study 
was conducted with 80 bar and restaurant workers in the city of Nequen, Argentina 
which showed that after three months of implementation of 100% SFL, there was a 
significant reduction in SHS exposure among these workers.94 It was observed that 
there were significant reductions in respiratory symptoms (57.5% pre-SFL to 28.8% 
post-SFL), and sensory irritation symptoms (86.3% pre-SFL to 37.5% post-SFL) among 
these workers; while there were significant improvements over the same period in forced 
vital capacity as observed through spirometry.94  
 
2.1.5.2. Impact on smoking prevalence, intensity and quitting  
Smoke-free laws have also been shown to be associated with a decrease in the 
prevalence of smoking and an increase quit rate.95-97 In a secondary analysis of 
repeated cross-sectional health survey data (2003-2008) from about 54,333 British 
adults, it was observed that after the introduction of SFL in 2007, there was a significant 
decrease in the prevalence of smoking at work from 14% to 2%, inside bars or pubs 
from 34% to 2%, inside canteens, restaurants, and cafes from 9% to 1% and at homes 
from 65% to 55%.98 Another study conducted in the US as part of the Community 
Intervention Trial for Smoking Cessation (COMMIT) trial with smoker employees 
suggested that those working in smoke-free workplaces were 2.3 times more likely to 
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quit smoking and smoked on an average 3.85 lesser cigarettes compared with those 
who were employed in workplaces where smoking occurred.95 In England, in response 
to the SFL, quit attempts among smokers did increase temporarily.99 In the first five 
months following implementation of the SFL, 19% of the smokers who made a quit 
attempt did so in response to the SFL.99 A study conducted in China also showed 
reduction in the prevalence and volume of smoking, and higher quit attempts among 
workers employed in a smoke-free workplace (vs. those working in the workplace where 
only some restrictions were in place), a major limitation being that it was conducted in a 
single multi-national company.100 
 
2.1.5.3. Impact on attitudes and social norms around secondhand smoke 
exposure and support for smoke-free legislation 
Studies from HICs suggest that SFL may change attitudes and social norms about 
exposing others to SHS at home,32-34 as well as in private vehicles.36 Cheng et al. 
conducted secondary analysis on data from tobacco use supplement to current 
population survey (TUS-CPS) (1992-2007) from the US and found that among the 
people living with smokers, living in smoke-free homes was seven times more likely 
when they were living in a county with100% smoke-free workplaces (compared with 
those living in counties with partial or no smoke-free workplaces).33 Among the people 
not living with smokers, the odds were four times.33 Another cohort study assessing the 
impact of SFL on smoking behaviour found similar reductions in smoking at home after 
the introduction of comprehensive SFL in Ireland (85% to 80%; p=0.002) and the UK 
(82% to 76%; p=0.003).35 Further, a more recent study conducted in the US has shown 
that 100% smoke-free indoor air laws increase the likelihood of having voluntary smoke-
free homes by 5% and smoke-free cars by 4%.36 Among LMICs, only one study from 
India has been published which used the GATS data and suggested that those 
employed indoors in a smoke-free workplace are twice as likely to have a smoke-free 
home.37 There is a need for further research on this aspect in LMICs. This is important 
because, in certain cultures in LMICs, tobacco smoking is deeply rooted in the cultural 
context and is highly socially acceptable which can act as a hindrance to effective 
tobacco control in that society. Research from HICs indicates that SFL changes social 
norms around exposing others to tobacco smoke, which is why in such settings people 
are also adopting voluntary smoke-free policies at homes and in cars contrary to the 
tobacco industry claim that SFL would increase smoking in homes.  
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The growing support for and popularity of smoke-free laws have also been studied 
earlier in the developed countries.101  In the study conducted by Fong et al. in Ireland, 
significantly more adult smokers supported smoke-free laws in bars/pubs (from 13% 
pre-ban to 46% post-ban), restaurants (from 45% pre-ban to 77% post-ban) and 
workplaces (from 43% pre-ban to 67% post-ban), one year after implementation when 
compared to before implementation.35 The evaluation of SFL in France suggested that 
support for SFL increased significantly after its implementation and has remained so 
even five years after.102 Similar support in favour of the SFL has been observed in other 
countries such as the US, New Zealand, and Scotland.101 In LMICs as well, strong 
support for smoke-free policies has been documented. Surveys in Brazil after 
implementation of SFL have shown that 85% of the people favoured smoke-free public 
places and 83% supported smoke-free restaurants while a poll conducted in urban 
Uruguay after implementation of 100% SFL has shown that 80% of its population 
supported this policy measure.103  
 
2.1.5.4. Impact on business and economy 
The tobacco industry tried to perpetuate the myth that SFL would harm the businesses 
particularly, the hospitality business and would cause damage to national economies. In 
the earlier section on harms of tobacco smoking and SHS exposure, the economic cost 
related to buying tobacco products (for the user), the healthcare cost of treatment of 
smoking related diseases and the indirect costs were discussed. These costs far 
outweigh the benefits due to the revenue that tobacco generates. For example, in 
England, the total cost of tobacco smoking to the society in 2015 was estimated to be 
£13.9 billion per year, including the direct and indirect costs, while the revenue 
generated through tobacco taxation was estimated to be £12.3 billion per year.104 
Similarly, in India, the revenue generated through tobacco amounts only to 17% of the 
total economic cost of tobacco use.15 As per the evidence described earlier, SFL leads 
to reduced smoking and exposure to SHS and increased quit rates and would, therefore, 
lead to a decline in the economic cost of tobacco smoking. SFL in that sense would only 
be beneficial to the economy as the loss of revenue would be offset by greater savings 
on the economic cost of tobacco smoking.  Apart from this benefit, studies conducted in 
HICs have shown that absenteeism is higher among smokers than non-smokers and 
that smoker employees take longer breaks in between their work.105 Smoke-free 
workplaces are more likely to require less maintenance and repairs and have a lower 
likelihood of catching fires due to cigarette butts.105 Three large reviews studied the 
economic impact of SFL in 2003,31 2005,106 and 2009,21 and consistently reported that 
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such policies do not have a negative impact on the business profits, and revenue or 
employment (particularly at hospitality venues). In fact, an increase in profits and 
business following implementation of the SFL has been well-documented in the middle- 
and high-income countries (e.g. Mexico City,107 Argentina,108 the US,109 and New 
Zealand110).  
 
2.1.5.5. Impact on health outcomes 
Initial research studying the impact of SFL on health outcomes started from the year 
2004 onwards, which focused on reduction in hospital admissions for AMI among adults 
after implementation of the SFL in Helena (Montana),111 Pueblo (Colorado),112 and 
Piedmont (Italy).113 Khuder et al. studied the impact of SFL in Bowling Green, Ohio, on 
adult hospital admissions due to ischemic heart disease (IHD) (including AMI, and other 
heart conditions such as angina) and heart failure.114 The results of the Helena 
(Montana) study which showed a 40% fall in AMI admissions due to the SFL were 
particularly criticised due to its small sample size (304 cases) resulting in wide 
confidence intervals (CIs) for the point-estimates.111 Dinno and Glantz compiled 
evidence from these early studies (from the US and Italy) in a meta-analysis and 
concluded that the SFL led to a 27% reduction (RR 0.73 95% CI 0.56-0.89) in hospital 
admissions due to heart disease (including IHD and heart failure).115 Later, three meta-
analyses conducted in 2008 (19% reduction),116 2009 (17% reduction),117 and 2013 
(23% reduction)118 reported significant but lower reductions in the risk of AMI following 
SFL implementation. Two other meta-analyses reported a 10% and 12% reduction in the 
risk of acute coronary events (this included in addition to AMI, ACS, coronary heart 
disease including angina and heart failure, and IHD) following introduction of 
comprehensive SFL119 and SFL,120 respectively. Jones et al. further observed that the 
reduction was much higher in locations with comprehensive SFL (14% reduction) 
compared with locations which had partial SFL (8% reduction).120  
 
Callinan et al. conducted a systematic review to assess the impact of SFL on multiple 
parameters (smoking, exposure to SHS, ACS hospitalizations, respiratory and sensory 
symptoms among the hospitality industry workers and others) in 2010.28 For the health 
outcomes, twelve studies describing the impact of SFL on hospital admissions or deaths 
due to ACS were included up to the year 2009. Ten studies showed a positive impact of 
the SFL on hospital admissions (reduced admissions post-SFL); one study showed 
reduced deaths due to ACS whereas another study showed better prognosis following 
49 
 
ACS among non-smokers.28 The most recent systematic review, Frazer et al. was an 
update of Callinan et al.’s review and reported the impact of SFL on multiple health 
outcomes e.g. cardiovascular, respiratory and perinatal outcomes and observed a 
consistently positive impact of national SFL on reducing adverse cardiovascular 
outcomes (ACS/AMI/stroke), asthma, lung function, and mortality associated with 
smoking-related illnesses.27 The effects of SFL on COPD and perinatal health were 
inconsistent; while they reported significant health benefits among the countries with 
comprehensive SFL compared to countries with partial SFL. Frazer et al. also report the 
relevant impact of SFL on health outcomes among the sub-groups (mostly age and 
gender) for cardiovascular outcomes.27 While they present some indicators for SES, the 
impact of SFL on socioeconomic inequalities in health outcomes has not been 
discussed in detail.  
 
A study was conducted in Uruguay using data from 37 hospitals to assess the impact of 
its 100% SFL introduced in 2006 on hospital admissions for AMI.69 It was observed that 
two years after the introduction of SFL, there was a significant decline in hospital 
admissions for AMI by 22% overall (compared with hospitalizations in the two years prior 
to the legislation), and across all sub-groups (private/public hospitals, men/women and 
age groups).69 Another study was conducted in Santa Fe (implemented 100% SFL in 
2006) and Buenos Aires (implemented partial SFL) (Argentina) to assess the impact of 
the legislation on hospital admissions due to ACS.121 There was a significant 13% 
decline in ACS hospitalizations in Santa Fe immediately after the intervention, followed 
by a sustained decline; no immediate or sustained decline was evident in Buenos Aires, 
indicating that 100% SFL was more effective in reducing ACS hospitalizations compared 
with partial SFL.121  
 
Apart from its impact on adult health outcomes, evidence of the impact of SFL on child 
and perinatal health outcomes has also been steadily accumulating. Been et al. 
conducted a meta-analysis of studies published between 1975 and 2013 and studied the 
effect of SFL on three outcomes: low birth weight, pre-term delivery and hospital 
attendance for asthma.29 Out of the 11 studies from Europe and North America included 
in the meta-analysis, it was observed that SFL was associated with significantly reduced 
hospital admissions for pre-term births (10.4% reduction; four studies) and 10.1% 
reduction in hospital admissions for asthma (three studies).29 Another study conducted 
by Been et al. in 2015 studied the impact of England’s SFL on childhood admissions for 
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respiratory tract infections (RTIs) using the Hospital Episode Statistics database.122 It 
was observed that immediately following the implementation of SFL, there was a 3.5% 
reduction in RTI admissions of which, 13.8% were attributable to lower RTI. The decline 
in upper RTI was more gradual and occurred at the rate of 1.9% per year after 
implementation of the SFL.122  
 
The benefits of SFL probably primarily accrue due to the reduction of active smoking 
and reduction of SHS exposure in public places. However, the benefits may also partly 
arise due to a change in social norms around exposing others to SHS. Early on, there 
were concerns that SFL would lead to behavioural compensation and therefore, would 
lead to increased smoking in private places such as homes. Research mostly conducted 
in HICs,32-35 and in India,37 have shown that these concerns have not materialised as 
those employed in smoke-free workplaces have been shown to be more likely to stay in 
smoke-free homes. This evidence indicates that SFL may positively alter social norms 
around exposing others to SHS or improves the sensitivity of smokers towards exposing 
non-smokers to tobacco smoke.  
 
2.1.6. Challenges to implementation and evaluation of smoke-free legislation 
 
2.1.6.1. Political economy 
Despite the availability of evidence about the benefits associated with SFL and other 
evidence-based tobacco control policies, their implementation and enforcement in the 
majority of LMIC settings remain inadequate. Bump and Reich suggest that this is 
mainly due to a lack of LMIC specific research that looks into the political economy for 
tobacco control.38 According to the authors, politics, tobacco, wealth, economy, and 
power are highly interlinked and can act as hindrances to tobacco control (including the 
SFL) if not properly researched. Further, the authors suggest that providing traditional 
information, education, and communication to most stakeholders is not enough and 
requires proper analysis of the politics and economics of tobacco. The authors describe 
five relevant policy areas and suggest that a political economy analysis in these could 
open up opportunities for effective tobacco control. The five policy areas are: 1) a lack of 
information among the general public and relevant policymakers about the harms of 
tobacco use, which is further clouded by misinformation campaigns and interference by 
transnational tobacco companies 2) multi-national and national tobacco trade and 
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related disputes 3) smuggling of tobacco products 4) industry interference to raising 
taxes and SFL and 5) conflicting priorities of various ministries or departments within the 
Government.38 An editorial by leading tobacco control advocates has described how the 
tobacco industry tries to interfere with tobacco control measures by engaging in 
consultations or agreements with Governmental agencies or policymakers (for example 
in Pakistan, India, and Laos).123 Such involvement of the tobacco industry in public 
health matters derails and definitely delays the implementation and enforcement of 
strong tobacco control measures including comprehensive SFL.123 In addition to tobacco 
industry interference,124 specific challenges to the implementation and enforcement of 
SFL in LMICs are: the lack of required enforcement capacity and resources, and gaps in 
knowledge about the harmfulness of tobacco use and SHS exposure.39 Lax enforcement 
of the smoke-free laws, a lack of political will and a tedious policy formulation process 
are the other barriers.40  
 
2.1.6.2. Tobacco industry generated myths 
After the evidence about harms of tobacco smoke became well-established and people 
started supporting the SFL, the tobacco industry recruited ‘ventilation experts’ to 
propagate the myth that ventilation could be a better alternative to 100% smoke-free air. 
However, scientific studies have revealed that this is a myth and that ventilation systems 
are neither feasible nor effective in protecting non-smokers from exposure to SHS.21 
Only comprehensive SFL can protect non-smokers from such exposure. Despite the 
existing evidence of the ineffectiveness of ventilation systems, several public places in 
HICs as well as in LMICs continue to have such ventilation systems to remove the 
tobacco smoke from enclosed rooms. Another well-known myth that was propagated by 
the tobacco industry was that SFL would lead to substantial economic losses to the 
concerned businesses e.g. the hospitality industry, including restaurants and bars, which 
was also supported by some industry-sponsored research. A systematic review was 
conducted by Scollo et al. to study the economic impact of SFL on the hospitality 
industry.31 The authors observed that 94% of the studies which reported a negative 
impact of SFL were industry sponsored. Such studies were several times more likely to 
report a subjective outcome and were several times less likely to be peer-reviewed 
(compared with the non-industry sponsored research). The best quality studies 
demonstrated either a neutral or a positive effect of the SFL on restaurant and bar sales 
or employment.31 Such myths are often used (successfully in several LMICs) to delay 
and dilute strong SFL, often leading to exemptions (for public places such as bars, 
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restaurants, hotels), resulting in the implementation of partial SFL which has been 
shown to be ineffective.21, 23 
 
2.1.6.3. Knowledge gaps around harms of secondhand smoke among the 
general public 
A report combining findings from the International Tobacco Control Policy Evaluation 
(ITC) Project and the Global Tobacco Surveillance System (GTSS) showed that 
knowledge of harms associated with exposure to SHS is low in HICs as well as in 
LMICs.39 The ITC study follows cohorts of smokers, ex-smokers and non-smokers in 
around 20 countries (both HICs and LMICs) through surveys while the GTSS surveys 
adults, youth, health personnel and school personnel through separate surveys in 
multiple LMICs. Further details about GTSS are described in chapter 4. The ITC report 
showed that over 50% of the smokers in Viet Nam and China are unaware of the fact 
that exposure to SHS leads to heart disease.39 Further, even in HICs such as Australia, 
Canada, UK and the US, almost 50% of the smokers are unaware of the fact that their 
smoking can lead to heart disease among non-smokers exposed to SHS around them.39 
Such lack of knowledge in the general public could lead to a lack of support for SFL as 
they are not likely to be aware of the benefits associated with comprehensive SFL.  
 
Some of the lack of knowledge among the politicians might be genuine whereas part of 
it may be construed as a result of interactions with the tobacco industry. For example, 
when large pictorial health warnings were proposed by the Government of India, 
consultation of a Parliamentary committee with the tobacco industry before 
implementation of large warnings led the Chair of the committee to comment that there 
was no Indian evidence that tobacco use was associated with cancer and that the 
current laws were based on studies conducted in other countries.123 This was despite 
the fact that there have been numerous case-control and cohort studies conducted in 
India which have conclusively documented that tobacco causes different types of 
cancers. It is also a widely known and a scientifically proven fact.  
 
2.1.6.4. Newer and alternative types of tobacco products and smoke-free 
legislation 
Globally, electronic cigarettes (e-cigarettes) are the most popular form of electronic 
nicotine delivery systems (ENDS) that do not burn tobacco but use a vaporised mixture 
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containing nicotine that is inhaled by the user. The e-cigarette liquid (that is vaporized by 
inhalation) comprises of nicotine, propylene glycol, with or without glycerol and 
flavouring agents.125 The tobacco industry claims that it can be used safely in enclosed 
spaces without exposing the non-smokers to SHS; alternatively, it can also be used as a 
cessation product by delivering nicotine to the smoker without actual tobacco smoking. 
A recent review which studied the effects of e-cigarettes, its constituents and its policy 
implications suggests that e-cigarettes contain substances such as carbonyl compounds 
in concentrations which can be cardiotoxic.126 Further, nicotine itself can cause 
hemodynamic and metabolic changes that can increase the risk of cardiovascular 
events.126 The review concluded that e-cigarettes are not safe to be used as cessation 
products or as harm reduction alternatives.126 Despite the existing evidence and the 
WHO recommendations to regulate the sale of e-cigarettes, these products are rapidly 
becoming popular. Twenty-three countries have completely banned the sale of e-
cigarettes including Brazil, Uruguay, Thailand, Seychelles, Singapore and the majority of 
countries of the Middle-East.127 As of February 2016, 71 countries across the globe 
regulate e-cigarettes in one or the other way.128 Only three countries have completely 
banned the use of e-cigarettes in public places (Cambodia, Jordan, and the United Arab 
Emirates).127 There is, however, no global consensus yet on whether these products 
should be covered under the SFL.   
 
There have also been concerns about violations of the SFL in Hookah/Shisha bars. 
Hookah or Shisha use typically entails passing tobacco smoke through water before it is 
inhaled. Flavoured varieties with or without added tobacco are also available in the 
market. It is believed to be a safer variety of smoked tobacco as smoke first passes 
through water before being inhaled; however, the smoke contains the same harmful 
chemicals and is not a safer product.129 Hookah/Shisha bars are known to flout the SFL 
and their employees have been known to be exposed to high SHS concentrations. 
Being a product of the Middle-East, which has also become popular in the developed 
settings, violations of the SFL by Hookah bars have been reported from both HICs as 
well as LMICs.130-132 Hookah/Shisha bars need to be subject to the same SFL as other 
indoor workplaces/public places in countries which have implemented the smoke-free 
laws.  
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2.1.6.5. Lack of data and research from LMICs 
Monitoring of tobacco use and prevention policies (including the SFL) is recommended 
by the WHO for effective tobacco control.23 Article 20 of the WHO FCTC requires Parties 
to establish tobacco surveillance systems in respective jurisdictions to monitor tobacco 
use and SHS exposure, its patterns, determinants, and the associated health and 
economic consequences.16 GATS and Global Youth Tobacco Survey (GYTS) are the 
examples of national surveillance systems to regularly monitor tobacco use using 
validated scientific methods.133 Other independent research studies can complement 
such data collection efforts. However, a majority of the countries of the world still have 
no data or partial and infrequent data while only 65 countries (28 of these, LMICs) of the 
world covering 30% of the world’s population have recent, periodic and representative 
data available.23 Monitoring systems are still weak in many LMICs while tobacco use in 
these countries is rising.134 Out of the 77 studies included in the recent review by Frazer 
et al., which studied the impact of SFL on smoking, exposure to SHS and health 
outcomes, only two studies (2.6% of total studies) were from LMICs (Panama and 
Turkey).27 The resulting lack of research evidence on the prevalence and other aspects 
related to SHS exposure including the effectiveness of SFL in LMICs acts as a barrier to 
more widespread adoption of SFL in these settings. 
 
2.1.7. Facilitators to implementation of smoke-free legislation 
 
2.1.7.1. Health and economic benefits of smoke-free legislation 
Even though there are numerous barriers to implementation and evaluation of SFL in 
LMICs, several facilitating factors also exist which can ensure that comprehensive SFL 
is implemented in these settings. As outlined in the earlier sections, there are 
spectacular health benefits associated with implementing the SFL among children 
(reduced pre-term deliveries, emergency hospitalisations for asthma) as well as among 
adults (mortality and hospitalisations due to cardiovascular and respiratory diseases). 
Kalkhoran and Glantz estimate that even a 10% reduction in the emergency department 
visits due to asthma and hospital admissions due to the implementation of SFL and 
other tobacco control laws could generate savings of US$ 7 billion annually for the US 
and Europe collectively.41 Generally, it is assumed that the return on investing in 
tobacco control initiatives such as the SFL would give delayed returns in the form of 
improved health and economic gains, making the politicians hesitant to implement such 
policies. Contrary to this belief, there is evidence that the returns are incredibly fast. 
Kalkhoran and Glantz exemplify this through California’s tobacco control programme 
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which provided a 100 fold economic gain on the investment between 1989 and 2008 
(investment-US$ 2.4 billion; gain-US$ 243 billion).41 The health and economic gains due 
to the implementation of SFL and other tobacco control policies, therefore, provide a 
strong justification in their favour for the LMIC settings.  
 
2.1.7.2. Tobacco control advocates and organisations 
Several LMICs have a strong presence of one or more civil society groups/organisations 
actively working in the field of tobacco control or even national tobacco control bodies 
(as a part of the public sector). For example, in India, there is a National Tobacco 
Control Cell (NTCC) which is involved in policy planning, mass media campaigns, 
product regulation, monitoring, and surveillance as well as capacity building for tobacco 
control initiatives.135 Apart from this Government agency, there is a coalition called the 
Advocacy Forum for Tobacco Control (AFTC), which is a collective of health 
professionals, public health experts, researchers, as well as various Indian non-
governmental organisations (NGOs).136 AFTC is active in the field of tobacco-related 
advocacy, research, capacity building and awareness generation. In Brazil, there is the 
National Commission for implementation of FCTC (CONICQ) as well as the National 
Agency for Sanitary Surveillance (ANVISA) (product regulation) which are entrusted with 
responsibility for effective tobacco control.22 In the US and South America, the American 
Non-smoker’s Rights Foundation is actively working to protect the non-smokers from 
tobacco smoke at various levels of Government and through various action-oriented 
initiatives/programmes.137 Apart from such groups/organisations, agencies such as the 
WHO and various UN bodies have a presence in several LMICs in the form of regional 
offices. They also work in close collaboration with the Health Ministries or the Health 
Departments of several countries which can leverage their technical expertise in relation 
to tobacco control, including implementation and evaluation of the SFL. Such groups 
and organisations actively working in the field of tobacco control in the LMIC settings 
represent a huge opportunity for implementation of comprehensive SFL and other 
tobacco control policies.   
 
2.1.7.3. Pre-existing tobacco control policies and programmes 
Several LMICs have pre-existing tobacco control policies, including the SFL. The WHO 
notes that in the majority of LMIC settings, SFL is not comprehensive as several 
exemptions (at public places such as bars, restaurants, hotels, airports, etc.) exist to 
100% smoke-free policies.23 However, based on the available research evidence, these 
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countries can easily strengthen their SFL by adding one or more exempted public places 
to their list of smoke-free public places and thereby move progressively towards 
implementing comprehensive SFL. For example, the Government of India is planning to 
remove exemptions which currently allow DSRs at hotels with more than 30 rooms and 
restaurants with more than 30 seats.138 Once this has been done, India will only be one 
step away from comprehensive SFL, as DSRs will still be permitted at the airports. Apart 
from this, some LMICs such as Brazil and India have existing national-level tobacco 
control programs which have already incorporated all or several of the WHO FCTC 
provisions including Article 8 (protection from exposure to tobacco smoke).22, 135 
Dedicated resources have been earmarked for implementation of activities under these 
national tobacco control programmes. Such pre-existing laws and programmes 
represent an opportunity to strengthen the existing tobacco control legislation/activities 
in the LMIC settings.  
 
2.1.7.4. Increasing public support for smoke-free legislation and tobacco 
control 
A few decades ago, tobacco control was not even the topic of debate in LMICs. This 
scenario in LMICs has changed over the years and people are now increasingly talking 
about tobacco-related issues and policies. Results from a longitudinal study (ITC 
Project) conducted with adult smokers from seven cities in China show that between 
2007 and 2012, the support for complete smoking ban in indoor workplaces, restaurants 
as well as bars has grown steadily in all the seven cities.139 The authors observed that 
the support for strong SFL was higher than that observed before the implementation of 
comprehensive SFL in Ireland, implying that China is now ready for implementation of 
comprehensive SFL.139 Another study conducted with participants aged 14 years and 
above in Ashanti region of Ghana (in 2011) showed that awareness of the health risks of 
tobacco smoke exposure and support for comprehensive SFL (97%) was very high 
among the participants.140  Similarly, strong support for comprehensive SFL after its 
implementation has been observed among the countries of Latin America such as 
Uruguay, Brazil, and Mexico.141 Such increasing support for SFL in LMICs represents 
increasing acceptance of SFL by the public and therefore, an opportunity to implement 
comprehensive SFL or to strengthen existing SFL.  
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2.2. Rationale and justification for this thesis 
Although globally there has been a decline in the age-standardized death rates and 
disability rates associated with smoking and SHS exposure from 1990 to 2015 as shown 
by the recent GBD study,1 LMICs (majority of them still in stage II and III of the tobacco 
epidemic) are still expected to be affected by major health and economic adverse 
consequences attributable to tobacco smoking in the future, as 80% of the world’s 
smokers reside in these settings.2 The healthcare costs of treating tobacco-related 
diseases and the resulting indirect costs are extremely high and several times higher 
than the revenues generated through the tobacco business. Such huge economic losses 
are unaffordable for any country, particularly the resource poor LMICs. Therefore, there 
is an immediate need for these countries to take appropriate tobacco control measures 
(consistent with the WHO FCTC) including protection of the people from exposure to 
tobacco smoke through the adoption of comprehensive SFL.16  
 
Despite the growing evidence about the adverse consequences of smoking and SHS 
exposure, as well as effectiveness of the SFL (in reducing smoking, SHS exposure, 
morbidity and mortality associated with exposure to tobacco smoke, a positive effect on 
the hospitality business and related employment as well as on social norms and 
attitudes),21, 27 implementation and enforcement of SFL (along with other tobacco control 
measures) remains weak in several LMIC settings compared with the HIC settings.23 
Among several barriers to implementation of SFL in the LMIC settings, a key factor is 
inadequate monitoring mechanisms resulting in the lack of data, research, and 
evaluation. Therefore, there is a lack of evidence to ascertain whether the same health 
and economic benefits of SFL accrue in the context of LMICs as observed in HICs. For 
example, socioeconomic inequalities are clearly evident in HICs where smoking and 
exposure to SHS is higher among the poorer or low SES groups compared with the rich, 
indicating the need for targeted tobacco control strategies including comprehensive 
SFL.6, 7 There is limited evidence from LMICs on socioeconomic inequalities in exposure 
to SHS. Further, there is yet insufficient and unclear evidence on the impact of SFL on 
socioeconomic inequalities in health outcomes. As tobacco smoking and SHS exposure 
can increase health inequalities, it is important to evaluate if SFL only benefits the rich or 
is pro-equity for key health outcomes. If the reduction in morbidity and mortality 
associated with exposure to tobacco smoke is higher among the low SES groups (vs. 
the high SES groups) after implementation of SFL, such legislation may be shown to be 
effective in reducing health inequalities. Research, mostly from HICs shows that the SFL 
is effective in positively altering social norms towards exposing non-smokers to tobacco 
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smoke, therefore resulting in voluntary measures such as smoke-free homes and private 
vehicles.21 This could lead to additional health benefits among the vulnerable women 
and children and the non-smokers through protection from SHS exposure. However, 
there is scant evidence from LMICs in this regard. Some LMICs such as India have 
implemented their tobacco control programmes (with SFL implementation and 
enforcement as a key activity), however, evaluation of the impact of the programme on 
smoking (and therefore exposure to SHS) has not been undertaken and relevant 
implications for the LMIC settings remain unknown.  
 
The lack of research evidence and the resulting weak implementation and enforcement 
of SFL and other tobacco control policies in general, in the LMIC settings, threaten the 
achievement of 25x25 target for reducing premature NCD related mortality,19, 142 and the 
UN SDG Goals which call for ensuring healthy lives and promoting well-being for all at 
all ages as well as reducing inequalities within and among countries.20, 143 This study will 
contribute to the evidence base on what works to strengthen the SFL and tobacco 
control in general, in LMICs and what are the associated impacts of SFL on health 
equity. 
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Chapter 3: Impact of smoke-free legislation on socioeconomic inequalities in 
health outcomes associated with exposure to tobacco smoke among adults  
 
In section 2.1.5.5, the health benefits associated with SFL were described. SFL is 
associated with significant reductions in hospitalizations and mortality due to smoking-
related health conditions particularly, the CVDs and respiratory diseases,27, 28 and the 
benefits are significantly higher with comprehensive SFL compared with partial SFL.27 
As smoking and SHS exposure (in HICs) are known to be higher among the low SES 
groups or the poor, it is likely that the adverse health effects of exposure to tobacco 
smoke are also socially patterned and are higher among the disadvantaged, therefore 
exacerbating health inequalities. According to the UN SDG 10, policies and programmes 
should aim at reducing inequalities.143 Although the health benefits of SFL have been 
extensively studied (mainly in HICs), the equity impact of SFL on health outcomes is not 
yet reported. A systematic review was conducted to examine this aspect as a part of this 
thesis. In this chapter, the systematic review has been described in the form of a 
research paper, which addresses Aim 1 (to study the impact of SFL on socioeconomic 
inequalities in health outcomes related to exposure to tobacco smoke) and Aim 5 (to 
generate research evidence to strengthen implementation and enforcement of strong 
tobacco control policies including comprehensive SFL in the LMIC settings) and the 
corresponding objectives 1, 4 and 5 of this thesis.  
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
61 
 
 
 
 
62 
 
Author Rights and Permissions 
This research paper is intended to be submitted to PLoS Medicine journal.  
 
As this research paper has not been submitted to the journal yet, during submission of 
this thesis, a request for a one-year embargo period on the online electronic version of 
thesis (e-thesis) has been requested from the London School of Hygiene & Tropical 
Medicine library.  
 
PLoS Medicine Licences and Copyright 
If and when this research paper is accepted for publication in PLoS Medicine, the 
following terms shall apply: 
 
PLOS applies the Creative Commons Attribution (CC-BY) license to articles and other 
works we publish. If you submit your paper for publication by PLOS, you agree to have 
the CC-BY license applied to your work. Under this Open Access license, you as the 
author agree that anyone can reuse your article in whole or part for any purpose, for 
free, even for commercial purposes. Anyone may copy, distribute, or reuse the content 
as long as the author and original source are properly cited. This facilitates freedom in 
re-use and also ensures that PLOS content can be mined without barriers for the needs 
of research.  
 
Articles and accompanying materials published by PLOS on the PLOS Sites, unless 
otherwise indicated, are licensed by the respective authors of such articles for use and 
distribution by you subject to citation of the original source in accordance with the 
Creative Commons Attribution (CC BY) license. 
 
Complete details of PLoS journals’ Licenses and Copyrights are available here: 
http://journals.plos.org/plosone/s/licenses-and-copyright)  
 
PLoS journals’ terms of use are available here: https://www.plos.org/terms-of-use 
63 
 
Section D – Student’s role in multi-authored work 
This research paper is authored by Dr. Marhazlinda Jamaludin, Dr. Gaurang P. Nazar, 
Dr. Georgios Tsakos, Prof. Richard G. Watt and Prof. Christopher Millett in this order. I 
am the second author while Dr. Marhazlinda is the first and the corresponding author for 
this manuscript. Two Ph.D. students (myself from LSHTM and Dr. Marhazlinda from 
University College London [UCL]) have contributed collectively and equally for this work. 
Prof. Christopher Millett from Imperial College London is co-supervising me as well as 
Dr. Marhazlinda; while Prof. Richard Watt and Dr. Georgios Tsakos are supervising Dr. 
Marhazlinda at UCL.  
 
 The work was jointly conceptualised by myself and Dr. Marhazlinda under the 
guidance of Prof. Millett (and other supervisors), wherein it was pre-decided and 
agreed upon to undertake this work jointly and with equal contributions from both 
the students. The authorship order was also agreed upon a priori.  
 A draft of the systematic review protocol was developed by Dr. Marhazlinda and 
first shared with me wherein I contributed to editing and revising the protocol, 
and then after an agreement between the two students, the protocol was shared 
with the supervisors. Based on inputs from the supervisors, the protocol was 
further revised, submitted and subsequently published in the PROSPERO 
International prospective register of systematic reviews, University of York, 
Centre for Reviews and Dissemination (PROSPERO 2016: CRD42016035744). 
The protocol is available online from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD4201603574
4 
 A search strategy was developed by the two students jointly for Medline first and 
agreed upon with guidance from the supervisors.  
 Dr. Marhazlinda conducted the database searches. Relevant literature (by title) 
was shared with me from all the relevant databases and other sources including 
a number of previously published systematic reviews and meta-analyses on a 
closely related topic. The two students separately reviewed the titles and the 
abstracts of relevant literature and also the reference lists of previous systematic 
reviews and meta-analyses. 
 The two students separately applied the inclusion/exclusion criteria and then 
came up with a final number of research papers to be included in the study. Any 
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disagreements were resolved through discussion and with the guidance of a third 
reviewer, Prof. Millett.  
 Using appropriate and valid data extraction and quality (risk of bias) assessment 
forms, the two students separately undertook data extraction and quality 
assessment initially. Thereafter, we mutually discussed and agreed upon final 
tables to be included in the study in consultation with the supervisors. Any 
disagreements/queries were resolved in consultation with the third reviewer.  
 Due to heterogeneous nature of studies in terms of geographic locations, SFL 
across countries, health outcomes studied and measures of socioeconomic 
status included in the studies, it was decided as per the guidance of supervisors 
to present a narrative synthesis with a graphical representation (Harvest Plot) 
instead of a meta-analysis.  
 The background, results and discussion section including data synthesis 
presented in this research paper were drafted by me in consultation with Dr. 
Marhazlinda and Prof. Millett. The methods section was initially drafted by Dr. 
Marhazlinda and then revised by me in consultation with Prof. Millett. 
 Work on finalising the research paper for submission to journal is in progress and 
will be completed in the due course.  
 It has been agreed upon between all the authors and the supervisors that the 
draft of this work will be included in the theses of both Ph.D. students (in 
research paper form for my thesis and in the usual book style format for Dr. 
Marhazlinda). 
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* 
3.1. Smoke-free legislation and socioeconomic inequalities in smoking-related 
morbidity and mortality among adults: a systematic review  
 
3.1.1.  Abstract 
 
3.1.1.1.  Objective 
To investigate the impact of SFL on socioeconomic inequalities in smoking-related: a) 
disease-specific morbidity and mortality and b) all-cause mortality. 
 
3.1.1.2.  Data sources 
We searched Medline, Embase, Web of Science, Scopus, CINAHL Plus, DARE, Global 
Health (CAB), Cochrane Central Register of Controlled Trials (CENTRAL), IndMed, 
SciELO, IMEMR, IMSEAR, AMED, LILACS, AIM and KoreaMed from inception to 
September 2016 using detailed search strategies. Reference lists of known credible 
reports, reviews, meta-analyses, and websites closely related to the topic were also 
screened.  
 
3.1.1.3.  Study selection 
All experimental, quasi-experimental or observational studies in English language which 
investigated the impact of SFL (national/state/regional/local or city level; 
comprehensive/partial; with or without a comparison group) in public places on 
socioeconomic inequalities in morbidity and mortality associated with cardiac, 
cerebrovascular, respiratory and other smoking-related diseases among adults ≥18 
years were eligible for inclusion. Cross-sectional, modelling/simulation, cost, and 
qualitative studies were excluded.  
 
3.1.1.4.  Data extraction methods 
Relevant data extraction and quality assessment for risk of bias (using the Cochrane 
EPOC criteria for interrupted time series [ITS] studies and EPHPP criteria for 
observational studies) was undertaken using validated tools by two researchers 
*Jamaludin M, Nazar GP, Tsakos G, Watt RG, Millett C. Smoke-free legislation and socioeconomic 
inequalities in smoking related morbidity and mortality among adults: a systematic review. To be 
submitted in PLoS Medicine. 
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separately and any disagreements were resolved by consultation with a third reviewer.  
 
3.1.1.5.  Data synthesis 
A combination of graphical and narrative methods was used, including a novel matrix or 
‘Harvest Plot’ to test competing hypotheses. The null hypothesis was no SES 
differences (neutral effect) in the effect of SFL; alternative hypotheses were: 1) positive 
effect: greater health benefits among the low SES groups 2) negative effect: greater 
health benefits among the high SES groups 3) mixed effect. A total of eight studies were 
included, all from the high income countries (HICs) (six ITS studies and two before-after 
studies). Five studies reported the impact of national comprehensive SFL; three studies 
reported the impact of partial SFL. Implementation of comprehensive SFL led to either a 
positive effect (3 studies) or no effect (2 studies); partial SFL led to either no effect (2 
studies) or an unclear effect (1 study). The majority of studies had a suitable study 
design and were high-quality studies (except two before-after studies). The choice of 
SES indicator appeared to be important in influencing outcomes. 
 
3.1.1.6.  Conclusions 
Comprehensive SFL has the potential to reduce socioeconomic inequalities in health 
outcomes resulting from exposure to tobacco smoke; partial SFL may not. Research 
from LMICs is lacking. Countries must strengthen their tobacco control policies and 
move towards comprehensive SFL to achieve the UN SDG goals of reducing 
inequalities and premature mortality from NCDs by 2030.  
 
3.1.2.  Introduction 
 
3.1.2.1.  Global burden of secondhand smoke exposure and related harms 
Apart from the adverse health consequences of smoking, exposure to secondhand 
smoke (SHS) is also causally associated with coronary heart disease, lung cancer, 
nasal irritation, stroke and adverse reproductive outcomes (e.g. low birth weight) among 
adults; and middle ear disease, respiratory illnesses and sudden infant death syndrome 
among children.8 As per the Global Burden of Disease (GBD) 2015 study, in the year 
2015, about 0.9 million deaths globally were attributable to SHS exposure, in addition to 
the 6.4 million deaths due to tobacco smoking.1 Deaths due to SHS exposure accounted 
for 1.6% of the global deaths and 1% of disability-adjusted life years (DALYs) lost.1 Most 
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of the deaths and disabilities due to SHS exposure are observed among the women and 
children.1, 56 In 2015, tobacco smoking and SHS exposure collectively, was the third 
leading risk factor for global burden of disease, responsible for 6.9% of DALYs lost.1  
 
3.1.2.2.  Socioeconomic differentials in SHS exposure and resulting health 
inequalities 
Exposure to SHS has been shown to be highest among the children, and the non-
smoking men and women from low- and middle-income countries (LMICs) in European 
and Western Pacific Region (between 50-60%), followed by high income countries 
(HICs) (30-40%) and LMICs of African, South East Asian, American and Eastern 
Mediterranean Regions (10-40%).144 In HICs as well as in the majority of LMICs, it has 
been observed that smoking and exposure to SHS are higher among those belonging to 
the low socioeconomic status (SES) e.g. the less educated and the poor.42, 145-147 Low 
SES groups, therefore, are also more likely to suffer from the adverse health and 
economic consequences of smoking and SHS exposure, thereby resulting in health 
inequalities. 
 
3.1.2.3.  Smoke-free legislation and review evidence of its effectiveness on 
health outcomes 
Guidelines for Article 8 of the WHO Framework Convention on Tobacco Control (FCTC) 
recommend comprehensive smoke-free legislation (SFL) (100% smoke-free 
environments in all indoor workplaces and public places, public transport, and as 
appropriate, other public places), without any exceptions, for complete protection of the 
non-smokers from exposure to environmental tobacco smoke.62 Further, such policies 
should not be voluntary and should not allow the use of designated smoking rooms 
(DSRs) and mechanical ventilation to remove the tobacco smoke, as these have been 
shown to be ineffective.62 By 2014, only 18% of the world’s population was covered by 
comprehensive SFL as per WHO MPOWER report.23 Most of the countries of the world 
still have partial or no SFL.  
 
Initial research studying the impact of SFL on health outcomes started from year 2004 
onwards, which focused on reduction in hospital admissions for acute myocardial 
infarction (AMI) after implementation of SFL.111-113 Dinno and Glantz compiled evidence 
from these early studies (from the US and Italy) in a meta-analysis and concluded that 
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SFL led to a 27% reduction (RR 0.73 95% CI 0.56-0.89) in hospital admissions due to 
heart disease (including ischemic heart disease [IHD] and heart failure)114.115 
Subsequently, three meta-analyses conducted in 2008 (19% reduction),116 2009 (17% 
reduction),117 and 2013 (23% reduction)118 reported significant but attenuated reductions 
in the risk of AMI following SFL implementation. Two other meta-analyses reported a 
10% and 12% reduction in the risk of acute coronary events (this included in addition to 
AMI, acute coronary syndrome (ACS), coronary heart disease including angina and 
heart failure, and IHD) following the introduction of comprehensive SFL119 and SFL,120 
respectively. Jones et al. further observed that the reduction was much higher in 
locations with comprehensive SFL (14% reduction) compared with locations which had 
partial SFL (8% reduction).120 However, the differential effects of SFL by SES were not 
assessed. 
 
Preliminary review evidence on the differential effects of SFL by SES indicated that the 
benefits of SFL were higher among the affluent population as they were more likely to 
visit restaurants and pubs than those from the disadvantaged groups; this may have 
continued to widen existing inequalities.148 Evidence, however, was limited as some of 
the studies yielded contradictory findings, thus, the conclusions were inconsistent.149, 150 
Other reviews had attempted to stratify, but none reported any differential effects of 
tobacco control interventions by SES.96, 151-153 Thomas et al. found no strong evidence to 
associate the effects of SFL with income and educational levels.154 A review by Hill et al. 
reported mixed effects of SFL on socioeconomic inequalities in exposure to tobacco 
smoke.155 Findings of Brown et al. indicated increased socioeconomic inequality in 
smoking among youth as 19 out of 25 studies reviewed showed negative equity impact 
of partial, regional or voluntary SFL where affluent populations were more responsive to 
interventions.156  
 
Despite studying the differential effects of SFL on health outcomes such as AMI, and 
acute coronary events, reviews conducted by Callinan et al.28 and Lin et al.118 did not 
report the differential effects by SES. The most recent systematic review, Frazer et al. 
was an update of a 2010 review by Callinan et al.,28 and reported the impact of SFL on 
multiple health outcomes e.g. cardiovascular, respiratory and perinatal.27 They observed 
a consistently positive impact of national SFL on reducing adverse cardiovascular 
outcomes (ACS/AMI/stroke), asthma, lung function, and mortality associated with 
smoking-related illnesses.27 The effects of SFL on chronic obstructive pulmonary 
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disease (COPD) and perinatal health (low birth weight/small for gestational age 
babies/pre-term deliveries) were inconsistent; while they reported significant health 
benefits among the countries with comprehensive SFL compared to countries with 
partial SFL.27 Frazer et al. also report the relevant impact of SFL on health outcomes 
among sub-groups.27 Apart from the age- and gender-specific results, they did report 
impact on some health outcomes by socioeconomic indicators (five papers that have 
also been included in our present study).27 Despite presenting a fairly extensive 
evaluation of the SFL, they do not include a detailed analysis and in-depth discussion on 
impact of SFL on socioeconomic inequalities in health outcomes and it was not an 
objective of their study.  
 
As smoking and SHS exposure are higher in low SES groups, it is highly plausible that 
they would benefit more from SFL and therefore, the health inequalities will reduce. On 
the other hand, some argue that people belonging to high SES groups: may be smoking 
at a higher frequency vs. those from the low SES groups,157, 158 are more likely to 
frequent hospitality venues such as restaurants, bars, hotels etc. where such laws are 
newly implemented,159 are more likely to make successful quit attempts with 
professional help following SFL implementation,159 and are more likely to visit/work at 
places with comprehensive (rather than partial) SFL (vs. the low SES groups who are 
more likely to work at places covered by partial/no SFL).6, 21 Therefore, it is plausible that 
SFL or comprehensive SFL unduly benefits the rich, thereby increasing health 
inequalities. On the basis of mixed results of earlier reviews, although smoking 
restrictions have been shown to be effective, the potential of these interventions to 
reduce smoking-related health inequalities is still inconclusive. The introduction of SFL 
in many countries now provides opportunities to strengthen the evidence. The resulting 
evidence would be important to address the debate whether SFL/comprehensive SFL 
increase or decrease health inequalities. 
 
SFL is expected to have an impact through two causal pathways: 1) reductions in active 
smoking 2) reductions in SHS exposure among non-smokers.160 These may influence 
health outcomes differently in different social strata. Previous systematic reviews have 
combined findings on smoking behaviour and health outcomes and concluded that the 
weight of evidence suggests neutral equity impacts or lower benefits in poor groups.148, 
161 But this may be because studies which focus on smoking behaviours only capture 
one part of the causal pathway which is pro-rich. An updated review of all the papers 
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which focus on health outcomes is therefore warranted as the number of studies has 
increased since these reviews have been published.  
 
Our aim was to conduct a systematic review to investigate the impact of SFL on socio-
economic differences in: a) smoking related disease-specific morbidity and mortality and 
b) all-cause mortality. Our specific objectives were to systematically evaluate the impact 
of SFL in public places on socioeconomic differences in a) smoking related disease-
specific morbidity among adults; i) acute coronary events (AMI) and other cardiac 
diseases (ACS and coronary heart diseases) ii) cerebrovascular accident (stroke) and 
other cerebrovascular diseases (transient ischaemic attack (TIA)) iii) respiratory 
symptoms and other respiratory diseases (asthma and COPD) iv) lung cancer;  b) 
cause-specific and all-cause mortality among adults. 
 
3.1.3.  Methods  
A review protocol specifying the objectives, search strategy, inclusion/exclusion criteria, 
outcomes, data extraction and synthesis methods has been documented and registered 
with the International Prospective Register of Systematic Reviews (PROSPERO), 
Centre for Reviews and Dissemination, University of York (Registration no: 
CRD42016035744). The protocol is attached in Appendix B-1 and available online at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016035744 
 
3.1.3.1.  Eligibility criteria 
 
Inclusion criteria 
Primary studies which investigated the impact of SFL in public places on socioeconomic 
inequalities in morbidity and mortality associated with cardiac, cerebrovascular, 
respiratory and other smoking-related diseases among adults aged 18 years and above 
were eligible for inclusion. SFL referred to any comprehensive or partial ban on smoking 
in public places including bars or restaurants and workplaces, at community, regional, 
city, state or national level. A comprehensive ban referred to 100% smoke-free indoor 
public places and workplaces while a partial ban was when there existed exemptions to 
SFL e.g. smoking allowed in designated areas or in specific indoor public places such as 
casinos, bars, and the like.162 Following the Cochrane Effective Practice and 
Organisation of Care (EPOC) guidelines,163 randomised controlled trials (RCTs; 
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including cluster RCTs), controlled clinical trials (CCTs; including cluster CCTs), quasi-
experimental studies including interrupted time-series (ITS) and controlled before-after 
studies were the study types considered eligible for inclusion. As per the results of our 
scoping search, we anticipated a small number of these study types to fulfil the EPOC 
criteria, therefore, we decided to expand the eligibility criteria to include the following 
types of studies in addition: uncontrolled before-after studies, prospective and 
retrospective cohort, case-control, and nested case-control studies. We considered 
income/wealth, education, occupation, race and geographic location/area as indicators 
of SES. Some studies reported the use of a complex composite score for SES. Primary 
outcomes were socioeconomic differences in disease-specific mortality i.e., sudden 
cardiac death and death from; i) AMI, ii) stroke, iii) asthma and COPD, iv) lung cancer 
and all-cause mortality among adults. Secondary outcomes were socioeconomic 
differences in: i) hospital admission due to AMI, ii) hospital admission due to stroke, iii) 
hospital admission due to other smoking-related cardiac diseases (ACS and coronary 
heart diseases), iv) hospital admission due to other smoking-related cerebrovascular 
diseases such as TIA, v) emergency department visits due to respiratory illness 
(respiratory symptoms, asthma and COPD) and finally hospital admission due to lung 
cancer.  
 
Exclusion criteria 
Cross-sectional studies, modelling/simulation studies, cost and qualitative studies were 
excluded. Studies focusing on intermediate outcomes such as smoking behaviours, 
SHS exposure and other outcome indicators such as quitting/quit attempts, knowledge, 
attitudes, and air quality were also excluded.  
 
3.1.3.2.  Data sources and search strategy 
Relevant Medical Subject Headings (MeSH) phrases and free text were used as 
keywords to retrieve eligible published studies from databases: MEDLINE, EMBASE, ISI 
Web of Science, SCOPUS, CINAHL Plus, Global Health (CAB), Cochrane Central 
Register of Controlled Trials (CENTRAL), IndMed, SciELO, IMEMR, IMSEAR, 
KoreaMed, AMED, LILACS and AIM from inception to September 2016. Initial searches 
for each database were updated to include literature up to September 2016. The search 
strategy used for MEDLINE and EMBASE is provided in Appendix B-2. The strategy 
was adapted for other databases. Only the studies published in the English language 
were included and the references of the retrieved relevant articles, conference abstracts 
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and proceedings, and citations of articles of interest were also screened for additional 
studies. We also screened the reference lists of known credible reports on this topic 
such as the WHO MPOWER Reports (2009, 2015),23, 162 IARC Monograph Vol 13,21 the 
US Surgeon General’s report (2006),6 the Institute of Medicine (IOM) report (2010),164 
and the references cited on the CDC website.165 Some details on the presence of 
comprehensive or partial SFL in the selected studies were obtained from other credible 
sources e.g. 2015 WHO MPOWER Report23 and www.tobaccocontrollaws.org website 
of Campaign for Tobacco Free Kids (CTFK).166 Review articles were not included but 
their reference lists were used as key sources for study identification. 
 
3.1.3.3.  Study selection 
Out of the studies retrieved, duplicates were first removed, and eligibility criteria were 
then applied to the titles and abstracts. Two reviewers (MJ and GPN) independently 
screened the titles and the abstracts for potentially eligible studies and assessed the full 
text of remaining potentially relevant studies to confirm inclusion. The study selection 
process is described in the form of a PRISMA flow diagram in Figure 3.1. EndNote 
Referencing Software (Clarivate Analytics, Philadelphia, v.X7) was used to manage all 
the citations. In the case of duplication, only the largest study was retained to avoid 
duplication of information. In the event of a disagreement, a third reviewer was 
consulted (CM).  
 
3.1.3.4.  Data extraction and quality assessment 
Relevant data were extracted using a standardised and customised form which included 
authors’ names and the year of publication, study design, place where the study was 
undertaken, SES indicators used, type of intervention, health outcomes assessed, 
findings and impact on health inequalities (Table 3.1). Standard guidelines appropriate 
for community studies and clinical trials included in Cochrane Collaboration tool were 
adapted for assessing the suitability of the study design.167 The quality of included ITS 
studies was assessed using the seven risk of bias assessment criteria outlined in the 
Cochrane Handbook and available on the EPOC website (Table 3.2).168 
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Figure 3.1: PRISMA flow diagram – study selection process  
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The seven quality criteria included: 1) intervention independent of other changes, 2) 
shape of the intervention effect pre-specified, 3) intervention unlikely to affect data 
collection, 4) knowledge of allocated intervention adequately prevented, 5) incomplete 
outcomes data adequately addressed, 6) study free from selective outcomes reporting, 
and 7) study free from other risks of bias. The EPOC suggested risk of bias criteria for 
ITS studies are attached in Appendix B-3. Accordingly, each criterion was scored as ‘low 
risk’, ‘high risk’ or ‘unclear risk’. The quality of before-after studies was assessed using 
the Effective Public Health Practice Project (EPHPP) quality assessment tool for 
quantitative studies (Table 3.3).169 The six quality criteria included in the EPHPP tool 
were: 1) participant selection (representativeness), 2) blinding and randomization, 3) 
comparability of the groups at baseline, 4) reliability of data collection tools, 5) attrition 
rates, and 6) attributability to the intervention. The EPHPP tool and the study rating 
criteria are attached in Appendix B-4. The studies were classified according to their 
quality ratings into low, moderate or high-quality studies. As we used two different 
quality criteria (EPOC and EPHPP) described above, for uniformity in reporting, we 
report the number and percentage of quality criteria fulfilled by each study. Data 
extraction and quality assessment of the included studies were done independently by 
two reviewers (MJ and GPN) and any disagreement was resolved through discussion or 
by referral to a third reviewer (CM). 
 
3.1.3.5.  Data synthesis and reporting 
Due to the heterogeneous SES indicators and multiple health outcomes reported by the 
studies included in this review, a meta-analysis was deemed to be unsuitable. Thus, a 
novel hypothesis-testing approach was used to examine the balance of evidence about 
the differential equity effects of intervention employed. Following this approach, data 
was synthesized using a combination of graphical and narrative methods, including a 
novel matrix or ‘Harvest Plot’ (Figure 3.2) devised by Ogilvie et al.170 For each dimension 
of socioeconomic inequality (e.g. income/wealth, education, occupation, area 
deprivation, or a composite index), we populated the relevant row of this matrix by 
placing a bar representing each study in one of the four columns representing the 
following competing hypotheses:  
i) The null hypothesis was defined as no evidence of differential effects in the 
effectiveness of SFL for any given socioeconomic indicators. 
ii) The alternative hypotheses were: 
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a) There was a positive effect of SFL on socioeconomic inequalities in smoking-
related morbidity and mortality, which meant that the intervention was more effective in 
less advantaged groups (defined for this purpose as the less affluent, those with a lower 
level of education, those in less skilled occupational groups, those with lower incomes or 
most disadvantaged racial or ethnic group in the context of a particular study) or that 
these groups were more responsive to the SFL. 
b) There was a negative effect of SFL on socioeconomic inequalities in smoking-
related morbidity and mortality, meaning that the intervention was more effective in more 
advantaged groups (defined as the more affluent, those with a higher level of education, 
those in higher-skilled occupational group, those with higher incomes or more 
advantaged racial or ethnic group in the context of a particular study) or that these 
groups were more responsive to the SFL. 
c) There was a mixed effect of SFL on socioeconomic inequalities in smoking-
related morbidity and mortality, which meant that both, the positive effect and the 
negative effect were observed (for different types of outcomes) in the same study.  
d) There was an unclear effect of SFL on socioeconomic inequalities in smoking-
related morbidity and mortality, which meant that the results were ambiguous and a 
clear effect of SFL could not be ascertained.  
 
A key to the interpretation of Harvest Plot matrix is shown in Box 3.1 and therefore, is 
placed before Figure 3.2. In the plot, each study has been represented by a bar in each 
row for which that study had reported relevant results. Suitability of the study design was 
indicated by the height of the bar, where the tallest bars represented the most suitable 
study designs and the lowest bars represented the least suitable study designs. Each 
bar was annotated with the number (and the percentage) of other methodological criteria 
(seven in the case of EPOC and six in the case of EPHPP) met by that study.  
 
3.1.4.  Results 
Out of a total of 2793 unique research papers screened using titles and abstracts, 15 
papers were potentially eligible for inclusion. After reviewing full texts of these eligible 
papers, eight papers were finally included in our study. The flowchart for study selection 
process is shown in Figure 3.1. The majority of literature during the search was included 
from electronic databases and from reference lists of existing reports and meta-analyses 
or systematic reviews.  
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Table 3.1 shows data from the included studies. Out of the eight studies included in this 
review, all were all from HICs. One study each from Italy,149 the UK,171 Ireland,172 New 
Zealand,173 Scotland,150 and Norway174 was included; while two of the studies included 
were from the US.158, 159 Six of the included studies were ITS studies with no concurrent 
comparison groups;149, 150, 159, 171-173 while Eagan et al.174 and Head et al.158 were (single 
measurement) before-after studies without and with a concurrent comparison group 
respectively. The included studies reported socioeconomic inequalities in the impact of 
comprehensive149, 150, 171-173 or partial158, 159, 174 SFL implemented at national149, 150, 171-174 
or regional158, 159 level on either hospital admissions/discharges,149, 150, 158, 159, 171, 173 or 
out-of-hospital/pre-hospital deaths,149, 150, 172 owing to cardiovascular (acute coronary 
events,149 AMI,158, 171, 173 IHD,172 stroke,150, 158, 172 and TIA158) or respiratory (COPD,158, 172 
and asthma158, 159) causes using retrospective, secondary, mortality or hospital 
discharge data on adult participants. Eagan et al. reported the impact of SFL on 
socioeconomic inequalities in changes in respiratory symptoms;174 while Liu et al. 
reported the impact of SFL on participants aged more than or equal to 16 years.171 The 
indicators of SES in the included studies were area deprivation,149, 150, 171, 173 
education,174 race,158, 159 and a composite SES indicator (inclusive of structural 
[education, occupation, family composition, and nationality] and material [Car access, 
unemployment, house tenure] indicators of SES).172 Other indicators of SES such as 
occupation and income/wealth were not reported in any of the included studies.  
 
3.1.4.1.  Socioeconomic inequalities in the impact of comprehensive SFL on 
health outcomes 
Five studies published between 2008 and 2014, one each from Italy,149 the UK,171 
Ireland,172 New Zealand,173 and Scotland150 reported the impact of a national 
comprehensive SFL on health outcomes (Table 3.1). Three of these five studies 
reported an overall positive effect of comprehensive SFL on health outcomes.149, 171, 173 
Three of the five studies reported a positive effect of comprehensive SFL on 
socioeconomic inequalities in health outcomes i.e. the SFL was found to be more 
effective in the lower SES groups compared with the high SES groups.149, 171, 172 
Cesaroni et al. reported that one year after the nationwide comprehensive SFL 
implementation in Italy, reduction in the age-standardized acute coronary events 
(including out of hospital deaths and hospital admissions) among those in 35-64 years 
age group was significantly higher among the residents of most deprived areas 
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compared with residents of least deprived areas.149  Liu et al., reported that three years 
after the nationwide comprehensive SFL implementation in the UK, reduction in the age-
standardized hospital admissions for AMI in Liverpool was highest in the most deprived 
wards (census areas), followed by the middle ranked wards and the least deprived 
wards. They further reported a reduction in absolute as well as the relative risk of 
hospitalisation due to AMI among the most deprived groups compared with the least 
deprived groups.171 Stallings-Smith et al. reported that five years after the 
implementation of a nationwide comprehensive SFL in Ireland, the age- and gender-
standardized mortality reductions for IHD, stroke, and COPD were concentrated in the 
most deprived tertiles by specific structural indicators of SES as well as the composite 
index.172 One of the five studies under the comprehensive national SFL category 
reported that one year after its implementation in New Zealand, despite a significant 
reduction in AMI hospital admissions (in Christchurch) in the 55-74 year age group 
among the less deprived (vs. the more deprived groups), such reduction was not 
consistently observed across all the age groups, suggesting a neutral or no effect on 
socioeconomic inequalities.173 Last of the five studies under the comprehensive national 
SFL category reported that four years after its implementation in Scotland, there was a 
significant decline in pre-hospitalization deaths and hospital admissions due to cerebral 
infarction in the least deprived quintile, however, there was a reported significant 
increase in the immediate next deprivation quintile. No long term significant effect was 
observed in the other deprivation quintiles.150 We, therefore, reached a consensus that 
the SFL had a neutral effect on inequalities in stroke deaths and hospitalisations in 
Scotland.
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Table 3.1: Data extraction form for the impact of smoke-free legislation (SFL) on socioeconomic inequalities health outcomes among adults 
Author, 
Year of 
study 
Study design Country, 
High/Low 
income 
SES indicator/s Intervention 
(National or 
Regional) 
Outcomes Effects/Impacts on Overall outcome and 
SES inequalities 
Summary 
(Positive, 
Negative, 
Neutral, 
Unclear, 
Mixed) 
 
Comprehensive Smoke-free Legislation 
 
Cesaroni et 
al, 2008149 
Interrupted time 
series with no 
concurrent 
comparison 
group 
Rome, Italy 
High Income 
Area deprivation – 
Composite index 
derived from 
Census 2001 data  
distributed into 
quintiles 
 
National  Age-standardized acute 
coronary events (out-of-
hospital deaths and hospital 
admissions) in city residents 
35 to 84 years of age 
comparing the data from 
pre- (2000 –2004) and post-
legislation (2005) 
Overall, there was a significant decline in 
acute coronary events post-legislation among 
35-64 year (RR 0.89; 95% CI 0.85-0.93) and 
65-74 year (RR 0.92; 95% CI 0.88-0.97) old 
groups. 
 
SES inequalities: Significant decline in acute 
coronary events among the 35-64 years 
(youngest group) belonging to low SES 
categories: 
 
Quintile 3 – RR 0.88; 95% CI 0.79-0.98 
Quintile 4 – RR 0.90; 95% CI 0.81-0.99 
Quintile 5 (lowest SES) -  RR 0.85; 95% CI 
0.77-0.93 
 
The protective effect of the law seemed to be 
stronger for residents living in low 
socioeconomic areas than for those living in 
high socioeconomic areas 
Positive 
effect on 
inequalities 
Liu et al, 
2013171 
Interrupted time 
series with no 
concurrent 
comparison 
group 
Liverpool 
(City), UK 
High income 
Area deprivation – 
Wards divided into 
3 groups of 10 
wards each 
National  Trend gradient and change 
points (by trend regressions 
analysis) in age-
standardised MI admissions 
in Liverpool between 2004 
and 2012 in those ≥16 years 
of age; by sex and by 
socioeconomic status.  
Overall, between ‘2005-2006’ and ‘2010-
2011’, MI admissions reduced by 42%. 
 
SES inequalities: Between ‘2005-2006’ and 
‘2010-2011’, MI admissions reduced by 45%  
for the 10 most deprived wards, 42.3% for the 
10 middle-ranked wards, and 38.6% for the 
10 most affluent wards 
 
The average absolute risk difference between 
the most and the least deprived wards over 
the first 2 years was 69.8 MI admissions per 
100 000 person-years. The rate for the final 2 
years was 32 MI admissions per 100 000 
Positive 
effect on 
inequalities 
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person-years (A rate ratio of 0.46, 95% CI of 
0.044 to 4.76). 
 
The average rate ratio between the most and 
the least deprived wards over the first 2 years 
was 1.38. The relative difference for the final 
2 years was 1.26 (A ratio of 0.91, 95% CI of 
0.43 to 1.91). 
Stallings-
Smith, 
2014172 
Interrupted time 
series with no 
concurrent 
comparison 
group 
Ireland 
High income 
7 discrete 
indicators:- 
Structural: 
Education, 
occupation, family 
composition, 
nationality 
Material: Car 
access, 
unemployment, 
house tenure 
 
A composite 
index:-  
combination of 
structural and 
material indicators 
National  Monthly age and gender-
standardised mortality rates 
for IHD, stroke, and COPD 
for the period of 2000–2010 
among those ≥35 years of 
age, stratified by tertiles of 
each SES indicator 
 
SES inequalities: Post-ban mortality 
reductions by structural SES indicators were 
concentrated in the most deprived tertile for 
all causes of death. For IHD and COPD, 
least deaths were seen only in the most 
deprived tertile by education and in local 
authority areas of Ireland with the greatest 
population of non-Irish/non-UK nationals. 
Strongest effects in the most deprived tertile 
by manual occupation and families of ≥5 
persons were observed only for IHD. For 
Stroke, strongest effects were observed in 
the most deprived tertiles by manual 
occupation and families of ≥5 persons. 
 
Reductions in deaths by material SES 
indicators were more equitable across SES 
tertiles by male unemployment, population 
unemployment, and rented/free housing 
tenure. Greater effects observed in the 
intermediate and most deprived tertiles by the 
no car access indicator.  
 
 
For IHD and COPD, effects were attenuated 
in the composite index when compared to 
effects by discrete SES indicators.    
Positive 
effect on 
inequalities 
Barnett et al, 
2009173  
Interrupted time 
series with no 
concurrent 
comparison 
group 
Christchurch
, New 
Zealand 
High Income 
Neighbourhood 
(Area) deprivation 
– Census Area 
Unit quintiles 
based on NZ 
Deprivation Index 
National   Rate of AMI hospital 
admissions before 
(2003/04) 
and after (2005/06) the 
introduction of the SFL to 
assess whether there was a 
significant change over time 
among patients ≥30 years of 
age. 
Overall, there was a decline in AMI 
admission rates after the implementation of 
the smoke-free legislation (RR 0.92; 95% CI 
0.86–0.99).  
 
SES inequalities: Only among the 55 to 74 
year age group AMI admissions were 
significantly lower in less deprived areas post 
SFL implementation – quintile 2 (RR 0.76; CI 
0.59–0.97) 
Neutral 
effect on  
inequalities 
80 
 
 
No consistent effects of SFL on AMI 
admissions by deprivation were observed 
across three age groups (30-54; 55-74; ≥75) 
Mackay et 
al, 2013150 
Interrupted time 
series with no 
concurrent 
comparison 
group 
Scotland 
High income 
Area deprivation – 
quintiles derived 
from Scottish 
Index of Multiple 
Deprivation 
National  Percentage step (on the day 
of SFL) and slope (post-
SFL) change in stroke 
incidence (both pre-hospital 
deaths and hospital 
admissions) including all 
strokes, and its sub-types - 
cerebral infarction, 
intracerebral haemorrhage 
and unspecified stroke 
using morbidity and 
mortality data from 2000 to 
2010.  
Overall, there was no significant decrease in 
the incidence of cerebral infarction (-0.40%) 
or confirmed stroke (-0.23%) in the long term 
after SFL implementation.  
 
SES inequalities: Significant decrease in 
cerebral infarction in quintile 1 (most affluent) 
by -2.01% and a significant increase in 
quintile 2 by 1.30% in the long term after SFL. 
No significant effect on other deprivation 
quintiles 
 
A significant increase in confirmed stroke only 
in quintile 2 by 0.91% in the long term after 
SFL. No significant effect on other deprivation 
quintiles 
Neutral 
effect on  
inequalities 
 
Partial Smoke-free Legislation 
 
Eagan et al., 
2006174 
Before-after 
study (without 
concurrent 
comparison 
group) 
Norway, 
High income 
Educational level 
 
National  Change in mean sum-score 
for five respiratory 
symptoms from before (May 
2004) to after SFL 
implementation (Sept/Oct 
2004) among hospitality 
industry workers 
Overall, there was a pronounced and 
significant decrease in mean sum-score (for 
all the 5 respiratory symptoms) from baseline 
to follow-up (1.72 to 1.60; p<0.001). Fully 
adjusted results were significant but have not 
been presented. 
 
SES inequalities: There was no significant 
difference in the changes in mean sum-score 
of five respiratory symptoms among workers 
across educational levels.  Fully adjusted 
results for SES have not been presented.  
Neutral 
effect on 
health 
inequalities 
Head et al., 
2012158 
Before-after with 
a concurrent 
comparison 
group 
Beaumont 
and Tyler, 
Texas, US 
High Income 
Racial difference 
(non-hispanic 
blacks vs. whites) 
 
Regional   Change in hospital 
discharge rates for 5 
tobacco-related conditions 
(AMI, TIA, stroke, COPD, 
asthma) before (2004-2006) 
and after (2006-2008) SFL 
implementation in 
Beaumont, Tyler 
(comparison group- no 
SFL), and all Texas 
Overall, hospital discharges for AMI and CVA 
declined significantly by 26% and 29% 
respectively after SFL implementation in 
Beaumont. There was a concurrent 27% 
decline in CVA discharge rates in Tyler.  
 
SES inequalities: Hospital discharges 
declined significantly for both, blacks and 
whites, for AMI and CVA in Beaumont after 
the ban.  
Negative  
effect on  
Inequality 
 (COPD 
 and asthma)  
 
Neutral effect on  
Inequality  
(acute  
MI, CVA and 
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examined by race.  
COPD discharges declined by 36% and 
asthma discharges declined by 31% only 
among whites (but not among blacks in 
Beaumont) 
total  
discharges) 
Marchese et 
al., 2015159 
Interrupted time 
series with no 
concurrent 
comparison 
group 
Michigan, 
US 
High income 
Racial difference 
(blacks vs. whites) 
 
Regional  Monthly rate of adult asthma 
hospitalisations (20 to 64 
year-old patients) in 
Michigan before (Jan 2002 
to May 2010) and after (May 
2010 to Dec 2012) 
implementation of the SFL 
Overall, adjusted results showed that there 
was an 8% reduction in the population-wide 
rate of asthma hospitalisations in the 12 
months after the implementation of SFL (RR, 
0.92; 95% CI, 0.90–0.93). 
 
SES inequalities: In the first 12 months of 
the ban, black hospitalisation rates decreased 
7% (RR 0.93 95% CI 0.91-0.95) and white 
hospitalisation rates decreased 10% (RR 
0.90 95% CI 0.88-0.92).  
 
Unclear 
effect on 
inequalities 
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Table 3.2: Quality of studies based on a scale of suitability of study design and seven items for risk of bias assessment for Interrupted Time Series Studies from 
EPOC 
Study/ Author Suitability of study design Intervention 
independent 
of other 
changes 
(Criterion 1) 
Shape of 
the 
intervention 
effect pre-
specified 
(Criterion 2) 
Intervention 
unlikely to 
affect data 
collection 
(Criterion 3) 
Knowledge of 
allocated 
interventions 
adequately 
prevented 
(Criterion 4) 
Incomplete 
outcomes 
data 
adequately 
addressed  
(Criterion 5) 
No selective 
outcomes 
reporting 
(Criterion 6) 
Study free 
from other 
risks of bias 
e.g. 
seasonality 
(Criterion 7) 
 A B C D E        
Cesaroni et al., 
2008149 
 X    Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Barnett et al., 
2009173 
 X    High risk Low risk Low risk Low risk Low risk Low risk High risk 
Liu et al., 2013171  X    High risk Low risk Low risk Low risk High risk Low risk High risk 
Mackay et al., 
2013150 
 X    Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Stallings Smith et 
al., 2014172 
 X    Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Marchese et al., 
2015159 
 X    Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Suitability of study design was summarised using a five-point scale from A (most suitable) to E (least suitable).  
 
Suitability of Study Design 
 
a. Category A: The study design includes concurrent comparison groups AND prospective measurement of exposure and outcome 
b. Category B: The study design includes at least two 'before' measurements and at least two 'after' measurements but no concurrent comparison group 
c. Category C: The study design involves single 'before' and 'after' measurements with concurrent comparison group 
d. Category D: The study design involves single 'before' and 'after' measurements with no concurrent comparison group 
e. Category E: The study design involves measurements of exposure and outcome made at a single point in time 
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Table 3.3: Quality of studies based on a scale of suitability of study design and six items for risk of bias assessment for quantitative studies from EPHPP 
Study / 
Author 
Suitability of study design Quality of study 
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Eagan et al., 2006174 
 
   X  Weak 
 
Moderate Moderate Moderate  Weak Weak 
 
Head et al., 2012158 
 
  X   Moderate Moderate Weak Strong Moderate Weak 
Suitability of study design was summarised using a five-point scale from A (most suitable) to E (least suitable).  
 
 
Suitability of Study Design 
 
a. Category A: The study design includes concurrent comparison groups AND prospective measurement of exposure and outcome 
b. Category B: The study design includes at least two 'before' measurements and at least two 'after' measurements but no concurrent comparison group 
c. Category C: The study design involves single 'before' and 'after' measurements with concurrent comparison group 
d. Category D: The study design involves single 'before' and 'after' measurements with no concurrent comparison group 
e. Category E: The study design involves measurements of exposure and outcome made at a single point in time 
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Box 3.1: Key to Harvest Plot Matrix of evidence of socioeconomic inequalities in the effects of smoke-free 
legislation (SFL) on smoking-related health outcomes among adults 
 
No effect  
 
Defined as no evidence of differential effects in the effectiveness of the intervention for any 
given socioeconomic indicators 
 
Positive effect 
 
Defined as evidence that less advantaged groups in terms of the less affluent, those with a 
lower level of education, those living in more deprived area or most disadvantaged racial or 
ethnic group in the context of a particular study are more responsive to the intervention 
 
 
Negative effect 
 
Defined as evidence that more advantaged groups in terms of the more affluent, those with 
a higher level of education, those living in more affluent area or more advantaged racial or 
ethnic group in the context of a particular study are more responsive to the intervention 
 
 
Mixed effect 
 
Defined as evidence that there are mixed effects of the intervention on both advantaged and 
disadvantaged groups in responding to intervention 
 
 
Unclear effect 
 
Defined as evidence that there are unclear effects of the intervention on both advantaged 
and disadvantaged groups in responding to intervention 
 
 
Bars in row 
 
Each bar in each row represents one study 
 
Colour of bars 
& 
Type of SFL 
        
       ACE / MI                                                             ACE / MI 
       Stroke          Stroke 
       Respiratory/ COPD/ Asthma                              Respiratory/ COPD/ Asthma 
 
Comprehensive SFL (Blue bar)                     Partial SFL (Red bar) 
 
Height of bars 
 
Low, medium, high based solely on the suitability of design, where:  
 
Highest  =  Suitability category A or B, 
Medium  =  Suitability Category C or D, 
Low        = Suitability Category E. 
 
Category A: The study design includes concurrent comparison groups AND prospective 
measurement of exposure and outcome. 
 
Category B: The study design includes at least two 'before' measurements and at least two 
'after' measurements but no concurrent comparison group. 
 
Category C: The study design involves single 'before' and 'after' measurements with  
concurrent comparison group 
 
Category D: The study design involves single 'before' and 'after' measurements with no 
concurrent comparison group. 
 
Category E: The study design involves measurements of exposure and outcome made at a 
single point in time. 
 
Number above each 
bar 
Total number (and percentage) of quality items from EPHPP passed which indicate strong 
and moderate quality. Maximum 6 (representative of the sample; randomization of 
intervention allocation; comparability of groups at baseline (where relevant); credibility of 
data collection tools; attrition rate (where relevant) or sample size; attributability of observed 
effects to intervention) (Used in case of two before-after studies) 
 
OR  
 
Total number (and percentage) of risk of bias criteria met which indicate low risk of bias in 
EPOC review of risk of bias criteria. Maximum 7 (intervention independent of other changes, 
shape of intervention pre-specified, intervention unlikely to affect data collection, knowledge 
of intervention adequately prevented, incomplete outcomes data adequately addressed, no 
selective outcomes reporting,  study free from other risk of bias ) (Used in case of six ITS 
studies) 
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Impact of smoke-free legislation (SFL) on socioeconomic inequalities in health 
outcomes 
 
 
 
 
 
Positive effect 
 
 
No effect 
  
Negative 
effect 
  
Unclear 
effect 
 
      
         Education 
 
 
 
 
 
3 (50%) 
  
 
 
 
 
 
 
Occupation 
 
 
 
 
 
   
 
 
Income 
 
 
 
 
 
   
 
 
Area deprivation 
7 (100%)  4 (57%)    
  
 
 
 5 (71%)  7 (100%) 
 
 
  
 
 
Race 
 
 
 
 
        
       
       4 (67%)   
                          
      
 
7 (100%) 
 
 
Composite score 
7 (100%) 
 
 
 
 
   
Figure 3.2: Harvest plot of evidence of socioeconomic inequalities in the effects of smoke-free 
legislation (SFL) on smoking related health outcomes and quality of included studies based on 
suitability of study design and study quality criteria 
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Findings of quality assessment for each of the included studies assessing the impact of 
comprehensive SFL are shown in Table 3.2 and represented graphically by the Harvest 
plot in Figure 3.2. The key for interpretation of the Harvest plot is described in Box 3.1. 
All the five studies149, 150, 171-173 describing the impact of comprehensive SFL were ITS 
studies without a concurrent comparison group, for which the suitability of the study 
design was classified as the highest (represented by tallest, blue coloured bars in the 
harvest plot). Three of the five studies fulfilled all the seven criteria (EPOC) for 
assessment of risk of bias within the studies, indicating the least possibility of bias and 
high quality of these studies.149, 150, 172 Liu et al.171 met four (except intervention 
independent of other changes, incomplete outcomes data adequately addressed, and 
study free from other risk of biases) while Barnett et al.173 met five (except intervention 
independent of other changes, and study free from other risk of biases) of the seven 
EPOC criteria for assessment of risk of bias within the studies, indicating some 
possibility of bias and moderate quality of these studies. Three of the five studies 
describing the impact of comprehensive SFL fulfilled the alternative hypothesis. Three of 
the studies demonstrated a positive effect of the SFL on socioeconomic inequalities (two 
on cardiac outcomes149, 171 and one on stroke, cardiac as well as respiratory 
outcomes172). Two studies demonstrated a neutral effect of the SFL on socioeconomic 
inequalities in stroke mortality150 and cardiac hospital admissions.173  
 
3.1.4.2.  Socioeconomic inequalities in the impact of partial SFL on health 
outcomes 
One study from Norway published in 2006 and included in this review reported the 
impact of a national, partial SFL on socioeconomic inequalities in changes in respiratory 
symptoms among hospitality industry workers.174 Two studies from the US, one from 
Texas (2012)158 and one from Michigan (2015)159 reported the impact of regional, partial 
SFL on socioeconomic inequalities in hospital discharge rates for five tobacco-related 
respiratory symptoms (a morning cough, daytime cough, phlegm cough, dyspnoea and 
wheezing) and asthma hospitalizations respectively (Table 3.1). Overall, all the three 
studies showed a positive effect of partial SFL on the health outcomes. Two of these 
three studies reported no effect of the partial SFL on socioeconomic inequalities in 
health outcomes.  Eagan et al. reported that five months after implementation of a 
national level, partial SFL in Norway, there were no significant differences in the 
changes in mean sum-score of five respiratory symptoms among workers across 
educational levels.174 Head et al. reported that two years after implementation of a local 
partial SFL in Beaumont (Texas) hospital discharges due to AMI, and stroke and total 
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discharges declined significantly among the non-Hispanic blacks as well as non-
Hispanic whites, compared with Tyler (Texas) where there was no SFL, showing no 
effect of Beaumont’s partial SFL on socioeconomic inequalities. There was, however, a 
negative effect of the SFL on COPD and asthma discharges, where there was a 
significant decline in discharges only among the non-Hispanic whites but not among 
non-Hispanic blacks.158 Marchese et al. reported that 12 months after implementation of 
the state-wide partial SFL in Michigan, there was a significant decline in asthma 
hospitalisations among both, the blacks and the whites.159 The decline was however 
marginally higher among whites compared with blacks and statistically insignificant, 
suggesting an unclear effect of the partial SFL on socioeconomic inequality in asthma 
hospitalisations.159 
 
Quality assessment of the studies reporting the impact of partial SFL as observed from 
the Harvest plot (Figure 3.2) and the tables 3.2 and 3.3 shows that Marchese et al. was 
an ITS study without a concurrent comparison group, for which the suitability of the 
study design was classified as the highest (represented by tallest red coloured bars in 
the harvest plot).159 Eagan et al.174 was a before-after study without a concurrent 
comparison group while Head et al.158 was a before-after study with a concurrent 
comparison group. Both, Eagan et al. and Head et al. studies were classified as medium 
in terms of suitability of study design (represented by medium red coloured bars in the 
harvest plot). Marchese et al. fulfilled all the seven criteria (EPOC) for assessment of 
risk of bias within the studies, indicating least possibility of bias and high quality of the 
study.159 Eagan et al. met three of the six criteria (EPHPP) (except representativeness, 
attrition or drop rate, and attributability to the intervention) for assessment of risk of bias 
within the studies,174 while Head et al.158 met four of the six EPHPP criteria (except 
comparability, and attributability to the intervention) indicating the possibility of bias and 
weak quality of these studies as per the EPHPP criteria. One of the three studies 
reporting the effect of partial SFL fulfilled the alternative hypothesis. Marchese et al. 
reported an unclear effect of partial SFL on socioeconomic inequalities in asthma 
hospitalisations.159 Eagan et al. favoured the null hypothesis of no effect of the SFL on 
socioeconomic inequalities in changes in respiratory symptoms.174 Head et al. favoured 
null hypothesis in the case of total discharges, and discharges due to AMI and stroke; 
while a negative effect on socioeconomic inequalities was observed in the case of 
COPD and asthma.158  
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3.1.5.  Discussion  
This systematic review closely examines existing global research on the impact of SFL 
on socioeconomic inequalities in health outcomes (morbidity and mortality) associated 
with exposure to tobacco smoke such as AMI, acute coronary events, IHD, stroke, TIA, 
COPD, and asthma. We found only eight studies till the time of completion of this 
review, which could be included. All of these eight studies were from HICs of Europe, 
the US, and New Zealand. This is a significant research gap, more so for LMICs, as SFL 
is the most widely adopted tobacco control measure globally, with 49 countries (15 HICs 
and 34 LMICs) covered by comprehensive SFL; while 139 countries are reported to 
have partial SFL.23 Therefore, there is a clear and urgent need for LMICs to undertake 
studies of the impact of SFL on socioeconomic inequalities in health outcomes related to 
tobacco smoke exposure. 
 
Most of the studies we reviewed were ITS studies,149, 150, 159, 171-173 without a concurrent 
comparison group (the type of study design used when randomization is difficult; as the 
SFL is introduced nationwide in some countries, it is not possible for them to get a 
suitable comparison group in the same country) and were highly suitable in terms of the 
study design for evaluation of the impact of policies implemented at population level and 
at a clearly defined point in time.175 Only two studies158, 174 were before-after studies (one 
with a control group and another without a control group) which were are considered to 
be relatively weaker in terms of suitability of the study design.176 Uncontrolled before-
after studies cannot account for secular trends and sudden changes in outcomes while 
controlled before-after studies suffer from an inability to ensure baseline comparability of 
the intervention and control (which is not randomly selected) groups, making it difficult to 
attribute the change in the outcome to the intervention.176 Accordingly, we observed that 
these two before-after studies also did not meet some of the EPHPP risk of bias criteria, 
due to which, they were classified as weak in terms of study quality. Therefore, results of 
these before-after studies need to be interpreted with caution.  
 
Overall, we found evidence that implementation of comprehensive SFL led to either a 
positive effect (three out of five studies) on socioeconomic inequalities in health 
outcomes or no effect (two out of five studies); while implementation of partial SFL led to 
either no effect (two out of three studies) or an unclear effect (one out of three studies). 
Our findings, therefore, suggest that only comprehensive, 100% smoke-free indoor 
public and workplace policies can lead to a reduction in socioeconomic inequalities in 
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health outcomes related to tobacco smoke exposure by benefitting the low SES groups 
more (compared with the high SES groups); while partial SFL may not reduce 
inequalities. Our findings are consistent with some of the earlier studies. A study was 
conducted in England in 2005 when the UK Government decided to exempt pubs not 
serving catered food and private members’ clubs from SFL and thereby introduce partial 
SFL.177 Most of the pubs not serving catered food were located in the deprived areas of 
England and in these areas, almost 67% of these venues would be exempt from the 
SFL while in the affluent areas, only 33% of these venues would be exempt.177 This 
finding suggested that introduction of partial SFL would worsen socioeconomic 
inequalities in health and the prevalence of smoking.177 Similar findings were reported in 
another study conducted in North West England in the same year.178 After the 
introduction of a comprehensive SFL in England in July 2007, a study assessed its 
impact on hospital admissions due to childhood respiratory tract infection (RTI).122 Post 
implementation of comprehensive SFL, gradual decline in childhood RTI hospitalisations 
was significantly higher in the most deprived children compared with the most affluent, 
indicating that implementation of comprehensive SFL would lead to a reduction in health 
inequalities.122 Unlike our findings, however, a systematic review assessing the impact 
of tobacco control policies on smoking among youth showed an equity negative effect of 
comprehensive, national level SFL.156 
 
Our findings potentially contribute to clarify the dilemma arising from some of the earlier 
research which suggested that SFL led to increasing health inequalities.148 Further, as 
people belonging to the low SES groups (whose exposure to tobacco smoke and SHS is 
higher compared with the high SES groups) are more likely to be working in or 
frequenting places with partial/no SFL,6, 21 it is even more important to implement and 
enforce comprehensive SFL at such indoor venues to protect this vulnerable group.  
 
Area deprivation was considered as the indicator for SES in half of the studies included 
in our review.149, 150, 171, 173 We found evidence from two studies that people living in more 
deprived areas (representative of low SES) were likely to have greater reductions in 
adverse cardiac outcomes (compared with those living in less deprived areas);149, 171 
while two other studies using area deprivation as an indicator of SES showed no effect 
on inequalities.150, 173 This measure of SES, derived from the census data and 
sometimes by combining information from multiple Government data sources may not 
always be suitable for LMICs where such data might not always be available and where 
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deprivation may be a much more complex issue.179, 180 Two studies considered race as 
an indicator of SES and showed either no effect of partial SFL on health inequalities158 
or an unclear effect of partial SFL in reducing asthma hospitalisations among the Whites 
(compared with the Blacks).159 Both of these studies were from the United States where 
there exists a racial wealth gap with African Americans faring worse (have lesser assets 
compared with the Whites) due to issues such as lower incomes, lower inheritance rates 
and discrimination in housing markets.181 Race as an indicator of SES also may not be 
suitable for the LMIC settings. One study reported education as an indicator of SES and 
found no effect on inequality.174 Education as an indicator of SES is fairly easy to assess 
and interpret (even in LMICs) but it misses out on the complexity of deprivation or SES 
when considered as a standalone indicator of SES. One study used a composite score 
(a combination of seven structural and material indices of SES) as an indicator of 
SES.172 Alkire and Santos mention that deprivation is multidimensional and describe the 
Multidimensional Poverty Index (MPI) developed specifically for LMICs, which consists 
of 10 indicators from three different dimensions – education, health and standard of 
living.179 Such measures, although complex to interpret, would be helpful to provide the 
depth required to assess socioeconomic inequalities in outcomes and would also be 
suitable for the LMIC settings. None of the included studies reported ‘occupation’ or 
‘income/wealth’ as indicators of SES. These two measures along with education and 
assets possessed, either as discrete indicators or in the form of a composite index are 
the most commonly reported SES indicators in the LMIC settings.  
 
To some extent, our findings indicate that the choice of SES indicator may influence the 
outcomes (as SES is an important confounding factor in the association between 
implementation of SFL and the health outcomes) and hence, studies should assess the 
impact of interventions (SFL in our case) on differences in health outcomes across 
multiple indicators of SES instead of focusing on one particular indicator.182 For 
example, equity positive effect or no effect on equity was observed in case of studies 
which reported ‘area deprivation’ as an indicator of SES; an unclear effect or no effect 
on equity was observed in case of ‘race’ as an indicator of SES; while no effect on 
equity was observed in case of ‘education’ as an indicator of SES. We, however, cannot 
be confident about this as the number of studies reporting each type of SES indicator 
was very low in this review. Future studies should explore this research question.  
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3.1.5.1.  Strengths and limitations 
Previous reviews present conflicting evidence (and some of them demonstrate no effect 
or a negative effect) with respect to the impact of SFL on socioeconomic inequalities in 
health outcomes related to exposure to tobacco smoke.148, 155 Moreover, previous 
reviews assessing the impact of SFL have clubbed together health outcomes and 
smoking behaviour.148, 155 Causal pathways indicate that SFL has an impact through a 
reduction in active smoking as well as a reduction in SHS exposure,160 which could 
potentially lead to differential effects by SES on health outcomes. It is possible that 
previous reviews only captured the causal pathway which favoured the high SES 
groups. Our updated review is therefore vital as it specifically focuses on and analyses 
in depth, SES differences in health outcomes. We have made a considerable effort to 
include literature from several databases, existing known reports and systematic 
reviews/meta-analyses related to the topic, as well as grey literature available online to 
ensure that all the relevant published and unpublished literature was included in our 
review. However, in these types of studies, there is always a possibility that some 
informal or unreported evaluation of SFL was missed. An important challenge in this 
review was to undertake comparisons across different indicators of SES reported in the 
studies. In order to deal with this, instead of just presenting a narrative synthesis, we 
adopted a validated methodology – the Harvest plot,154, 170 to test competing hypothesis 
with respect to the impact of SFL on socioeconomic inequalities in health outcomes 
resulting from exposure to tobacco smoke. We used two different quality assessment 
criteria, EPOC for ITS studies (which captures more information on intervention fidelity) 
and EPHPP for before-after studies (which captures more information on study design 
features). Ideally, intervention fidelity would be important for both ITS and before-after 
studies. We, however, used standard guidelines and our quality assessment results 
should be interpreted cautiously in light of limited comparability between the two study 
types.  
 
3.1.5.2.  Policy implications 
The United Nations Sustainable Development Goals (UN SDGs) specify the following 
two important targets for reducing inequalities (Goal 10) and improving health outcomes 
(Goal 3): 1) Ensure equal opportunity and reduce inequalities of outcome, including by 
eliminating discriminatory laws, policies and practices and promoting appropriate 
legislation, policies and action in this regard143 2) By 2030, reduce by one-third 
premature mortality from non-communicable diseases through prevention and treatment 
(for which reducing tobacco use has been recognized as critical).20 In order to ensure 
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timely achievement of both these SDG targets, it is important that pro-equity, population-
level tobacco control policies such as comprehensive SFL are urgently implemented and 
enforced across all the countries. This is particularly important in LMICs which bear the 
highest tobacco-related burden2 and are lacking more in terms of implementation of 
comprehensive SFL.23 It is equally important that countries which do not yet have any 
SFL or have implemented partial SFL take appropriate steps towards implementation of 
comprehensive SFL, as outlined in the WHO FCTC62 and the WHO MPOWER183 to 
protect the vulnerable low SES groups.  
 
The national/state/regional Governments (particularly in the LMIC settings) should 
encourage and support high-quality research to evaluate the impact of population-level 
policy measures such as SFL. Along with the differential impact of policies by 
demographic indicators, it is important for researchers to assess differences by SES as 
well when SES is likely to be an important confounding factor in the association between 
the policy intervention and the outcome/s. As measuring SES or deprivation can be 
complex in LMICs, research should focus on multiple appropriate SES indicators as well 
as on composite indicators of SES.   
 
3.1.6.  Conclusion  
Comprehensive SFL has the potential to reduce socioeconomic inequalities in health 
outcomes resulting from exposure to tobacco smoke; partial SFL may not. Research 
from the LMIC settings focusing on this issue is lacking. Countries must strengthen their 
tobacco control policies and move towards comprehensive SFL along with other 
evidence-based tobacco control measures to achieve the UN SDG goals of reducing 
inequalities and premature mortality from NCDs by 2030.  
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Chapter 4: Secondhand smoke exposure and the impact of smoke-free legislation 
on protection against exposure to tobacco smoke: Multi-country evidence from 
Global Adult Tobacco Survey 
 
4.1.  Global Tobacco Surveillance System 
In order to help its member nations implement effective tobacco control measures, the 
WHO devised the FCTC and the MPOWER strategy.183 The MPOWER consists of 
guidance on implementation of six evidence-based tobacco control strategies to reduce 
the demand for tobacco183: 
1) Monitor tobacco use and prevention policies 
2) Protect people from tobacco smoke 
3) Offer help to quit tobacco use 
4) Warn about the dangers of tobacco 
5) Enforce bans on tobacco advertising, promotion, and sponsorship 
6) Raise taxes on tobacco 
 
Article 20.2 of the WHO FCTC urges parties to: 
 “Establish, as appropriate, programmes for national, regional and global surveillance of 
the magnitude, patterns, determinants and consequences of tobacco consumption and 
exposure to tobacco smoke. Towards this end, the Parties should integrate tobacco 
surveillance programmes into national, regional and global health surveillance 
programmes so that data are comparable and can be analysed at the regional and 
international levels, as appropriate.”16 
 
In the late 90’s some HICs collected some form of data on tobacco use behaviour, 
however, there was no uniform data collection system in most LMICs which would 
enable comparison of tobacco use and policy measures across these countries.184 To 
overcome this issue and towards fulfilment of ‘M’ of the MPOWER strategy and Article 
20.2 of the FCTC, the WHO, in collaboration with the Centers for Disease Control and 
Prevention (CDC) and the Canadian Public Health Association (CPHA) developed the 
Global Tobacco Surveillance System (GTSS) in 1999.133 The aim of GTSS is to enable 
capacity building among the WHO member nations to monitor tobacco use and related 
indicators so that they can design, implement and evaluate interventions for tobacco 
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control and monitor progress on implementation of tobacco control policies.133 GTSS 
provides uniform survey methodology and protocols, common core survey questionnaire 
(with the freedom to incorporate country-specific questions), standardised data 
collection, management, analysis and reporting guidance.  GTSS comprises of four 
types of surveys.133 
Three school-based surveys:  
1) Global Youth Tobacco Survey (GYTS) (13-15 year-old youth) 
2) Global School Personnel Survey (GSPS) (Adult school personnel) 
3) Global Health Professional Student Survey (GHPSS) (adults-medical, dental, 
pharmacy, nursing students) 
One household level survey: 
4) Global Adult Tobacco Survey (GATS) (non-institutionalized adults aged ≥15 
years of age) 
All the surveys collect data on the following185-188: 
a) Prevalence of tobacco use 
b) Knowledge and attitudes 
c) Access and availability 
d) Exposure to SHS 
e) Economics 
f) Media and advertising 
g) Cessation 
h) School curriculum and training 
i) Demographics 
 
Figure 4.1 shows the GTSS plan.189 After the survey is conducted, data is analysed and 
reported as per standardised protocols. The feedback from the periodically repeated 
surveys not only provides information about tobacco use behaviour but it also helps 
develop and strengthen national tobacco control programmes/plans and monitor 
progress. GTSS also allows development of applied research in the field of tobacco 
control wherein the data from various components can be used freely by tobacco control 
researchers for undertaking secondary data analyses. For example, the data from GTSS 
components, protocols, reports, country-factsheets, questionnaires and other survey 
related material are freely available for download from the GTSSData website.190 GTSS 
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also allows for enhancement of the role of civil society where they can be engaged in 
surveillance, monitoring, policy and programme development.184  
 
4.2.  Global Adult Tobacco Survey 
GATS, the newest component of GTSS launched since 2007, is a nationally 
representative cross-sectional household survey of non-institutionalized adults aged 15 
years and over.133, 191 It is considered to be the global standard for monitoring adult 
tobacco use and key tobacco control indicators. GATS employs standardised survey 
methodology with a few country-specific variations in the questionnaire.192 The GATS 
core questionnaire and the optional questions are available from the GTSSdata website 
at: https://nccd.cdc.gov/gtssdata/Ancillary/Documentation.aspx?SUID=4&DOCT=1.192 
GATS is designed to collect household as well as individual level data. The individual 
questionnaire includes questions on demographics, tobacco use and cessation, 
exposure to SHS, economics of tobacco use, anti- or pro-tobacco media exposure, and 
knowledge/attitudes/perceptions regarding the harms of tobacco use.192  Multi-stage 
cluster sampling design is used in GATS. The three stages of sampling in GATS 
involve193: 
a) First stage of sampling – Selection of Primary Sampling Units (PSUs) which are 
specific geographical regions in a country (Minimum 100 PSUs and 400 smaller 
Figure 4.1: Global Tobacco Surveillance System (GTSS) Plan – The process of implementation of GTSS and 
relevance for national tobacco control policies/programmes189 
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segments selected through probability proportional to size technique to ensure regional 
representation with each selected smallest area consisting of around 250 households) 
b) Second stage of sampling – After house listing exercise in each of the selected 
geographical area, approximately 25 households are randomly selected from the 
selected PSUs. 
c) Third stage of sampling – Random selection of an eligible participant from the 
selected households (also possible to select specific gender if gender randomization is 
required).  
 
The recommended minimum participant sample size for implementation of GATS in any 
country is 8000 per region when results are to be reported jointly by urbanicity and 
gender and 4000 per region when results are to be reported separately by urbanicity 
and gender.193 The minimum required sample size would be expected to move upward 
when considering design effect in excess of 2 and participant non-response or 
ineligibility.193  
 
Once the required number of households are selected from each geographic region, 
trained interviewers visit the households for surveys. During the visit, the interviewers 
obtain demographic information from any adult household member about all household 
members and with the help of electronic hand-held devices, they then randomly select 
one eligible member ≥ 15 years of age (in some countries, this selection can be stratified 
by gender) from each household, to participate in the survey.194 The selected participant 
from each household is then invited to participate in the GATS. The GATS questionnaire 
is then administered by the trained interviewers to consenting participants using 
electronic hand-held devices.194  
 
In order to account for the complex multi-stage design of GATS, sampling weights are 
employed for analysing GATS data. Sampling weights are intended to account for the 
probability of inclusion of each participant in the survey, non-response rates, differential 
demographic composition and other such factors which affect the sample 
composition.195 
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Between 2008 and 2011, the first round of GATS was implemented in 17 LMICs in five 
WHO regions (Table 4.1). Country-specific, anonymous GATS data for 16 of the 17 
LMICs (all but Indonesia) was freely available from the CDC GTSSData website,196 
which was used for secondary analyses in this study. Data for Malaysia only became 
available on the CDC website during later stages of this study and hence in some of the 
analyses presented as part of this study, Malaysia was not included. Moreover, 
subsequently, GATS has been conducted in 10 additional countries till December, 
2016.191 The additional countries include Argentina, Costa Rica, Greece, Kazakhstan, 
Kenya, Nigeria, Pakistan, Panama, Qatar, and Senegal. Data for 23 countries is now 
available from the CDC GTSSData website.196 
 
Table 4.1: Global Adult Tobacco Survey (GATS) countries in WHO Regions (2008-2011) 
South East Asian 
Region (SEAR) 
Western Pacific 
Region (WPR) 
Region of the 
Americas (AMR) 
European Region 
(EUR) 
Eastern Mediterranean 
Region (EMR) 
India China Brazil Poland Egypt 
Bangladesh Malaysia Mexico Romania  
Thailand Philippines Uruguay Russian Federation  
Indonesia Viet Nam  Turkey  
   Ukraine  
 
 
This chapter, along with the two research papers which are included in it, addresses 
Aims 2, 3, and 5 of the thesis. The first research paper presented in this chapter 
addresses Aim 2 (To study the association between SFL and exposure to SHS in the 
home in the LMIC settings) and the corresponding objective 2a. The second research 
paper presented in this chapter addresses Aim 3 (To study socioeconomic inequalities 
in exposure to SHS at home and in the workplace in LMICs) and the corresponding 
objective 2b. These research papers have also been published in peer-reviewed 
journals and presented as oral and poster presentations at international conferences 
and therefore, this chapter also addresses Aim 5 (To generate research evidence to 
strengthen implementation and enforcement of strong tobacco control policies including 
comprehensive SFL in the LMIC settings) and the corresponding objective 5. 
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* 
4.3.  Association between being employed in a smoke-free workplace and living 
in a smoke-free home: Evidence from 15 low- and middle-income countries 
 
4.3.1.  Abstract 
 
4.3.1.1.  Objective 
To assess whether being employed in a smoke-free workplace is associated with living 
in a smoke-free home in 15 low- and middle-income countries (LMICs). 
 
4.3.1.2.  Methods  
Country-specific individual level analyses of cross-sectional Global Adult Tobacco 
Survey data (2008–2011) from 15 LMICs was conducted using multiple logistic 
regression. The dependent variable was living in a smoke-free home; the independent 
variable was being employed in a smoke-free workplace. Analyses were adjusted for 
age, gender, residence, region, education, occupation, current smoking, current 
smokeless tobacco use and number of household members. Individual country results 
were combined in a random-effects meta-analysis. 
 
4.3.1.3.  Results  
In each country, the percentage of participants employed in a smoke-free workplace 
who reported living in a smoke-free home was higher than those employed in a 
workplace not smoke-free. The adjusted odds ratios (AORs) of living in a smoke-free 
home among participants employed in a smoke-free workplace (vs. those employed 
where smoking occurred) were statistically significant in 13 of the 15 countries, ranging 
from 1.12 [95% CI 0.79–1.58] in Uruguay to 2.29 [1.37–3.83] in China. The pooled AOR 
was 1.61 [1.46–1.79]. 
 
4.3.1.4.  Conclusion 
In LMICs, employment in a smoke-free workplace is associated with living in a smoke-
free home. Accelerated implementation of comprehensive smoke-free policies is likely to 
* Modified from original publication - Nazar GP, Lee JT, Glantz SA, Arora M, Pearce N, Millett C. 
Association between being employed in a smoke-free workplace and living in a smoke-free home: 
evidence from 15 low and middle income countries. Preventive Medicine. 2014;59:47-53.  
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result in substantial population health benefits in these settings.  
 
4.3.2.  Introduction 
Approximately 600,000 deaths are attributable to secondhand smoke (SHS) exposure 
globally each year.56 Adverse health effects from SHS exposure include sudden infant 
death syndrome and respiratory disorders in children and lung, breast cancer,197, 198 
cardiovascular disease and poorer reproductive outcomes in adults.6, 199 The bulk of the 
burden from SHS exposure falls on women and children living in low- and middle-
income countries (LMICs), where 80% of the world's smokers reside2 and where SHS 
exposure at home is typically high, ranging from 17% in Mexico to 73% in Viet Nam 
among countries participating in the Global Adult Tobacco Survey (GATS).53 Further, 
SHS exposure at home among non-smokers is higher among females compared with 
males.53  
 
Comprehensive smoke-free policies have high levels of public support and have been 
associated with substantial health benefits.21, 35, 200 These include reduced tobacco 
consumption and increased quit attempts, the virtual elimination of SHS from 
workplaces, lower hospital admission rates for myocardial infarction and stroke, lower 
admissions for acute respiratory illness in both children and adults,160, 201 and lower rates 
of small for gestational age births.202 However, these health benefits are not equitably 
distributed as only 16% of the world's population are covered by comprehensive smoke-
free policies.17  
 
Research evidence suggests that smoke-free workplace policies may change social 
norms about exposing others to SHS in the home.32-35 These findings indicate that early 
concerns that smoke-free workplace policies would lead to behavioural compensation 
through an increase in smoking at home have not materialised; rather, results from 
richer countries32-34 and India37 have consistently found that people employed in a 
smoke-free workplace are more likely to live in a smoke-free home. Replication of this 
finding in other LMICs would indicate that implementation of smoke-free policies in these 
settings will likely result in substantial reductions in tobacco-related harm globally. This 
study examines whether there is an association between being employed in a smoke-
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free workplace and living in a smoke-free home in 15 LMICs participating in GATS 
between 2008 and 2011.  
 
4.3.3.  Methods 
 
4.3.3.1.  Study design, setting, and data 
This study involved secondary analysis of GATS data from15 LMICs. GATS is a 
nationally representative cross-sectional household survey of non-institutionalized adults 
aged 15 years and over.191 It is considered to be the global standard for monitoring adult 
tobacco use and key tobacco control indicators. GATS employs standardised survey 
methodology with a few country-specific variations in the questionnaire and is designed 
to collect household as well as individual level data. Multi-stage cluster sampling design 
is employed in GATS to select a nationally representative study sample. Between 2008 
and 2011, the first round of GATS was implemented in 17 LMICs in five WHO regions.190 
Country-specific, anonymous GATS data for 15 of the 17 LMICs (all but Indonesia and 
Malaysia) was freely available from the CDC GTSS Data website, which was used for 
secondary data analysis. Poland and the Russian Federation are now classified as high 
income countries by the World Bank; however, when the first round of GATS was 
conducted in these countries in 2009, they belonged to the upper middle income 
category. Therefore, for the purpose of our study, we treated them as middle income 
countries. 
 
4.3.3.2.  Study participants 
We used individual level data from the first round of GATS in each of the 15 LMICs. 
GATS respondents in each country who reported working indoors (or both indoors and 
outdoors) but outside their home were included as participants for this study. 
Observations with missing values in the dependent or independent variables were 
dropped to obtain a final sample for each country. The proportion of missing cases 
ranged from 0.1% in Uruguay to 8.5% in China (Table 4.2). Table 4.2 describes the total 
number of participants included in our study from each of the 15 LMICs which ranged 
from 1174 in Romania to 12,912 in Brazil. 
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4.3.3.3.  Measures 
The GATS questionnaire includes core questions on tobacco use, SHS exposure at 
work and in the home, and socio-demographic information. For the present study, the 
dependent variable was ‘living in a smoke-free home’. A participant was classified as 
living in a smoke-free home if he/she replied ‘never’ to the question: How often does 
anyone smoke inside your home? If the participant responded ‘daily’, ‘weekly’, ‘monthly’, 
or ‘less than monthly’, he/she was considered as not living in a smoke-free home. The 
independent variable was ‘being employed in a smoke-free workplace’. The participant 
was classified as employed in a smoke-free workplace if he/she answered ‘no’ to the 
question: During the past 30 days, did anyone smoke in the indoor areas where you 
work? 
 
The potential confounders included were: age group, gender, residence, education, 
occupation, current smoking, current smokeless tobacco (SLT) use and number of 
household members. A country-specific region variable was also included for India, 
Thailand, China, Brazil, Poland and Ukraine (this information was not available for other 
countries). Current SLT use was not included as a covariate for Uruguay, Romania, and 
Turkey as there were only a very small number of users or no data on SLT use was 
available. In China, the occupation variable consisted of five categories rather than two 
as the categorization for employment differed substantially from other countries.203 Due 
to a negligible number of participants educated up to the primary level in Romania, 
Russian Federation, and Ukraine, we merged these with the ‘up to secondary level’ 
education category. See Supplementary Table in Appendix C-1 for a detailed description 
of the definitions of variables used in this study.   
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 a Occupation categories in China differed from those of other LMICs. Five occupation categories were considered for China and hence have not been presented in this table for maintaining uniformity. 
b In Brazil, education categories were defined differently and were incomparable to those from other GATS countries.  
c In Uruguay, there were no current smokeless tobacco users in the study population. 
d In Romania, the category ‘Primary’ for the education variable contained only 1 case and hence, was merged with the category ‘Secondary’. Moreover, the study sample in Romania contained only six cases of current smokeless tobacco users which constituted a 
negligible proportion and hence has not been presented in the table.  
e In Russian Federation and Ukraine, the category ‘Primary’ for the education variable contained only 10 and 8 cases respectively and hence, were merged with the category ‘Secondary’ 
f In Turkey, no data was available on current smokeless tobacco use from the GATS survey.  
Table 4.2: Description of participants living in smoke-free homes among those working indoors in GATS countries (2008-2011) – Weighted %  
  SEAR WPR AMR EUR EMR 
  India 
N=12,561 
Bangladesh 
N=1,663 
Thailand 
N=4,999 
Chinaa 
N=1,711 
Philippines 
N=2,083 
Viet Nam 
N=2,373 
Brazilb 
N=12,912 
Mexico 
N=2,026 
Uruguayc 
N=1,805 
Poland 
N=2,973 
Romaniad 
N=1,174 
Russian 
Federatione 
N=5,426 
Turkeyf 
N=2,007 
Ukrainee 
N=2,741 
Egypt 
N=4,365 
Smoke-free at home 57.2 40.6 69.5 13.1 45.6 15.9 64.5 73.4 54.6 43.3 43.3 51.8 37.4 65.7 37.0 
Smoke-free at work 
Yes  64.0 53.0 73.3 20.5 53.3 22.1 66.6 74.5 55.3 48.5 49.3 56.6 42.4 70.7 41.8 
No 41.7 34.1 58.5 9.2 28.9 11.1 58.0 68.5 51.1 33.0 31.7 43.4 28.8 55.4 33.8 
Age Group (yrs) 
15-29 53.1 40.6 63.9 11.7 43.3 12.9 62.9 75.8 43.9 42.7 39.2 51.6 31.4 60.1 30.8 
30-44 58.8 39.2 70.7 14.7 47.7 17.4 66.2 71.3 60.1 46.9 45.0 52.2 40.5 67.1 40.2 
45-59 59.9 46.3 75.8 11.5 47.0 19.1 64.1 72.2 56.4 38.9 42.1 51.0 40.0 66.6 40.2 
≥60 62.4 30.1 63.7 11.5 38.0 17.0 64.0 76.3 63.5 46.6 58.3 55.7 56.9 80.9 48.1 
Gender  
Male 56.4 40.1 64.5 11.2 42.7 14.7 65.4 72.2 54.2 44.2 44.1 52.9 38.2 64.7 35.8 
Female 61.6 44.6 74.7 16.2 48.6 17.3 63.6 75.2 55.0 42.2 42.4 50.8 34.8 66.8 41.1 
Residence 
Urban 65.4 47.4 74.0 17.2 55.8 21.9 64.8 73.2 54.4 43.4 37.7 49.9 37.8 64.7 41.3 
Rural 49.0 35.9 65.6 06.8 25.6 10.8 58.2 75.0 59.1 43.0 57.8 59.3 35.3 69.8 31.1 
Education 
Primary 44.2 31.1 58.8 5.0 26.4 9.7 - 76.0 54.7 39.7 - - 34.0 - 27.4 
Secondary 58.8 45.8 69.6 11.5 45.6 18.3 - 73.5 53.6 39.9 43.9 50.7 34.1 62.7 34.6 
Tertiary 71.8 67.2 81.1 18.5 59.4 22.3 - 71.3 58.6 52.7 41.9 52.7 49.2 71.4 48.8 
Occupation  
Employed 58.7 55.8 69.8 - 46.8 21.1 65.4 72.9 54.4 43.3 41.9 51.7 37.1 65.6 38.0 
Self-employed 55.1 34.5 68.1 - 40.7 11.4 62.0 75.0 55.8 43.3 59.1 53.4 38.8 67.8 32.3 
Current smoking  
Yes  28.8 27.6 47.8 8.1 25.7 10.2 34.6 65.2 29.7 17.7 24.7 36.8 26.2 46.7 12.8 
No 63.4 49.5 76.0 16.0 52.5 18.2 70.1 75.7 63.7 58.0 53.4 63.3 47.3 76.0 48.0 
Current smokeless tobacco use  
Yes  38.8 33.6 54.1 9.3 47.4 31.8 46.9 41.1 - 63.4 - 27.2 - 57.0 15.9 
No 63.5 42.9 69.5 13.1 45.6 15.9 64.5 73.6 54.6 43.2 43.5 51.9 - 65.8 37.7 
Missing cases (%) 7.1 8.2 1.6 8.5 2.2 2.8 4.0 3.6 0.1 4.2 1.5 2.7 1.5 2.6 3.3 
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4.3.3.4.  Statistical analysis 
We conducted country-specific, individual level data analysis for each LMIC. We tested 
for bivariate associations between the independent variable with the dependent variable 
using Chi-square tests. Country-specific multiple logistic regression models were run to 
estimate the adjusted odds ratio (AOR) and 95% confidence interval (95% CI) of living in 
a smoke-free home if employed in a smoke-free workplace compared with being 
employed in a workplace where smoking occurred. The logistic regression models were 
adjusted for all the covariates described above (with country-specific exclusions) to 
minimise confounding and ensure comparability of findings across countries. Age and 
number of household members were treated as continuous variables. In Brazil, the 
‘education’ variable was not included in the model because the variable definition was 
not comparable with other GATS countries,147 however, we did conduct a sensitivity 
analysis by including education variable in the model and found that the results were 
consistent with those obtained without including it in the model. 
 
We tested for multicollinearity between the covariates adjusted for in the analysis for 
each country. The multicollinearity diagnostics variance inflation factor (VIF) values were 
all less than five, indicating reasonable independence between the predictor variables 
for each country-specific model.204 The only exception to this was Egypt where we 
observed evidence of multicollinearity between the variables “national region” and 
“residence” (urban/rural). The variable ‘national region’ was removed from the model in 
Egypt to maintain uniformity as that variable was not available for several other 
countries as well. Country-specific sampling weights were applied for all analyses to 
account for the complex study design. 
 
To estimate the overall association of being employed in a smoke-free workplace with 
living in a smoke-free home across the 15 LMICs, we calculated a pooled AOR and 95% 
CI using a random effects meta-analysis based on the AOR's from the individual 
countries. All the statistical analyses were conducted using STATA v.12.0. 
 
 
 
109 
 
4.3.4.  Results 
 
4.3.4.1.  Descriptive statistics 
Of the participants employed indoors outside the home, the percentage reporting a 
smoke-free workplace was 83% in Uruguay, 81% in Mexico, 76% in Brazil, 74% in 
Thailand, 70% in India, 68% in Ukraine and Philippines, 66% in Romania and Poland, 
64% in Russian Federation, 63% in Turkey, 44% in Viet Nam, 40% in Egypt and 35% in 
Bangladesh and China (data not shown). In all the 15 LMICs, the percentage of 
participants living in a smoke-free home was higher among those employed in a smoke-
free workplace compared with those employed in a workplace where smoking occurred 
(Fig. 4.2, Table 4.2). Among participants employed in a smoke-free workplace, the 
percentage living in a smoke-free home varied from 21% in China to 75% in Mexico. 
Among participants employed in a workplace that was not smoke-free, the percentage 
living in a smoke-free home varied from 9% in China to 69% in Mexico. Table 4.2 
describes the country-specific percentages of participants reporting living in smoke-free 
homes by their socio-demographic characteristics. 
 
4.3.4.2.  Multiple logistic regression analysis 
There were significant positive associations between being employed in a smoke-free 
workplace and living in a smoke-free home in all LMICs except Uruguay and Mexico 
(Fig. 4.3, Table 4.3). The AOR estimates ranged from 1.12 [0.79–1.58] in Uruguay to 
2.29 [1.37–3.83] in China. The pooled AOR for the all-country data was 1.61 [1.46–
1.79]. Female participants were less likely than males to live in a smoke-free home in 
most LMICs but associations were only significant in India, Bangladesh, Brazil, Poland, 
Russian Federation, Turkey, Ukraine, and Egypt. Participants from urban settings in 
India, Thailand, China, Philippines, Viet Nam, Brazil, and Egypt were significantly more 
likely to live in a smoke-free home compared with those from the rural settings. In 
contrast, participants from rural settings were significantly more likely to live in a smoke-
free home in Romania, Russian Federation, and Ukraine. The likelihood of living in a 
smoke-free home significantly increased with increasing education level in India, 
Bangladesh, Thailand, Philippines, Ukraine, and Egypt. Non-smokers were consistently 
more likely to live in a smoke-free home than smokers. No association was observed 
between SLT use and living in a smoke-free home. 
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Figure 4.2: Percentage of participants living in smoke-free homes by smoke-free status of the workplace in 15 GATS 
countries (2008–2011) 
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Figure 4.3: Forest plot showing country-specific and pooled adjusted odds ratios (95% CIs) of living in a smoke-free 
home among those employed in a smoke-free workplace compared with those employed in workplaces where 
smoking occurred (GATS 2008–2011) 
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Table 4.3: Association of being employed in a smoke-free workplace with living in a smoke-free home among those working indoors in GATS countries (2008-2011) – Adjusted Odds Ratio [95% CI]a 
  SEAR WPR AMR EUR EMR 
  India 
N=12,561 
Bangladesh 
N=1,663 
Thailand 
N=4,999 
China 
N=1,711 
Philippines 
N=2,083 
Viet Nam 
N=2,373 
Brazil 
N=12,912 
Mexico 
N=2,026 
Uruguay 
N=1,805 
Poland 
N=2,973 
Romania 
N=1,174 
Russian 
Federation 
N=5,426 
Turkey 
N=2,007 
Ukraine 
N=2,741 
Egyptb  
N=4,365 
Smoke-free at work 
Yes  2.09 
[1.77, 2.46] 
1.71 
[1.22, 2.41] 
1.52 
[1.20, 1.93] 
2.29 
[ 1.37, 3.83] 
2.15 
[1.65, 2.79] 
1.97 
[1.45, 2.67] 
1.35 
[1.20, 1.51] 
1.29 
[0.98, 1.70] 
1.12 
[0.79, 1.58] 
1.45 
[1.18, 1.79] 
1.99 
[1.43, 2.76] 
1.55 
[1.30, 1.85] 
1.64 
[1.28, 2.11] 
1.75 
[1.41, 2.18] 
1.30 
[1.09, 1.54] 
No 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 
Age (yrs) 
 1.02 
[1.01, 1.03] 
1.01 
[0.99, 1.02] 
1.02 
[1.01, 1.04] 
1.00 
[0.98, 1.03] 
1.00 
[0.99, 1.01] 
1.02 
[1.01,  1.03] 
1.01 
[1.003, 1.011] 
0.99 
[0.98, 1.00] 
1.02 
[1.01, 1.03] 
0.99 
[0.98, 1.00] 
1.01 
[0.99, 1.02] 
0.99 
[0.98, 1.00] 
1.02 
[1.01, 1.03] 
1.01 
[0.99, 1.02] 
1.02 
[1.01, 1.03] 
Gender  
Male 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 
Female 0.63 
[0.53, 0.76] 
0.52 
[0.33, 0.83] 
0.93 
[0.73, 1.17] 
0.89 
[0.46, 1.73] 
0.84 
[0.66, 1.07] 
0.73 
[0.52,1.02] 
0.84 
[0.76, 0.93] 
1.07 
[0.82, 1.38] 
0.89 
[0.73, 1.09] 
0.71 
[0.59, 0.87] 
0.76 
[0.57, 1.03] 
0.52 
[0.43, 0.63] 
0.62 
[0.45, 0.85] 
0.52 
[0.41, 0.66] 
0.58 
[0.48, 0.71] 
Residence 
Urban 1.57 
[1.32, 1.85] 
1.28 
[0.92, 1.77] 
1.31 
[1.04, 1.64] 
2.05 
[1.21, 3.48] 
3.06 
[2.31, 4.04] 
2.01 
[1.46, 2.77] 
1.28 
[1.01, 1.63] 
1.03 
[0.73, 1.44] 
0.81 
[0.60, 1.10] 
1.09 
[0.86, 1.39] 
0.48 
[0.33,  0.69] 
0.75 
[0.60, 0.93] 
1.06 
[0.81, 1.38] 
0.77 
[0.60, 0.99] 
1.31 
[1.08, 1.60] 
Rural 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 
Education 
Primary 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) - 1 (Ref) 1 (Ref) 1 (Ref) - - 1 (Ref) - 1 (Ref) 
Secondary 1.58 
[1.34, 1.86] 
1.54 
[1.12, 2.13] 
1.86 
[1.46, 2.37] 
1.43 
[0.70, 2.92] 
1.70 
[1.13, 2.56] 
1.60 
[1.08, 2.36] 
- 0.81 
[0.57, 1.15] 
0.98 
[0.72, 1.33] 
0.76 
[0.47, 1.24] 
1 (Ref) 1 (Ref) 0.98 
[0.77, 1.26] 
1 (Ref) 1.23 
[0.97, 1.57] 
Tertiary 2.26 
[1.83, 2.78] 
2.90 
[1.76, 4.78] 
2.54 
[1.92, 3.36] 
1.47 
[0.56, 3.87] 
2.39 
[1.58, 3.62] 
0.99 
[0.33, 3.02] 
- 0.73 
[0.49, 1.10] 
1.06 
[0.70, 1.60] 
1.05 
[0.63, 1.74] 
1.13 
[0.82, 1.55] 
1.04 
[0.88, 1.23] 
1.61 
[1.14, 2.28] 
1.30 
[1.03, 1.65] 
1.60 
[1.23, 2.09] 
Occupation  
Employed 0.99 
[0.85, 1.15] 
1.41 
[1.02, 1.93] 
0.86 
[0.66, 1.14] 
- 0.74 
[0.55, 0.99] 
1.35 
[0.97, 1.87] 
1.05 
[0.94, 1.17] 
0.89 
[0.61,1.30] 
1.08 
[0.78, 1.49] 
1.04 
[0.81, 1.35] 
0.44 
[0.27,  0.72] 
0.96 
[0.71, 1.32] 
0.88 
[0.66, 1.16] 
0.86 
[0.59, 1.28] 
0.88 
[0.67, 1.15] 
Self  
employed 
1 (Ref) 1 (Ref) 1 (Ref) - 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 
Current smoking  
Yes  1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 
No 4.49 
[3.62, 5.57] 
2.50 
[1.81, 3.47] 
3.07 
[2.34, 4.02] 
1.67 
[0.76, 3.65] 
2.84 
[2.05, 3.92] 
2.04 
[1.35, 3.06] 
4.53 
[3.98, 5.16] 
1.62 
[1.20,  2.19] 
4.18 
[3.09, 5.66] 
6.07 
[4.87, 7.57] 
3.78 
[2.74, 5.22] 
3.58 
[2.93, 4.37] 
2.47 
[1.91, 3.19] 
4.25 
[3.38, 5.35] 
7.64 
[6.04, 9.67] 
Current smokeless tobacco use  
Yes  1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) - 1 (Ref) - 1 (Ref) - 1 (Ref) 1 (Ref) 
No 1.84 
[1.54, 2.20] 
1.16 
[0.77, 1.75] 
1.64 
[0.50, 5.40] 
0.68 
[0.09, 5.38] 
1.73 
[0.48, 6.31] 
0 .22 
[0.03, 1.59] 
2.25 
[0.78, 6.48] 
3.12 
[0.83,11.68] 
- 0.36 
[0.06, 2.25] 
- 2.29 
[0.78, 6.68] 
- 0.86 
[0.10, 7.72] 
0.90 
[0.44, 1.86] 
Number of household members 
 0.96 
[0.93, 0.99] 
0.91 
[0.84, 0.99] 
0.94 
[0.89, 1.00] 
1.12 
[0.88, 1.42] 
0.94 
[0.88, 0.99] 
0.90 
[0.81, 0.99] 
0.98 
[0.95, 1.02] 
0.99 
[0.92, 1.06] 
0.99 
[0.90, 1.10] 
1.01 
[0.93, 1.08] 
1.17 
[1.03, 1.32] 
1.09 
[1.01, 1.17] 
0.96 
[0.90, 1.02] 
1.11 
[1.01, 1.21] 
0.91 
[0.85,  0.96] 
a Adjusted odds ratios and 95% CIs obtained from country-specific individual-level multivariate logistic regression models adjusted for age, gender, place of residence, education, occupation, current smoking, current smokeless tobacco use and number 
of household members. A country-specific region variable was also included in the models for India, Thailand, China, Brazil, Poland and Ukraine (not shown in the table to maintain uniformity as regions varied by country).  
b  Region variable was excluded from the country-specific regression model in Egypt due to collinearity (VIF>13) 
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4.3.5.  Discussion 
This study utilised data from the first round of GATS, conducted in 15 LMICs between 
2008 and 2011, to examine whether being employed in a smoke-free workplace is 
associated with living in a smoke-free home. We found positive associations in all of the 
15 LMICs studied (13 out of 15 being statistically significant) in individual level country-
specific analysis. The pooled estimate indicated that participants employed in a smoke-
free workplace were 60% more likely to live in a smoke-free home compared with those 
that worked where smoking occurred. These findings are consistent with those from 
previous studies conducted in high income settings. Cheng et al. in a longitudinal study 
conducted in the USA suggested that living in smoke-free homes was four to seven 
times more likely among those employed in a 100% smoke-free workplace (compared 
with those employed in workplaces where smoking occurred).33 Another longitudinal 
study found similar reductions in self-reported smoking among smokers in their home 
after the introduction of comprehensive smoke-free policies in Ireland (85% to 80%; p = 
0.002) and the UK (82% to 76%; p = 0.003).35 An evaluation of the smoke-free policy 
introduced in New Zealand in 2004 suggested that SHS exposure at workplaces 
decreased from 20% to 8% and the proportion of smoke-free homes increased from 
64% to 70% between 2003 and 2006.110  
 
Article 8 of WHO Framework Convention on Tobacco Control (FCTC) requires Parties to 
adopt and implement measures to reduce exposure to tobacco smoke in indoor 
workplaces, indoor public places, public transport and other public places.16 However, 
disparities observed in the implementation and enforcement of Article 8 of FCTC in 
LMICs17 suggest that these benefits are not being fully realised. Our study identified 
substantial differences in the percentage of participants employed in a smoke-free 
workplace who were living in a smoke-free home. This varied from 21% in China to 75% 
in Mexico. These findings highlight the role of other determinants of SHS exposure in 
the home, including smoking prevalence, the implementation of other tobacco control 
strategies and cultural norms, which vary considerably in the countries studied. 
Knowledge and attitudes about the harms of SHS exposure are also likely to play an 
important role in variations in the adoption of smoke-free homes.205 A recent study 
conducted in the United States has shown that clean indoor air laws increase the 
likelihood of having voluntary smoke-free homes by 3–5%.36 Despite the observed 
country-specific variations in the strength of association, the consistency of the observed 
relationship across major LMIC settings is noteworthy and favours comprehensive 
smoke-free policies as recommended by the WHO.199 
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Our study additionally implies that the benefits which arise out of smoke-free workplace 
policies are not only restricted to the direct health and economic benefits,21 but may also 
extend to changing societal norms around SHS exposure in the home in LMICs. 
Truelove et al. suggest that one pro-environmental behaviour may have unintended 
positive effects on another pro-environmental behaviour, a phenomenon called positive 
spillover effect, which may be moderated by several factors related to initial decision 
making, internal and external motivators, and similarity between the two behaviours.206 
Similarly, in our case, being employed in a smoke-free workplace was observed to have 
a positive spillover effect on living in a smoke-free home, which may have been 
moderated by changing social norms and similarity between the two behaviours. 
Highlighting the role of social contingencies and cultural influences in SHS exposure, 
Hovell and Hughes suggest that acceptability of smoking demonstrates an attitude of 
cultural tolerance towards smoking and SHS exposure, which ultimately leads to 
widespread recognition of smoking and exposing others to tobacco smoke as normative 
behaviour.207 Smoke-free policies serve to disrupt such reinforcement of smoking and 
SHS exposure, thereby aiding effective tobacco control.207 Our findings suggest that 
smoke-free policies may consistently lead to spreading of smoke-free norms in all of the 
major LMICs studied, irrespective of country-specific variations in tobacco use and 
implementation of smoke-free policies. Further, smoke-free policies can bring about 
behaviour change (quitting or prevention of smoking initiation) through such normative 
influences.208  
 
Our results show that women were less likely to live in a smoke-free home compared 
with men in most LMICs studied. This is not surprising given the generally higher 
prevalence of smoking among men in these settings.46 Women and children are usually 
exposed to SHS due to smoking by spouses or other family members at homes in 
LMICs, many of which still follow patriarchal norms,209 making it likely that women have 
little authority over allowance of smoking at home.210 Other explanations of high SHS 
exposure among women may include having no household rules for smoking, poor 
knowledge about the risks of SHS exposure and misconceptions regarding tobacco 
use.210 We reiterate the recommendations of Öberg et al.,56 who favour empowering and 
educating the women in LMICs to promote smoke-free policies to protect themselves 
and their families from SHS exposure. 
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In most of the LMICs studied, participants in urban settings were more likely to live in a 
smoke-free home compared with those from rural settings. This may be explained by the 
lower prevalence of smoking in urban settings compared to rural settings in LMICs. 
Moreover, this could also be explained by the typical enclosed structure of urban 
dwellings, which prevents smoke from dissipating to the outside environment and make 
smoke undesirable in this setting, compared with the rural dwellings which typically have 
more open space, that would allow the smoke to dissipate faster into the surrounding 
outer environment thereby minimizing discomfort due to the smoke. 
 
4.3.5.1.  Strengths and limitations 
We used nationally representative GATS data from 15 LMICs, which include some of 
the most populous nations of the world. We found a consistent association between 
being employed in a smoke-free workplace and living in a smoke-free home across 
these vastly differing cultural settings, which have different smoking prevalence rates 
and varying implementation of tobacco control policies, including smoke-free policies. 
We did not conduct country-specific analyses stratified by the comprehensiveness of 
SFL (estimated as the percentage of participants employed in smoke-free workplaces) 
as we did not observe significant changes in the strength of association with increasing 
levels of comprehensiveness of SFL. Our data were cross-sectional and restricted our 
ability to determine causal direction. However, in this case, the likelihood of reverse 
causality i.e. a person living in a smoke-free home resulting in a workplace becoming 
smoke-free seems unlikely, particularly for larger workplaces. Nevertheless, previous 
longitudinal studies conducted in high income countries have demonstrated that persons 
employed in a smoke-free workplace are more likely to live in a smoke-free home 
prospectively.33, 35, 36, 110 Standard definitions of SHS exposure at home and SHS 
exposure at workplace (in past 30 days) as reported in previously published literature 
were used.37, 53, 211, 212 However, it is possible that different definitions (e.g. daily/weekly 
exposure) may demonstrate different associations. Educational and occupational 
classifications varied and were not always comparable between GATS countries e.g. 
occupation in China and education in Brazil. For these, we conducted sensitivity 
analyses after excluding these variables from the analyses and our results remained 
substantially unchanged. We relied on self-reported measures of exposure to SHS at 
home and workplaces in the absence of biological markers such as cotinine levels. 
However, a good correlation has been shown between cotinine levels and self-reported 
measures in previous studies.213 
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4.3.5.2.  Policy implications 
The United Nations High-Level Meeting on non-communicable diseases (NCDs) in 
September 2011 recommended establishing tobacco-free workplaces as an important 
component for NCD prevention and control.214 Our findings provide some evidence to 
strengthen the case for rapid implementation of smoke-free policies in LMICs involving 
complete elimination of smoking and SHS exposure from workplaces. However, 
additional evidence at the population level showing the implementation of SFL results in 
an increased population prevalence of smoke-free homes in LMICs would also be 
compelling. Leadership and action at the national level by governments is the key to 
strengthening the implementation of smoke-free policies. The Government of Russian 
Federation recently demonstrated such leadership by enacting new comprehensive 
tobacco control policies, which resulted in smoke-free policies being extended beyond 
indoor public places to outdoor public places such as playgrounds and beaches from 
June 2013.215, 216 From 2014, all the hospitality venues, shopping areas, public transport, 
terminals and ports in Russian Federation are required to be 100% smoke-free. 
 
4.3.6.  Conclusion 
Associations between being employed in a smoke-free workplace and living in a smoke-
free home, previously demonstrated in high income countries, also exist in LMICs. 
Accelerating implementation of comprehensive smoke-free public place policies is likely 
to result in substantial population health gain in these settings. 
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4.4.  Socioeconomic inequalities in secondhand smoke exposure at home and 
at work in 15 low- and middle-income countries 
 
4.4.1.  Abstract 
 
4.4.1.1.  Introduction 
In high-income countries, secondhand smoke (SHS) exposure is higher among 
disadvantaged groups. We examine socioeconomic inequalities in SHS exposure at 
home and in the workplace in 15 low- and middle-income countries (LMICs). 
 
4.4.1.2.  Methods 
Secondary analyses of cross-sectional data from 15 LMICs participating in Global Adult 
Tobacco Survey (participants ≥ 15 years; 2008–2011) were used. Country-specific 
analyses using regression-based methods were used to estimate the magnitude of 
socioeconomic inequalities in SHS exposure: (1) Relative Index of Inequality (2) Slope 
Index of Inequality.  
 
4.4.1.3.  Results 
SHS exposure at home ranged from 17.4% in Mexico to 73.1% in Viet Nam; exposure at 
workplace ranged from 16.9% in Uruguay to 65.8% in Bangladesh. In India, 
Bangladesh, Thailand, Malaysia, Philippines, Viet Nam, Uruguay, Poland, Turkey, 
Ukraine, and Egypt, SHS exposure at home reduced with increasing wealth (Relative 
Index of Inequality range: 1.13 [95% confidence interval (CI) 1.04–1.22] in Turkey to 
3.31 [95% CI 2.91–3.77] in Thailand; Slope Index of Inequality range: 0.06 [95% CI 
0.02–0.11] in Turkey to 0.43 [95% CI 0.38–0.48] in Philippines). In these 11 countries, 
and in China, SHS exposure at home reduced with increasing education. In India, 
Bangladesh, Thailand, and Philippines, SHS exposure at workplace reduced with 
increasing wealth. In India, Bangladesh, Thailand, Philippines, Viet Nam, Poland, 
Russian Federation, Turkey, Ukraine, and Egypt, SHS exposure at workplace reduced 
with increasing education.  
* Modified from original publication - Nazar GP, Lee JT, Arora M, Millett C. Socioeconomic Inequalities 
in Secondhand Smoke Exposure at Home and at Work in 15 Low- and Middle-Income Countries. 
Nicotine & Tobacco Research. 2016;18:1230-9. 
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4.4.1.4.  Conclusion 
SHS exposure at homes is higher among the socioeconomically disadvantaged in the 
majority of LMICs studied; at workplaces, exposure is higher among the less educated. 
Pro-equity tobacco control interventions alongside targeted efforts in these groups are 
recommended to reduce inequalities in SHS exposure. 
 
4.4.2.  Implications 
SHS exposure is higher among the socioeconomically disadvantaged groups in high-
income countries. Comprehensive smoke-free policies are pro-equity for certain health 
outcomes that are strongly influenced by SHS exposure. Using nationally representative 
Global Adult Tobacco Survey (2008–2011) data from 15 LMICs, we studied 
socioeconomic inequalities in SHS exposure at homes and at workplaces. The study 
showed that in most LMICs, SHS exposure at homes is higher among the poor and the 
less educated. At workplaces, SHS exposure is higher among the less educated groups. 
Accelerating implementation of pro-equity tobacco control interventions and 
strengthening of efforts targeted at the socioeconomically disadvantaged groups are 
needed to reduce inequalities in SHS exposure in LMICs. 
 
4.4.3.  Introduction 
Exposure to secondhand smoke (SHS) has led to more than 600,000 deaths globally in 
2010,45 with women and children bearing the maximum brunt of it.56 Adverse health 
outcomes among adults include cardiovascular and respiratory diseases; among 
children, SHS exposure causes low birth weight, sudden death, and middle ear 
infections.6 Eighty percent of the world’s smokers live in the low- and middle-income 
countries (LMICs), and SHS exposure in homes, workplaces, and other public places in 
many LMIC settings remains high.53 The World Health Organization (WHO) Framework 
Convention on Tobacco Control (FCTC) recommends comprehensive smoke-free 
policies to protect people from SHS.162  
 
Socioeconomic status (SES) influences tobacco use with higher consumption among 
the poor and those with less education.147 A recent study examined socioeconomic 
inequalities in smoking in LMICs and suggested a similar overall negative gradient in 
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smoking (smoking being most prevalent among low SES groups) to that documented in 
high-income countries (HICs).217 In LMICs, as in HICs, strong tobacco control policies, 
including smoke-free regulations, are responsible for changing social norms by 
promoting smoking as an unacceptable behaviour, thereby protecting the non-smokers 
from SHS exposure.43, 218 Evidence from HICs suggests that SHS exposure is higher 
among the socioeconomically disadvantaged populations and occurs predominantly at 
homes and indoor workplaces;6 however, there is little nationally representative data 
available from LMICs on socioeconomic inequalities in SHS exposure in these settings. 
Understanding the degrees of socioeconomic inequalities in SHS exposure can help 
identify opportunities to reduce inequalities in health. We examine socioeconomic 
inequalities in SHS exposure at home and at the workplace in 15 LMICs using nationally 
representative data from the Global Adult Tobacco Survey (GATS). 
 
4.4.4.  Methods 
 
4.4.4.1.  Study design, setting, and data 
We conducted secondary analysis of the GATS data, which is available freely on the 
Global Tobacco Surveillance System (GTSS) website190 of the Centers for Disease 
Control and Prevention (CDC). GATS is a nationally representative cross-sectional 
household survey of noninstitutionalized adults aged 15 years and above.191 It is 
considered to be the global standard for monitoring adult tobacco use and key tobacco 
control indicators. GATS employs a standardised survey methodology with a few 
country-specific variations in the questionnaire and is designed to collect household as 
well as individual-level data. Multi-stage cluster sampling design is employed in GATS to 
select a nationally representative study sample. Between 2008 and 2011, the first round 
of GATS was implemented in 17 LMICs across five WHO regions.190 Country-specific, 
anonymous GATS data for 16 of the 17 LMICs (except Indonesia) was available from 
the CDC GTSSData website. Poland and the Russian Federation are now classified as 
HICs by the World Bank; however, when the first round of GATS was conducted in 
these countries in 2009, they belonged to the upper middle-income category. Hence, for 
the purpose of our study, we treated them as middle-income countries. Further, we 
excluded Brazil from our data analyses because a key variable of interest, that is, the 
“wealth index,” was not comparable with that of other countries. Therefore, we included 
data from 15 countries in our analyses. 
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4.4.4.2.  Study participants 
We used individual-level data from the first round of GATS (2008–2011) for each of the 
15 LMICs. Separate analyses were conducted to examine outcomes for “SHS exposure 
at home” and “SHS exposure at the workplace.” In each country, analyses for the former 
outcome included all the GATS participants 15 years of age or older, while for the latter 
outcome, all GATS participants 15 years of age or older, who reported working indoors 
(or both indoors and outdoors) but outside their home were included as participants. 
Observations with missing values in the dependent or independent variables were 
dropped to obtain a final sample for each country. 
 
4.4.4.3.  Measures 
 
Dependent Variables 
 
SHS Exposure at Home 
A participant was considered to be exposed to SHS at home if he/she responded “daily,” 
“weekly,” or “monthly” to the question: How often does anyone smoke inside your 
home? If the participant responded “less than monthly” or “never” to the question, 
he/she was considered not exposed to SHS at home.  
 
SHS Exposure at Workplace 
A participant was considered to be exposed to SHS at the workplace if he/she 
responded “yes” to the question: “During the past 30 days, did anyone smoke in indoor 
areas where you work?” If the participant responded “no” to the question, he/she was 
considered not exposed to SHS at the workplace.  
 
Participants who answered “don’t know” or “refused” to answer on either of the 
questions for the dependent variables were dropped from the study (see Supplementary 
Tables in Appendix C-2 and Appendix C-3 for further details).  
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Independent Variables 
 
Wealth Quintile 
Using a previously validated method, that is, the inverse possession weighting 
approach, we computed a summary score from a list of household assets that the 
participants possessed (e.g., electricity, flush toilet, car, and television).219, 220 This 
approach uses the inverse of the proportion of households with an asset as a weight for 
the indicator, that is, higher weights are given to least possessed assets.221 We then 
divided the summary score into wealth quintiles, the lowest quintile being the poorest 
and the highest quintile being the richest. 
 
Education 
Education was grouped into three categories in all countries—completed education up 
to: primary level (no formal education, less than primary school completed, and primary 
school completed); secondary level (less than secondary school completed, secondary 
school completed, and higher secondary school completed); and tertiary level 
(college/university/postgraduate degree completed).  
 
Other covariates included in the analyses were age group, gender, residence, and 
occupation. We also included the “geographic region” variable in the model for each 
country, whenever the variable was available. The countries in which “geographic 
region” variable was included were India, Thailand, China, Poland, and Ukraine. 
 
4.4.4.4.  Statistical methods 
We used three regression-based methods to measure different dimensions of 
socioeconomic inequalities in SHS exposure: (1) Relative Index of Inequality (RII); (2) 
Slope Index of Inequality (SII); and (3) Adjusted Odds Ratio (AOR). The RII and SII are 
regression-based summary measures of inequalities that take into account SHS 
exposure across the entire socioeconomic distribution in the study population, whereas 
the AOR is the ratio of SHS exposure between each category of the SES variable with 
its reference category.222, 223  
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To calculate RII and SII, individuals were cumulatively ranked (ranging from 0 to 1) 
according to their education and wealth status such that “0” represented the highest 
wealth/education level and “1” represented the lowest wealth/education level (RIDIT 
scores).5 The RIDIT scores for wealth and education were continuous variables unlike 
the use of these SES variables for calculating AOR where these were categorical 
variables. RII provides a prevalence rate ratio while SII gives a prevalence rate 
difference of SHS exposure—between participants with lower wealth/education levels 
and those with higher wealth/education levels.5 We used a “modified Poisson” approach, 
as suggested by Zou to compute SII and RII, which provides more robust estimates as 
compared to using the binary approach.224 All analyses for calculations of RII and SII 
were adjusted for age group and gender. Values of SII larger than 0 and RII values 
larger than 1 indicate that the poor are more likely to be exposed to SHS compared with 
the rich; similarly, the less educated are more likely to be exposed to SHS compared 
with the more educated.  
 
Further, we included interaction terms ([RIDIT scores for wealth levels × gender] and 
[RIDIT scores for education levels × gender]) in the country-specific generalised linear 
models to assess if inequalities in SHS exposure at home and at the workplace differed 
significantly by gender. We found that in the majority of these 15 countries, gender was 
not an effect-modifier. However, considering the findings of previously published 
studies,53 and our descriptive findings which suggest that gender differences exist in 
SHS exposure, we conducted disaggregated analysis by gender. 
 
We also ran country-specific multiple logistic regression models to estimate the 
relationship between SES and SHS exposure (at home and at the workplace) and 
calculated AORs comparing the lowest (the reference group) and the higher wealth 
quintiles, adjusted for age group, gender, residence, education, occupation, and region 
(for countries in which the variable was available). We tested for multicollinearity 
between all the covariates adjusted for in the analysis for each country. The 
multicollinearity diagnostics (variance inflation factor, VIF) were all less than 5, indicating 
that the assumption of reasonable independence among predictor variables was met. As 
SII and RII are more robust measures of inequality compared with the AOR, we present 
only those estimates in this paper. Moreover, the country-specific AOR estimates 
(Supplementary Figures in Appendix C-4 and Appendix C-5) were broadly consistent 
with the SII and RII estimates in the majority of the countries studied. 
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Sampling weights (STATA svy: command) were used to account for the complex, multi-
stage design of the GATS survey throughout the analyses. All the statistical analyses 
were performed using STATA version 13.1 (StataCorp LP, Texas). Exemption from 
ethics review for using anonymous secondary data freely available in public domain was 
obtained from the Research Ethics Committee at the London School of Hygiene and 
Tropical Medicine and Institutional Ethics Committee at Public Health Foundation of 
India. 
 
4.4.5.  Results 
 
4.4.5.1.  Descriptive statistics 
Table 4.4 shows that the number of participants ranged from 4091 in Malaysia to 67,006 
in India. The percentage of missing values was generally low (less than 5%) for all the 
15 countries studied and ranged from 0.1% in Uruguay to 3.7% in Malaysia. SHS 
exposure at home ranged from 17.4% in Mexico to 73.1% in Viet Nam. In India, 
Bangladesh, Thailand, Malaysia, the Philippines, and Viet Nam, the proportion of 
participants exposed to SHS at home was higher among poorer participants compared 
with that of richer participants. In India, Bangladesh, Thailand, Malaysia, the Philippines, 
Viet Nam, Uruguay, and Turkey, the proportion of participants exposed to SHS at home 
was higher among those with lower education compared to those with higher education. 
 
Table 4.5 shows that SHS exposure at workplace ranged from 16.9% in Uruguay to 
65.8% in Bangladesh. For this outcome, the proportion of missing cases was generally 
low (less than 5%) for all the countries studied, except Bangladesh and Malaysia, and 
ranged from 0.2% in Uruguay to 11.4% in Malaysia. In 14 of the 15 countries studied 
(except China), the proportion of participants exposed to SHS at the workplace was 
higher among those with lower education compared to those with higher education. The 
proportion of male participants exposed to SHS was notably higher as compared with 
females, particularly at workplaces. Supplementary tables in Appendix C-2 and 
Appendix C-3 show the numbers and proportion of missing cases in the dependent and 
independent variables for all the 15 countries for the outcomes “SHS exposure at home” 
and “SHS exposure at the workplace,” respectively.
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AMR = Region of the Americas; EMR = Eastern Mediterranean Region; EUR = European Region; GATS = Global Adult Tobacco Survey; SEAR = South-East Asia Region; SHS = secondhand smoke; WPR = Western Pacific Region. 
a For China, it was not possible to distinguish between Government employee, non-government employee or self-employed as occupation categories have been defined differently as compared with other countries. Hence, the category ‘Employed’ included all those participants 
who were either ‘Agriculture, Forestry, Fishery employee’ or ‘Transportation, equipment operator’ or, ‘Business or service industry employee’ or ‘Leaders of organizations’ or ‘Clerks’ or ‘Specialized Technician’ or ‘Medical and health personnel’ or ‘Teaching staff’ or ‘Soldier’.  
b For Poland, it was not possible to distinguish between Government employee and non-government employee categories as occupation categories have been defined differently as compared with other countries. Hence only one category ‘employed’ was considered to represent 
‘employed in company/enterprise’.  
c For Turkey, it was not possible to distinguish between Government employee and non-government employee categories as occupation categories have been defined differently as compared with other countries. Hence only one category ‘employed’ was considered to represent 
‘Paid employee’.  
Table 4.4: SHS exposure at Home among GATS participants (2008-2011) – Weighted % 
 SEAR WPR AMR EUR EMR 
 India 
N=67,006 
Bangladesh 
N=9,323 
Thailand 
N=20,437 
Chinaa 
N=13,302 
Malaysia 
N=4,091 
Philippines 
N=9,578 
Viet Nam 
N=9,866 
Mexico 
N=13,530 
Uruguay 
N=5,576 
Polandb 
N=7,640 
Romania 
N=4,472 
Russian 
Federation 
N=11,321 
Turkeyc 
N=8,900 
Ukraine 
N=8,092 
Egypt 
N=20,443 
Age group (years) 
≥15 to ≤29 39.9 53.3 36.6 68.8 42.2 53.9 75.6 18.5 44.8 46.1 46.1 36.9 64.1 27.4 64.8 
≥30 to ≤44 39.8 57.8 32.2 67.3 38.0 54.9 74.6 16.8 32.5 43.4 36.5 37.6 57.2 26.0 62.2 
≥45 to ≤59 40.3 54.6 31.2 69.1 36.0 55.6 71.9 17.4 33.5 50.1 38.8 35.8 53.1 25.4 61.9 
≥60 39.9 51.4 32.0 61.8 30.8 52.4 64.0 14.9 22.4 36.1 20.9 26.5 39.3 14.5 53.7 
Gender 
Male 40.6 58.2 37.4 70.5 43.2 58.1 77.2 17.3 36.8 45.0 37.8 36.7 56.2 25.3 61.3 
Female 39.2 51.2 29.2 63.9 33.3 50.6 69.2 17.5 31.4 43.6 33.2 32.9 56.4 22.0 63.8 
Residence 
Urban 29.4 44.6 25.4 60.1 35.7 43.4 63.3 19.0 34.0 42.9 40.9 35.8 55.1 24.2 57.5 
Rural 44.3 58.2 36.7 73.4 45.4 65.2 77.4 11.6 33.7 46.6 28.5 31.1 59.2 21.9 66.8 
Education 
Up to primary level 46.9 60.7 37.6 69.0 42.4 67.5 77.5 16.0 35.3 46.3 28.7 30.1 57.3 16.3 67.0 
Up to secondary level 33.8 46.3 30.9 69.7 39.6 49.4 69.5 17.9 33.1 46.6 35.5 35.6 56.9 25.0 61.9 
Up to tertiary level 20.4 21.3 15.4 51.3 25.7 31.1 45.6 20.0 31.0 31.3 39.1 33.5 47.6 20.3 47.5 
Wealth Quintile 
Q1 (Poorest) 48.6 67.5 45.2 66.5 52.2 69.5 77.5 11.0 37.3 47.2 35.2 37.2 60.3 23.6 62.5 
Q2 42.8 58.3 41.3 73.7 43.8 64.7 77.2 15.0 33.9 45.1 31.0 33.6 55.2 26.1 67.5 
Q3 40.8 53.1 33.6 69.0 41.6 59.6 77.2 16.4 33.5 46.2 29.6 33.3 56.1 24.0 64.9 
Q4 32.4 51.7 25.3 67.1 35.6 48.4 70.4 20.7 33.9 46.6 40.8 31.4 57.9 24.3 56.6 
Q5 (Most affluent) 22.9 38.9 13.5 60.6 28.0 34.6 58.9 19.0 32.8 37.2 36.7 37.3 53.1 20.0 53.9 
Occupation 
Govt employee 27.6 34.3 19.0  
69.7 
29.2 44.0 56.1 16.6 33.7 
46.0 
36.8 33.1 
55.4 
21.8 53.0 
Non-govt employee 40.5 37.7 36.0 43.2 53.7 65.4 19.7 37.2 40.5 40.6 29.7 64.3 
Self-employed 44.1 63.4 34.7 47.0 62.1 78.7 16.3 37.2 44.5 34.8 33.6 60.0 28.0 67.5 
Student 33.0 42.4 31.4 64.3 31.2 45.8 67.9 18.3 39.3 40.7 44.5 29.2 64.8 21.4 59.4 
Others (retd & 
homemakers) 
39.0 52.7 31.8 55.5 34.4 52.1 63.7 16.2 24.5 40.9 27.0 28.5 52.7 18.3 62.1 
Unemployed 44.0 46.1 32.3 63.6 37.4 51.9 64.1 21.2 47.8 58.6 49.4 47.2 69.5 31.5 64.1 
% reporting SHS 
exposure at home 
39.9 54.7 33.2 67.3 38.5 54.3 73.1 17.4 33.9 44.2 35.4 34.6 56.3 23.5 62.6 
% of missing cases 3.3 3.2 0.6 0.4 3.7 1.3 0.6 0.6 0.1 2.5 1.0 0.7 1.4 0.8 2.3 
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AMR = Region of the Americas; EMR = Eastern Mediterranean Region; EUR = European Region; GATS = Global Adult Tobacco Survey; SEAR = South-East Asia Region; SHS = secondhand smoke; WPR = Western Pacific Region. 
a Occupation categories in China differed from those of other LMICs. Five occupation categories were considered for China: Agriculture, forestry, fishery employee (78.5%); transportation equipment operator (61.7%); government, party, organization, company 
(73.3%); medical, health personnel (55.4%); teaching staff (54.8%). Not presented in table to maintain uniformity. 
b For Poland and Turkey, categorization of occupation into ‘Government employee’ and ‘Non-government employee’ was not possible due to the way categories were defined hence the categories were merged into one category ‘Employed’. 
c For Romania, the category educated up to primary level contained only one participant hence, this category was merged with educated up to secondary level for further analysis. 
Table 4.5: SHS exposure at Workplace among GATS participants employed indoors and outside their home (2008-2011) – Weighted % 
 SEAR WPR AMR EUR EMR 
 India 
N=12,852 
Bangladesh 
N=1,704 
Thailand 
N=5,021 
Chinaa 
N=1,859 
Malaysia 
N=996 
Philippines 
N=2,152 
Viet Nam 
N=2,419 
Mexico 
N=2,082 
Uruguay 
N=1,796 
Polandb 
N=3,030 
Romaniac 
N=1,175 
Russian 
Federation 
N=5,464 
Turkeyb 
N=2,160 
Ukraine 
N=2,761 
Egypt 
N=4,490 
Age group (years) 
≥15 to ≤29 31.4 64.6 20.8 63.7 40.9 26.6 49.3 18.4 18.3 31.0 38.8 38.4 37.8 32.3 59.5 
≥30 to ≤44 29.5 65.5 27.1 62.9 38.9 33.1 61.3 17.8 16.7 33.5 32.9 37.2 36.9 34.1 60.7 
≥45 to ≤59 29.9 68.7 29.9 72.5 41.6 37.5 58.2 22.2 16.8 35.4 34.1 35.2 38.4 30.3 59.7 
≥60 30.6 67.0 38.2 64.5 34.0 45.1 69.4 19.1 12.7 39.2 24.6 25.9 34.8 33.9 56.8 
Gender 
Male 32.7 70.3 33.2 77.1 46.6 38.5 68.9 22.2 21.9 41.6 36.8 48.2 40.5 43.3 61.6 
Female 17.9 29.2 18.5 47.5 30.2 25.5 41.4 13.8 11.9 24.5 31.4 26.3 27.6 21.9 54.2 
Residence 
Urban 27.9 59.7 23.4 65.2 42.2 24.9 52.8 18.9 16.8 31.4 35.2 37.2 35.6 32.5 59.1 
Rural 32.7 69.9 28.3 65.9 32.5 45.9 59.1 18.0 20.3 38.3 31.9 32.9 45.1 32.5 60.9 
Education 
Up to primary level 38.7 70.9 38.1 70.8 52.8 52.1 60.9 21.9 20.2 50.9  
36.1 
52.0 43.1 63.6 63.6 
Up to secondary 
level 
29.5 62.2 22.6 64.6 38.9 29.9 54.5 19.2 16.7 36.8 41.7 37.8 35.7 61.0 
Up to tertiary level 20.4 54.4 18.9 65.5 38.8 21.2 39.5 15.9 10.8 23.1 30.0 31.5 25.4 26.2 55.2 
Wealth Quintile 
Q1 (Poorest) 35.5 68.6 35.4 61.8 47.7 45.3 58.7 16.5 20.7 37.4 36.4 36.7 39.8 34.2 62.5 
Q2 37.2 68.2 29.8 66.7 31.1 41.0 56.3 20.3 14.1 31.1 35.4 34.1 31.2 36.1 58.6 
Q3 31.0 65.8 25.9 69.0 44.4 30.3 59.4 19.3 20.6 34.6 30.6 35.3 34.4 34.9 62.8 
Q4 28.5 68.2 25.9 68.1 40.7 31.8 53.9 17.3 18.6 32.7 36.9 36.9 39.7 27.5 60.6 
Q5 (Most affluent) 23.6 60.3 17.3 60.3 38.7 26.4 53.5 19.4 13.9 33.7 32.8 38.7 41.8 33.1 54.9 
Occupation 
Govt. employee 21.9 56.1 21.6 ─ 29.3 26.3 46.3 12.6 15.1  
32.1 
 
34.6 30.5  
32.3 
28.6 58.6 
Non-govt employee 28.5 41.8 24.6 ─ 40.6 25.8 33.4 19.5 16.4 33.2 40.8 34.6 60.8 
Self-employed 35.4 74.4 36.6 ─ 54.3 55.7 70.6 21.9 21.3 42.7 42.2 43.2 53.1 40.1 60.9 
% exposed to  
SHS at workplace 
30.3 65.8 26.0 65.5 40.1 32.2 56.2 18.8 16.9 33.6 34.3 36.3 37.4 32.5 59.9 
% of missing cases 4.9 6.0 1.2 0.6 11.4 0.8 0.9 0.9 0.2 2.4 1.4 2.1 0.5 1.9 0.6 
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4.4.5.2.  Socioeconomic inequalities in SHS exposure at home 
Table 4.6 presents the RII and SII estimates and their 95% confidence intervals (CIs), 
respectively, for wealth and education inequality in SHS exposure at home. These 
comparisons are also shown graphically in the supplementary figure in Appendix C-6.  
Socioeconomic inequalities by wealth 
In 11 of the 15 countries studied (India, Bangladesh, Thailand, Malaysia, the Philippines, 
Viet Nam, Uruguay, Poland, Turkey, Ukraine, and Egypt), the RII estimates were more 
than 1 and the SII estimates were more than 0, indicating that the poor are more likely to 
be exposed to SHS at home compared with the rich. There was substantial variation 
between the countries in SHS exposure at home by levels of wealth. The RII estimates 
ranged from 1.13 (95% CI 1.04–1.22) in Turkey to 3.31 (95% CI 2.91–3.77) in Thailand, 
while the SII estimates ranged from 0.06 (95% CI 0.02–0.11) in Turkey to 0.43 (95% CI 
0.38–0.48) in the Philippines. There was a different statistically significant association in 
Mexico (RII 0.57 95% CI 0.43–0.75) which suggested that the rich were more exposed 
to SHS at home than the poor. 
Socioeconomic inequalities by education 
In 12 of the 15 countries studied (India, Bangladesh, Thailand, China, Malaysia, the 
Philippines, Viet Nam, Uruguay, Poland, Turkey, Ukraine, and Egypt), RII estimates and 
their CIs were more than 1 and SII estimates and their CIs were more than 0 indicating 
that in these countries, those with less education are more likely to be exposed to SHS 
at home compared with the more educated. There was substantial variation between the 
countries in SHS exposure at home by levels of education. The RII estimates ranged 
from 1.28 (95% CI 1.16–1.43) in Turkey to 2.65 (95% CI 2.43–2.88) in India, while the 
SII estimates ranged from 0.07 (95% CI 0.02–0.12) in Ukraine to 0.48 (95% CI 0.43–
0.53) in the Philippines. 
 
Table 4.6 also presents findings of disaggregated analysis by gender for socioeconomic 
inequalities in SHS exposure at home. The results were in line with the overall 
observations made above; and for a majority of the countries, no significant gender 
differences were observed. Significant wealth inequality in SHS exposure at home was 
observed only among males in China, Uruguay, Turkey and Ukraine while significant 
education inequality in SHS exposure at home was observed only among males in 
Uruguay and the Russian Federation; and only among females in Ukraine. 
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AMR = Region of the Americas; CI = confidence interval; EMR = Eastern Mediterranean Region; EUR = European Region; GATS = Global Adult Tobacco Survey; SEAR = South-East Asia Region; SHS = secondhand smoke; WPR = 
Western Pacific Region. Bold values indicate significance level P < .05. 
a RII (Relative Index of Inequality) values estimated from country-specific individual-level generalised linear models adjusted for age group and gender. A value > 1 indicates that: the poor are more likely to be exposed to SHS at home compared with the rich (in 
case of wealth inequality) and the less educated are more likely to be exposed to SHS at home compared with the more educated (in case of education inequality) 
b SII (Slope Index of Inequality) values estimated from country-specific individual-level generalised linear models adjusted for age group and gender. A value > 0 indicates that: the poor are more likely to be exposed to SHS at home compared with the rich (in 
case of wealth inequality) and the less educated are more likely to be exposed to SHS at home compared with the more educated (in case of education inequality).
Table 4.6: Socioeconomic inequality in Secondhand Smoke (SHS) exposure at home 
 
Region/Country 
Wealth inequality Education inequality 
RII [95% CI] SII [95% CI] RII [95% CI] SII [95% CI]  
Males Females Totala Males Females Total b Males Females Totala Males Females Totalb 
SEAR 
India  
(N=67,006) 
1.99  
[1.78, 2.22] 
2.28 
[2.04, 2.56] 
2.12 
[1.94, 2.32] 
0.28  
[0.24, 0.33] 
0.32 
[0.28, 0.36] 
0.30 
[0.27, 0.33] 
2.41  
[2.18, 2.68] 
3.09  
[2.70, 3.54] 
2.65 
[2.43, 2.88] 
0.36 
 [0.32, 0.40] 
0.42  
[0.37, 0.46] 
0.38 
[0.35, 0.41] 
Bangladesh 
(N=9,323) 
1.92  
[1.66, 2.23] 
1.67 
[1.45, 1.92] 
1.81 
[1.62, 2.02] 
0.38 
 [0.30, 0.47] 
0.27  
[0.20, 0.34] 
0.32 
[0.27, 0.38] 
2.3 
 [1.93, 2.74] 
1.98  
[1.61, 2.42] 
2.14 
[1.87, 2.44] 
0.47  
[0.38, 0.56] 
0.35 
 [0.26, 0.45] 
0.41 
[0.34, 0.47] 
Thailand 
(N=20,437) 
3.48  
[2.96, 4.10] 
3.09  
[2.60, 3.67] 
3.31 
[2.91, 3.77] 
0.48  
[0.42, 0.54] 
0.35 
[0.30, 0.40] 
0.41 
[0.37, 0.45] 
2.65 
[2.19, 3.20] 
2.61 
[2.06, 3.29] 
2.62 
[2.24, 3.07] 
0.37  
[0.31, 0.42] 
0.31  
[0.25, 0.36] 
0.33 
[0.29, 0.38] 
WPR 
China 
(N=13,302) 
1.19 
 [1.02, 1.38] 
1.09  
[0.93, 1.28] 
1.15 
[0.99, 1.32] 
0.13  
[0.02, 0.24] 
0.06  
[-0.05, 0.17] 
0.10 
[-0.01, 0.20] 
1.38  
[1.22, 1.56] 
1.32  
[1.15, 1.51] 
1.35 
[1.21, 1.51] 
0.24  
[0.14, 0.34] 
0.19 
[0.10, 0.28] 
0.22 
[0.13, 0.30] 
Malaysia 
(N=4,091) 
2.26  
[1.73, 2.95] 
1.78  
[1.32, 2.39] 
2.08 
[1.68, 2.56] 
0.38  
[0.26, 0.49] 
0.19 
 [0.09, 0.30] 
0.29 
[0.20, 0.37] 
2.24  
[1.69, 2.96] 
1.71 
 [1.17, 2.51] 
2.05 
[1.64, 2.58] 
0.40  
[0.26, 0.53] 
0.19  
[0.06, 0.32] 
0.30 
[0.20, 0.39] 
Philippines 
(N=9,578) 
1.95  
[1.75, 2.19] 
2.30 
[2.03, 2.60] 
2.10 
[1.92, 2.30] 
0.41  
[0.34, 0.47] 
0.45  
[0.39, 0.51] 
0.43 
[0.38, 0.48] 
2.48  
[2.17, 2.84] 
2.31  
[2.01, 2.66] 
2.40 
[2.16, 2.67] 
0.53 
[0.46, 0.61] 
0.43 
 [0.36, 0.50] 
0.48 
[0.43, 0.53] 
Viet Nam 
(N=9,866) 
1.35 
[1.26, 1.45] 
1.24  
[1.15, 1.33] 
1.29 
[1.22, 1.37] 
0.24 
[0.18, 0.29] 
0.15 
[0.10, 0.21] 
0.20 
[0.15, 0.24] 
1.35 
 [1.24, 1.47] 
1.36 
[1.25, 1.48] 
1.35 
[1.26, 1.44] 
0.23 
[0.17, 0.30] 
0.22 
[0.16, 0.29] 
0.22 
[0.18, 0.27] 
AMR 
Mexico 
(N=13,530) 
0.58  
[0.39, 0.87] 
0.56  
[0.43, 0.73] 
0.57 
[0.43, 0.75] 
-0.09  
[-0.16, -0.02] 
-0.11  
[-0.15, -0.06] 
-0.10 
[-0.15, -0.05] 
0.84  
[0.55, 1.28] 
0.74 
 [0.51, 1.07] 
0.78 
[0.57, 1.07] 
-0.03 
[-0.10, 0.04] 
-0.05 
[-0.12, 0.01] 
-0.04 
[-0.09, 0.01] 
Uruguay 
(N=5,576) 
1.37  
[1.08, 1.74] 
1.22  
[0.90, 1.66] 
1.30 
[1.06, 1.60] 
0.12 
[0.03, 0.20] 
0.03  
[-0.05, 0.12] 
0.07 
[0.01, 0.14] 
1.57  
[1.14, 2.16] 
1.25 
[0.90, 1.72] 
1.41 
[1.09, 1.82] 
0.16 
[0.05, 0.28] 
0.05 
[-0.03, 0.14] 
0.10 
[0.03, 0.18] 
EUR 
Poland 
(N=7,640) 
1.53 
 [1.26, 1.86] 
1.27  
[1.09, 1.47] 
1.39 
[1.23, 1.56] 
0.18  
[0.10, 0.26] 
0.10  
[0.03, 0.16] 
0.14 
[0.09, 0.19] 
1.88 
[1.56, 2.26] 
1.52 
[1.28, 1.82] 
1.66 
[1.45, 1.89] 
0.31 
 [0.22, 0.39] 
0.18 
[0.10, 0.26] 
0.23 
[0.17, 0.29] 
Romania 
(N=4,472) 
1.06 
[0.81, 1.39] 
0.94  
[0.70, 1.27] 
1.00 
[0.82, 1.23] 
0.01 
 [-0.08, 0.10] 
-0.03 
[-0.12, 0.05] 
-0.02 
[-0.08, 0.05] 
0.96 
[0.66, 1.39] 
0.94 
[0.64, 1.40] 
0.94 
[0.71, 1.23] 
-0.01 
[-0.14, 0.12] 
-0.01 
 [-0.11, 0.09] 
-0.01 
[-0.09, 0.07] 
Russian Federation 
(N=11,321) 
1.20 
 [0.97, 1.47] 
0.91 
[0.73, 1.14] 
1.04 
[0.88, 1.23] 
0.06 
 [-0.01, 0.13] 
-0.03  
[-0.10, 0.03] 
0.01 
[-0.04, 0.06] 
1.29  
[1.01, 1.65] 
1.10  
[0.88, 1.37] 
1.15 
[0.98, 1.36] 
0.09 
 [0.00, 0.17] 
0.05 
 [-0.03, 0.12] 
0.05 
[-0.01, 0.11] 
Turkey 
(N=8,900) 
1.20  
[1.07, 1.34] 
1.06 
[0.95, 1.19] 
1.13 
[1.04, 1.22] 
0.10 
[0.04, 0.16] 
0.03  
[-0.04, 0.09] 
0.06 
[0.02, 0.11] 
1.20 
 [1.05, 1.37] 
1.40 
[1.20, 1.64] 
1.28 
[1.16, 1.43] 
0.11  
[0.03, 0.18] 
0.19 
[0.11, 0.28] 
0.14 
[0.09, 0.20] 
Ukraine 
(N=8,092) 
2.06 
[1.61, 2.62] 
1.26 
[0.93, 1.72] 
1.63 
[1.33, 1.99] 
0.17 
 [0.11, 0.24] 
0.02 
[-0.03, 0.08] 
0.09 
[0.04, 0.13] 
1.08 
[0.78, 1.50] 
1.91 
[1.28, 2.85] 
1.43 
[1.11, 1.84] 
0.02 
[-0.07, 0.10] 
0.10  
[0.03, 0.17] 
0.07 
[0.02, 0.12] 
EMR 
Egypt 
(N=20,443) 
1.24 
 [1.15, 1.34] 
1.12  
[1.05, 1.20] 
1.18 
[1.12, 1.23] 
0.14 
[0.09, 0.19] 
0.08  
[0.03, 0.12] 
0.11 
[0.08, 0.14] 
1.51 
[1.39, 1.64] 
1.48 
[1.36, 1.61] 
1.49 
[1.41, 1.58] 
0.26 
[0.21, 0.31] 
0.26  
[0.21, 0.31] 
0.26 
[0.22, 0.30] 
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4.4.5.3.  Socioeconomic inequalities in SHS exposure at workplace 
Table 4.7 presents the RII and SII estimates and their 95% CIs, respectively for wealth 
and education inequality in SHS exposure at the workplace. These comparisons are 
also shown graphically in the supplementary figure in Appendix C-7.  
Socioeconomic inequalities by wealth 
In four of the 15 countries studied (India, Bangladesh, Thailand, and the Philippines), RII 
estimates and their CIs were more than 1 and SII estimates and their CIs were more 
than 0 indicating that in these countries, the poor are more likely to be exposed to SHS 
at workplace compared with the rich. Variation was observed between the countries in 
SHS exposure at the workplace by levels of wealth. The RII estimates ranged from 1.18 
(95% CI 1.00–1.40) in Bangladesh to 2.30 (95% CI 1.83–2.90) in Thailand, while the SII 
estimates ranged from 0.12 (95% CI 0.01–0.23) in Bangladesh to 0.22 (95% CI 0.12–
0.31) in the Philippines.  
Socioeconomic inequalities by education 
In 10 of the 15 countries studied (India, Bangladesh, Thailand, the Philippines, Viet 
Nam, Poland, the Russian Federation, Turkey, Ukraine, and Egypt), RII estimates and 
their CIs were more than 1 and SII estimates and their CIs were more than 0 indicating 
that in these countries, those with less education are more likely to be exposed to SHS 
at workplace compared with the more educated. Substantial variation was observed 
between the countries in SHS exposure at the workplace by levels of education. The RII 
estimates ranged from 1.17 (95% CI 1.02–1.33) in Egypt to 3.22 (95% CI 2.39–4.34) in 
the Philippines, while the SII estimates ranged from 0.10 (95% CI 0.02–0.18) in Egypt to 
0.35 (95% CI 0.25–0.45) in the Philippines. 
 
Table 4.7 also presents findings of disaggregated analysis by gender for socioeconomic 
inequalities in SHS exposure at the workplace. In Bangladesh, wealth inequality in SHS 
exposure at the workplace was not observed among males and females independently, 
while education inequality was observed only among males in Bangladesh, the Russian 
Federation, Turkey, and Ukraine but not among females; and was not observed among 
either males or females in Egypt. However, in almost half of the countries, the results 
were in conformity with the overall observations made above with no significant gender 
differences. 
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AMR = Region of the Americas; CI = confidence interval; EMR = Eastern Mediterranean Region; EUR = European Region; GATS = Global Adult Tobacco Survey; SEAR = South-East Asia Region; SHS = secondhand smoke; WPR = 
Western Pacific Region. Bold values indicate significance level P < .05. 
a RII (Relative Index of Inequality) values estimated from country-specific individual-level generalised linear models adjusted for age group and gender. A value > 1 indicates that: the poor are more likely to be exposed to SHS at workplace compared with the rich (in case of wealth 
inequality) and the less educated are more likely to be exposed to SHS at workplace compared with the more educated (in case of education inequality). 
b SII (Slope Index of Inequality) values estimated from country-specific individual-level generalised linear models adjusted for age group and gender. A value > 0 indicates that: the poor are more likely to be exposed to SHS at workplace compared with the rich (in case of wealth 
inequality) and the less educated are more likely to be exposed to SHS at workplace compared with the more educated (in case of education inequality). 
Table 4.7: Socioeconomic inequality in Secondhand Smoke (SHS) exposure at workplace 
 
Region/Country 
Wealth inequality Education inequality 
RII [95% CI]  SII [95% CI]  RII [95% CI]  SII [95% CI]  
Males Females Totala Males Females Totalb Males Females Totala Males Females Totalb 
SEAR 
India  
(N=12,852) 
1.59  
[1.29, 1.96] 
3.86  
[2.21, 6.76] 
1.70 
[1.40, 2.08] 
0.16  
[0.09, 0.24] 
0.20  
[0.10, 0.29] 
0.17 
[0.11, 0.24] 
2.16  
[1.76, 2.65] 
4.74  
[2.50, 8.99] 
2.30 
[1.90, 2.80] 
0.27  
[0.20, 0.34] 
0.24  
[0.13, 0.35] 
0.26 
[0.20, 0.32] 
Bangladesh 
(N=1,704) 
1.18  
[0.99, 1.39] 
1.53  
[0.65, 3.62] 
1.18 
[1.00, 1.40] 
0.12  
[-0.01, 0.24] 
0.13 
 [-0.18, 0.43] 
0.12 
[0.01, 0.23] 
1.37  
[1.14, 1.63] 
1.32  
[0.53, 3.28] 
1.36 
[1.14, 1.63] 
0.22  
[0.09, 0.34] 
0.08  
[-0.20, 0.35] 
0.20 
[0.08, 0.31] 
Thailand 
(N=5,021) 
2.51  
[1.89, 3.35] 
1.88  
[1.30, 2.73] 
2.30 
[1.83, 2.90] 
0.30 
 [0.20, 0.40] 
0.14  
[0.06, 0.23] 
0.21 
[0.15, 0.28] 
3.00  
[2.21, 4.07] 
1.94 
 [1.18, 3.19] 
2.65 
[2.07, 3.40] 
0.38  
[0.27, 0.49] 
0.13  
[0.03, 0.22] 
0.23 
[0.16, 0.30] 
WPR 
China 
(N=1,859) 
0.95  
[0.76, 1.18] 
1.52  
[0.94, 2.47] 
1.02 
[0.82, 1.26] 
-0.05  
[-0.22, 0.12] 
0.22 
 [-0.04, 0.48] 
0.03 
[-0.12, 0.18] 
0.97  
[0.75, 1.25] 
1.23  
[0.71, 2.10] 
1.00 
[0.78, 1.28] 
-0.03  
[-0.22, 0.16] 
0.09  
[-0.16, 0.34] 
0.01 
[-0.16, 0.17] 
Malaysia 
(N=996) 
1.02  
[0.64, 1.61] 
1.23  
[0.55, 2.73] 
1.07 
[0.72, 1.57] 
0.01 
 [-0.20, 0.22] 
0.07  
[-0.16, 0.31] 
0.04 
[-0.11, 0.19] 
1.47 
 [0.87, 2.51] 
1.62  
[0.60, 4.38] 
1.51 
[0.95, 2.40] 
0.17  
[-0.07, 0.42] 
0.14  
[-0.13, 0.40] 
0.16 
[-0.02, 0.33] 
Philippines 
(N=2,152) 
1.87  
[1.37, 2.56] 
2.08  
[1.33, 3.27] 
1.94 
[1.49, 2.53] 
0.25  
[0.12, 0.39] 
0.19  
[0.07, 0.31] 
0.22 
[0.12, 0.31] 
3.81  
[2.64, 5.50] 
2.37  
[1.52, 3.69] 
3.22 
[2.39, 4.34] 
0.51  
[0.37, 0.65] 
0.24  
[0.11, 0.36] 
0.35 
[0.25, 0.45] 
Viet Nam 
(N=2,419) 
1.27 
 [1.07, 1.50] 
0.98  
[0.67, 1.42] 
1.21 
[1.03, 1.42] 
0.17  
[0.04, 0.29] 
-0.02  
[-0.16, 0.12] 
0.09 
[-0.01, 0.19] 
1.31  
[1.08, 1.58] 
1.43  
[1.01, 2.05] 
1.34 
[1.12, 1.59] 
0.19  
[0.05, 0.33] 
0.14 
 [-0.03, 0.31] 
0.17 
[0.06, 0.29] 
AMR 
Mexico 
(N=2,082) 
1.36 
 [0.79, 2.34] 
0.40  
[0.13, 1.21] 
1.00 
[0.58, 1.72] 
0.07  
[-0.06, 0.21] 
-0.10  
[-0.21, 0.01] 
-0.02 
[-0.12, 0.07] 
1.66  
[1.05, 2.60] 
1.06  
[0.45, 2.50] 
1.46 
[0.99, 2.17] 
0.12 
 [0.01, 0.23] 
0.01  
[-0.11, 0.12] 
0.07 
[-0.01, 0.14] 
Uruguay 
(N=1,796) 
1.43  
[0.84, 2.42] 
1.39  
[0.64, 3.02] 
1.42 
[0.92, 2.21] 
0.08 
 [-0.04, 0.21] 
0.04  
[-0.06, 0.15] 
0.06 
[-0.02, 0.14] 
1.41 
 [0.74, 2.69] 
2.38  
[0.99, 5.77] 
1.69 
[0.96, 2.96] 
0.07  
[-0.07, 0.21] 
0.12  
[-0.01, 0.25] 
0.10 
[0.00, 0.20] 
EUR 
Poland 
(N=3,030) 
1.18  
[0.93, 1.50] 
0.79  
[0.49, 1.29] 
1.06 
[0.85, 1.31] 
0.07  
[-0.03, 0.18] 
-0.06  
[-0.16, 0.05] 
0.00 
[-0.07, 0.08] 
2.47  
[1.80, 3.38] 
2.12  
[1.28, 3.51] 
2.36 
[1.82, 3.07] 
0.39  
[0.25, 0.53] 
0.18  
[0.06, 0.29] 
0.27 
[0.18, 0.35] 
Romania 
(N=1,175) 
0.93  
[0.56, 1.53] 
1.20  
[0.55, 2.63] 
1.02 
[0.66, 1.57] 
-0.03  
[-0.22, 0.16] 
0.06  
[-0.18, 0.29] 
0.01 
[-0.14, 0.16] 
1.75  
[0.93, 3.28] 
1.19  
[0.60, 2.35] 
1.45 
[0.91, 2.31] 
0.19  
[0.00, 0.39] 
0.05  
[-0.15, 0.25] 
0.12 
[-0.03, 0.26] 
Russian Federation 
(N=5,464) 
1.04  
[0.83, 1.32] 
0.97  
[0.68, 1.37] 
1.01 
[0.82, 1.25] 
0.02  
[-0.08, 0.13] 
-0.01  
[-0.10, 0.08] 
0.00 
[-0.07, 0.07] 
1.97  
[1.51, 2.57] 
1.32  
[0.84, 2.06] 
1.73 
[1.36, 2.19] 
0.32  
[0.20, 0.44] 
0.07 
 [-0.05, 0.18] 
0.17 
[0.08, 0.25] 
Turkey 
(N=2,160) 
0.81  
[0.61, 1.07] 
0.64  
[0.33, 1.25] 
0.78 
[0.61, 1.00] 
-0.08  
[-0.18, 0.02] 
-0.13  
[-0.31, 0.05] 
-0.09 
[-0.18, 0.00] 
1.79  
[1.37, 2.34] 
1.57  
[0.87, 2.86] 
1.74 
[1.36, 2.23] 
0.24  
[0.13, 0.36] 
0.14  
[-0.04, 0.32] 
0.21 
[0.12, 0.31] 
Ukraine 
(N=2,761) 
1.35  
[1.02, 1.78] 
1.20  
[0.73, 1.98] 
1.32 
[1.02, 1.70] 
0.13  
[0.01, 0.25] 
0.04  
[-0.07, 0.16] 
0.08 
[-0.01, 0.17] 
2.38  
[1.65, 3.42] 
1.21  
[0.66, 2.24] 
1.93 
[1.41, 2.64] 
0.34  
[0.21, 0.48] 
0.04  
[-0.09, 0.17] 
0.16 
[0.06, 0.25] 
EMR 
Egypt 
(N=4,490) 
1.05  
[0.92, 1.19] 
1.07  
[0.82, 1.39] 
1.05 
[0.94, 1.17] 
0.03  
[-0.05, 0.11] 
0.04 
 [-0.12, 0.20] 
0.03 
[-0.04, 0.10] 
1.14  
[0.98, 1.32] 
1.36 
 [0.99, 1.86] 
1.17 
[1.02, 1.33] 
0.08  
[-0.01, 0.18] 
0.17 
 [-0.01, 0.34] 
0.10 
[0.02, 0.18] 
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4.4.6.  Discussion 
Our study of socioeconomic inequalities in SHS exposure at homes and at workplaces 
in LMIC settings indicates that the poor are more likely to be exposed to SHS at home 
than the rich in 11 out of the 15 countries studied. The association was not so consistent 
between being poor and exposure to SHS at the workplace and was observed only in 
four out of the 15 countries studied. Less educated participants were consistently more 
likely to be exposed to SHS at home and at the workplace. Despite the observed gender 
differences in SHS exposure (particularly at the workplace) in the LMIC settings studied, 
and as reported in earlier studies,53, 147 we did not find significant gender differences in 
socioeconomic inequalities in SHS exposure at home in the majority of countries 
studied. In the case of SHS exposure at the workplace, we found some evidence that 
education inequality was observed only among males in some of the countries studied; 
however, in almost half of the countries studied, there were no significant gender 
differences. 
 
Our key findings are consistent with limited available data from LMIC settings. A study 
assessing correlates of SHS exposure at home among non-smoking adults in 
Bangladesh suggested that groups with lower educational attainment and literacy were 
more than twice as likely to be exposed to SHS at home than groups with higher 
educational attainment.225 A study conducted in Viet Nam using GATS data suggested 
that participants who had attained tertiary, high school, and secondary education were 
60%, 40%, and 30% less likely to be exposed to SHS at home, respectively, as 
compared with those who had attained only primary education.226 Another study 
conducted with adult participants in rural China showed that participants who did not 
complete high school education and who had low income were more likely to be 
exposed to SHS at home.227 Similar findings have been reported in studies from HICs.6, 
155, 228 
 
Palipudi et al. studied the socioeconomic determinants of active tobacco use in 13 
GATS countries (excluding Malaysia and Romania which have been included in our 
analyses) and concluded that current tobacco use (including current smoking or 
smokeless tobacco use, either daily or occasionally) increased with decrease in 
education levels in India, Bangladesh, Thailand, the Philippines, and Egypt; however 
there was an inverse association between tobacco use and education levels in 
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Turkey.147 We found that SHS exposure at home increased with a decrease in education 
levels in 12 countries including the five countries mentioned above for current tobacco 
use, as well as Turkey. The more consistent social patterning of SHS exposure (than 
active tobacco use) across countries found here may be explained by differences in 
social norms around exposing others to SHS in different socioeconomic groups within 
these settings. 
 
4.4.6.1.  Strengths and limitations 
Our study is based on findings from large nationally representative datasets from 15 
LMICs where the majority of the world’s smokers reside. We present RII and SII 
estimates as these are considered to be more robust measures of socioeconomic 
inequality compared with AORs.222, 223 Our study focused on socioeconomic inequalities 
in exposure to SHS at home and indoor workplaces as these are the two settings in 
which SHS exposure predominantly occurs.6 For the latter, we restricted our sample by 
excluding participants working exclusively outdoors (e.g. farmers and outdoor 
labourers), students, homemakers, the retired, and the unemployed. This may partly 
explain the absence of a socioeconomic gradient in SHS exposure in the workplace in 
several LMICs studied. Standard definitions of SHS exposure at home and SHS 
exposure at the workplace (in past 30 days) as reported in the previously published 
literature were used.37, 53, 211, 212 However, it is possible that different definitions (e.g. 
daily/weekly exposure) may demonstrate different associations. We were unable to 
examine occupation-based measures of SES as GATS provides limited information 
about occupational grades. Further, in the case of education variable, we merged “no 
formal education” with the next higher category “up to primary level” because 
participants in that category accounted for less than 10% of the study sample for a 
majority of the countries studied. For remaining countries, in which the percentage of 
participants in the “no formal education” category was more than 10%, we conducted 
sensitivity analyses by separating “no formal education” and “up to primary level” 
categories and found that our results remained unchanged. The authors acknowledge 
the heterogeneity that exists among the various LMICs studied in terms of the stage of 
tobacco epidemic, tobacco control policies, and diverse patterns in socioeconomic 
inequality; however, the fact that GATS provides uniform data from these countries 
allows broad comparisons to be drawn across these countries through studies such as 
ours and those previously published.147 Data from the first round of GATS is now at least 
four years old and may not reflect the current state of inequalities in SHS exposure, 
given the fact that tobacco control efforts (particularly smoke-free policies) have been 
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strengthened in some settings. We relied on self-reported measures of exposure to SHS 
at homes and workplaces in the absence of biological markers such as cotinine levels. 
Although earlier studies indicate a good correlation between cotinine levels and self-
reported measures,213 more recent studies suggest that self-reported measures of SHS 
exposure at home and at workplace often underestimate the true prevalence of SHS 
exposure in the absence of biomarkers such as serum cotinine.229 Future studies in 
LMICs should examine changes in SHS exposure and related socioeconomic 
inequalities over time and/or assess pre–post smoke-free legislation implementation 
changes. 
 
4.4.6.2.  Policy implications 
Our results show that SHS exposure at homes and at workplaces is high in a majority of 
the LMIC settings studied, reflecting considerable variation between countries. The 
study indicates that socioeconomic inequalities exist in exposure to SHS at homes as 
well as at workplaces (to some extent) in these settings. Nearly 71% of middle-income 
and 88% of low-income countries are still not protected by comprehensive smoke-free 
policies.23 Findings of the systematic review presented in Chapter 3 of my thesis and 
earlier studies have shown that voluntary, regional, or partial smoke-free policies are not 
likely to be effective and will often be equity negative.21, 161 Reasonably good evidence 
suggests that comprehensive smoke-free policies have an equity positive or neutral 
effect on health outcomes strongly influenced by SHS exposure. For example, recent 
work has shown that comprehensive smoke-free legislation in England was associated 
with a greater reduction in admissions for respiratory tract infections in children from 
lower SES groups.122 However, comprehensively enforced smoke-free policies may be 
less likely to be implemented in low SES settings.155 To address socioeconomic 
inequalities in SHS exposure at work, there is a need for accelerated implementation of 
comprehensive smoke-free policies.161 Addressing inequalities in SHS exposure at 
home would require addressing both inequalities in the prevalence of smoking and 
inequalities in social norms about exposing non-smokers to SHS. To reduce inequalities 
in smoking, the implementation of tobacco control policies needs to be strengthened 
particularly interventions that have been shown to be pro-equity, such as increasing 
tobacco taxation.230 Focused efforts are required to address social norms around 
exposing others to SHS (e.g. awareness through mass media campaigns and other 
educational interventions), targeting the socioeconomically disadvantaged groups. 
Smoke-free policies have been shown to have a positive influence on social norms 
concerning SHS exposure at home.43 
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4.4.7.  Conclusion 
SHS exposure at home is higher among the socioeconomically disadvantaged groups 
(the poor and the less educated) in the majority of LMICs studied. SHS exposure at the 
workplace is higher among the less educated groups in the majority of LMICs studied. 
Accelerated implementation of pro-equity tobacco control interventions, including 
increased taxation, along with targeted efforts among the socioeconomically 
disadvantaged groups are needed to reduce both, inequalities in SHS exposure as well 
as tobacco smoking in LMICs. 
 
4.5.  Summary 
To summarise, this chapter has provided a description of the GTSS and the GATS, 
followed by the results of two different analyses undertaken using GATS data from 15 
LMICs. The first paper concluded that being employed at smoke-free workplaces is 
significantly associated with living in smoke-free homes, indicating that such policies can 
bring about a change in social norms around exposing others to SHS. This shows the 
potential of SFL to bring about additional health benefits, particularly among women and 
children, who are most exposed to SHS at homes. Moreover, the paper also indicates 
that contrary to popular belief, SFL does not lead to shifting of smoking to home. In the 
second paper, socioeconomic inequalities in SHS exposure at home and at work were 
studied in 15 LMICs. SHS exposure at home was found to higher among the less 
educated and the poor while SHS exposure at work was found to be higher among the 
less educated. Socioeconomic inequalities evident in SHS exposure in HICs also exist in 
the LMIC settings, indicating a higher likelihood of health and other harms associated 
with exposure to tobacco smoke among the vulnerable poor groups in LMICs as well. 
The need for stronger and pro-equity tobacco control policies in general, including 
comprehensive SFL and additional targeted efforts among the low SES groups was 
highlighted through the paper. Such measures would not only reduce inequalities in 
SHS exposure but also reduce overall tobacco smoking in these settings.  
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Chapter 5: Evaluation of the impact of National Tobacco Control Programme on 
bidi and cigarette consumption in India 
 
5.1.  Tobacco control policies in India 
The Indian tobacco control law, ‘The Cigarettes and Other Tobacco Products 
(Prohibition of Advertisement and Regulation of Trade and Commerce, Production, 
Supply and Distribution) Act’, (COTPA) 2003, came into effect on May 1, 2004.24 The 
key provisions of COTPA 2003 include: Section 4 - prohibition on smoking in public 
places, Section 5 – prohibition of advertising, promotion and sponsorship of tobacco 
products, Section 6a – prohibition on sale of tobacco products to and by minors, Section 
6b – prohibition on sale of tobacco products within a radius of 100 yards around the 
educational institutions and Section 7 – display of specified pictorial health warnings on 
tobacco products.24 There are several other sections in COTPA which deal with 
enforcement and penalties in case of violations. In accordance with Article 8 of the WHO 
FCTC, Section 4 of COTPA prohibits smoking in public places. The 2004 smoke-free 
rules under COTPA had loopholes such as a lack of clear definition of public place 
resulting in poor segregation of smoking and non-smoking areas and a lack of 
enforcement authority. Under the new rules for Section 4 of COTPA, notified on October 
2, 2008, public places were clearly defined and included all indoor workplaces, public 
places, public transport as well as several other places frequented by public including 
stadiums, bus stops, railway stations, open auditoriums etc. (even though several of 
them are open spaces).231 As per the amended smoke-free law, it is mandatory to 
display a board at conspicuous spots (each entrance, each floor, each staircase, and 
the entrance of each lift) in public places with specifications as depicted in figure 5.1. 
Further, the name and the contact details of the authorised person to whom complaints 
can be reported in the case of violations are also to be displayed on the board. The 
smoke-free law in India however, is not comprehensive as DSRs are permitted in 
restaurants with a seating capacity of more than 30, hotels with more than 30 rooms and 
at airports. In case of violation of Section 4, offenders are liable for a penalty of up to 
INR200.232 
 
 
 
 
Figure 5.1: Specifications of the ‘no smoking’ board to be displayed 
at conspicuous locations at all public places in India 
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The COTPA Amendment Bill (2015) proposes several changes in COTPA (2004) 
including increasing the penalty for smoking in public places to INR1000 and revoking 
the permission to have DSRs at hotels and restaurants.138 Other key features of the bill 
include increasing the minimum age for sale of tobacco products from 18 to 21 years, 
banning the sale of loose cigarettes, increasing penalties for violations, and setting up of 
a National Tobacco Control Organization for appropriate implementation and 
enforcement of tobacco control laws. India also has a functional National Tobacco 
Control Programme (NTCP) and one of the major activity under the NTCP is 
implementation and enforcement of COTPA provisions including the SFL.135  
 
5.2.  National Tobacco Control Programme in India 
The Government of India enacted COTPA in 2003 and also ratified the WHO FCTC in 
2004 with an objective to limit tobacco use and control the resulting morbidity and 
mortality. In order to ensure effective implementation of the tobacco control policies at 
national and sub-national levels, and to fulfil its obligations under the WHO FCTC, the 
Government of India initiated the National Tobacco Control Programme (NTCP) in a 
pilot phase in the year 2007- 2008 with the following objectives135: 
 To bring about greater awareness about the harmful effects of tobacco use and 
tobacco control laws 
 To facilitate effective implementation of the tobacco control laws 
 
India has 29 states and seven union territories in total. In 2007-2008 (phase I), the 
NTCP was implemented in two districts from each of the selected nine Indian states. 
Subsequently, in 2008-2009 (phase II), the NTCP was expanded to include an additional 
12 states (and its 24 districts).135 The Indian states and districts covered under the 
NTCP between 2007 and 2009 are shown in Appendix D-1. The NTCP is now being 
expanded to cover all the states and union territories of India (with 672 districts) in a 
phased manner between 2012 and 2017.23 An initial budget for the period 2007-2012 of 
INR1.45 billion has now been increased to INR7.0 billion for the planned expansion in 
2012-2017.23, 233 It is also planned to engage dedicated personnel and other resources 
at all levels as a part of the NTCP expansion.  
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The NTCP in India follows a three tier system with structures and activities in place at 
national, state and district levels.135 Figure 5.2 shows the structure of India’s NTCP.  
National level:  
The National Tobacco Control Cell (NTCC) is led by the Ministry of Health & Family 
Welfare (MoHFW) and senior officers from the Directorate General of Health Services, 
assisted by a number of consultants in specific areas of tobacco control.135 The primary 
responsibility of NTCC is policy formulation, planning, and monitoring and evaluation of 
various activities under the NTCP. As tobacco is a complex and multi-dimensional issue, 
an inter-ministerial taskforce has been appointed, including 12 representatives from 
various Government departments, seven representatives of state Governments and two 
representatives from civil society organisations (CSOs), to garner greater multi-
stakeholder engagement. Additionally, a national level steering committee has also been 
constituted consisting of three Government representatives, CSOs and other non-
governmental bodies to handle matters relating to violations of section 5 (ban on 
tobacco advertising, promotion and sponsorship) of COTPA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Structure of India’s National Tobacco Control Programme (NTCP)135 
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The major activities of NTCC are: 
 National level public awareness campaigns  
 Setting up of tobacco product testing laboratories 
 Research on alternative crops/ livelihood of tobacco growers and workers 
 Monitoring and evaluation including surveillance 
 Integrating NTCP with other national programmes and as part of the National 
Health Mission (NHM) Framework 
State level: 
NTCP activities at the state level are led by a State Tobacco Control Cell (STCC) which 
is headed by a State Nodal Officer.135 The primary responsibility of STCC is overall 
planning, implementation and monitoring of different NTCP activities, and achievement 
of physical and financial targets at the state level. There also exists a State Level 
Coordination Committee (SLCC) consisting of multiple stakeholders including officials 
from various departments under the state Government. The committee is ultimately 
responsible for overseeing implementation of various state-level activities under the 
NTCP and enforcement of COTPA provisions (including the smoke-free policies). The 
major activities of STCC are: 
 Training of various stakeholders at state level 
 State level public awareness/information, education, communication (IEC) 
campaign 
 Monitoring tobacco control laws and reporting 
District level:  
NTCP activities at the district level are led by the District Tobacco Control Cell (DTCC), 
which is headed by the District Nodal Officer, supported by the District Level 
Coordination Committee (DLCC) and the enforcement squad, which is responsible for 
ensuring enforcement of COTPA provisions and monitoring compliance with laws.135 
The primary objective of DTCC is overall planning, implementation and monitoring of the 
NTCP activities, and the achievement of physical and financial targets at District level. 
The various activities of DTCC include: 
 Training and capacity building of relevant stakeholders at the district level 
 Implementation of school awareness programmes 
 Setting up and expansion of tobacco cessation facilities  
 IEC/Media campaign at the local level 
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 Monitoring and enforcement of tobacco control laws at the local level 
 
Apart from these, block and village level committees are encouraged under the NTCP 
for implementation of activities at respective levels.135 Each DTCC reports quarterly to 
the respective STCC detailing its activities conducted under the programme and 
expenses incurred on the activities. Similarly, each STCC reports quarterly to the NTCC.  
 
The Government of India has identified several challenges to implementation of the 
NTCP which are briefly listed below233: 
 Myriad varieties of tobacco products are available in India which complicates the 
implementation and enforcement of tobacco control policies while newer 
products keep emerging in the market e.g. e-cigarettes, SLT which are not well 
regulated.  
 Implementation, enforcement and compliance monitoring are mainly the 
responsibility of the state Governments, which lack capacity and resources while 
prioritising other issues over tobacco control. 
 Shifting of tobacco growing farmers to other suitable means of livelihood has 
been difficult due to large numbers of farmers involved in this occupation and a 
lack of research on this issue.  
 The lack of cooperation and coordination between non-health stakeholders in the 
Government to prioritise tobacco control.  
 Delays in the establishment of tobacco product testing laboratories. 
 Non-utilization of dedicated funds for the NTCP by the states results in a lack of 
implementation of programme activities or a delay in implementation.  
 The lack of consistent monitoring mechanism and manpower at all levels.  
 
5.3.  National Sample Survey Office - Household Consumer Expenditure Survey 
The National Sample Survey Office (NSSO), earlier known as the National Sample 
Survey Organization is a part of the Ministry of Statistics and Programme 
Implementation (MoSPI), Government of India. The NSSO has been conducting various 
nationwide sample surveys related to different socioeconomic aspects in India since the 
year 1950.234 The Household Consumer Expenditure Survey (CES) is one of the several 
types of surveys conducted by the NSSO. The CES is conducted every five years 
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across all the states and union territories of India (except some very inaccessible areas 
of Nagaland and Andaman & Nicobar Islands) since 1972-73. These surveys provide 
repeated cross-sectional data on household level consumption and expenditure on 
various food and non-food items.235 Apart from these five-yearly surveys, similar annual 
surveys are also conducted with a much smaller sample since 1986-87, which provide 
data between these large five yearly rounds.235 Table 5.1 lists some of the recent CES 
rounds.  
 
Table 5.1: Recent National Sample Survey Office (NSSO) Household Consumer Expenditure Survey Rounds in India 
Sr. No. Round Year Number in CES series 
1 55th 1999-2000 Sixth 
2 61st 2004-2005 Seventh 
3 66th 2009-2010 Eighth 
4 68th 2011-2012 Ninth 
 
 
The CES provides information about the household level consumption of more than 350 
food and non-food items (including goods and services) as well as the expenditure on 
these consumed items over a specific reference period – ‘past 30 days’ before the 
survey and ‘past 365 days’ before the survey for some non-food items. Specifically, the 
CES collects information about the household characteristics including demographic 
characteristics of the selected households, consumption of food, betel leaf, tobacco and 
intoxicants in the past 30 days, consumption of energy in the past 30 days, consumption 
of clothing, bedding and footwear for past 30 days as well as past 365 days, expenditure 
on education and medical goods and services in the past 30 days as well as past 365 
days, expenditure on miscellaneous goods and services including medical (non-
institutional), rents and taxes for the past 30 days and expenditure on purchase and 
construction of durable goods for domestic use in the past 30 days as well as past 365 
days.235 Table 5.2 shows the types of tobacco products for which information on quantity 
purchased and expenditure is collected under the CES.   
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Table 5.2: Tobacco products included in the National Sample Survey Office (NSSO) Household Consumer Expenditure 
Survey Rounds and their descriptions 
Smoked tobacco forms Smokeless tobacco forms 
1) Bidis (Bidi is made by rolling a dried, rectangular 
piece of temburni leaf (Diospyros melanoxylon) 
with 0.15-0.25 grams of sun-dried, flaked tobacco 
into a conical shape and securing the roll with a 
thread)236  
1)     Snuff (Snuff is dry powdered tobacco that is 
inhaled by snorting, applied or chewed)237  
2) Cigarettes  2)     Zarda (a moist or dry chewing tobacco mixed with a 
variety of colourings, spice essences, and perfumes)238  
3) Hookah tobacco (hookah is an Indian water pipe 
in which the tobacco smoke passes through water 
before inhalation)236 
3)     Leaf tobacco (natural, unprocessed tobacco leaf) 
4) Cheroot (A roll made from tobacco leaves, like a 
cigar, closed at both ends)236  
4)     Kimam (a fermented tobacco product made from 
tobacco, spices and essence)239  
 5) Surti (a blend of dried tobacco leaves and slaked 
lime)237  
 6) Other tobacco products 
 
 
Information such as the quantity of various products consumed in the household, per 
person (capita) consumption, total expenditure in the household and expenditure per 
capita (monthly per capita expenditure [MPCE]) can be derived from the CES surveys. 
The information in the CES is collected using a validated interviewer-administered 
questionnaire with either the adult head of the household or an equivalent adult member 
of the household ≥15 years of age through face to face surveys. Questionnaires specific 
to rounds 55 (http://www.ilo.org/surveydata/index.php/catalog/146/download/1510), 61 
(http://mail.mospi.gov.in/index.php/catalog/129/download/1464) and 68 
(http://mail.mospi.gov.in/index.php/catalog/145/download/1667) are available to 
download freely from the MoSPI website, Government of India.  
 
A stratified multi-stage sampling design is used in the CES, with the primary sampling 
units (PSUs) being the villages in rural settings and urban frame survey blocks in the 
urban settings.235 The households represent the ultimate sampling units (USUs) in both 
the rural and the urban settings. In the case of a large PSU, an intermediate stage of 
sampling is added which involves selection of two hamlet groups (from the PSU village) 
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and sub-blocks (from the PSU urban blocks). The PSUs are selected using a census 
listing of villages (using probability proportional to size with replacement) and urban 
blocks (simple random sampling without replacement) after initial stratification and sub-
stratification of rural and urban sectors and allocation of PSUs to states and union 
territories (as per probability proportional to population size). A minimum of eight urban 
and eight rural PSUs are allocated to each state/union territory. Further, if the population 
of the PSU is larger than 1200 or 600 (in the case of a rural area), the population is 
further divided into a number of hamlet groups/sub-blocks and two of these smallest 
units are selected from each PSU (one sub-unit with the largest population and other 
randomly selected). From each of the smallest sampling unit selected, households are 
selected using simple random sampling without replacement.  
 
The five-yearly CES have sample sizes of approximately 100,000 per round while the 
annual smaller CES rounds have much smaller sample sizes (~30,000 to 60,000).  
 
This chapter presents a published case study from India, which used three rounds of 
NSSO CES data (1999-2000; 2004-05; 2011-12) to evaluate the impact of its National 
Tobacco Control Programme (of which implementation/enforcement/monitoring of 
tobacco control laws including the SFL are major components at the district and state 
level) on the prevalence and the amount of active smoking. This chapter, therefore, 
addresses Aim 4 and Aim 5 of the thesis and the corresponding objectives 3 and 5.  
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impact of India’s National Tobacco Control Programme (NTCP) on bidi and 
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statistical tests including the two-part regression model using the difference-in-
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STATA. Specific guidance on statistical methods related to the difference-in-
differences method and the two-part models involved in this analysis was 
provided to me by Dr. Anup and Dr. Chang. Specific issues regarding the 
variables used in the analyses were discussed and resolved with inputs from Dr. 
Srivastava and Dr. Anup.  
 Apart from data analysis, I interpreted the statistical outputs and results with 
appropriate guidance from Dr. Anup.  
 I drafted the first cut of the entire paper fully by myself and then shared the paper 
with the co-authors for their inputs.  
 The paper underwent several rounds of revisions as per inputs from the 
supervisors and the co-authors; accordingly, I further worked on data analysis 
and revised the paper critically for intellectual content.  
 I, with guidance and approval from the co-authors, finalised the paper for 
submission to the journal.  
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* 
5.4.  Impact of India’s National Tobacco Control Programme on bidi and 
cigarette consumption: a difference-in-differences analysis  
 
5.4.1.  Abstract 
 
5.4.1.1.  Background 
Despite the importance of decreasing tobacco use to achieve Sustainable Development 
Goals (SDG) mortality reduction targets in low- and middle-income countries, 
evaluations of tobacco control programmes in these settings are scarce. We assessed 
the impact of India’s National Tobacco Control Programme (NTCP) on household-
reported consumption of bidis and cigarettes. 
 
5.4.1.2.  Methods 
Secondary analysis of cross-sectional data from nationally representative Household 
Consumer Expenditure Surveys (1999-2000; 2004-05 and 2011-12). Outcomes were: 
any bidi/cigarette consumption in the household in past 30 days and monthly 
consumption of bidi/cigarette sticks per person. A difference-in-differences two-part 
model was used to compare changes in bidi/cigarette consumption between NTCP 
intervention and control districts, adjusting for socio-demographic characteristics and 
time-based heterogeneity.  
 
5.4.1.3.  Findings 
Overall, there was a decline in bidi and cigarette consumption in India between 1999-
2000 and 2011-12. The NTCP was not associated with reductions in the proportion of 
households reporting bidi (adjusted odds ratio [AOR]: 1∙04, 95% confidence interval [CI]: 
0∙84–1∙28) or cigarette consumption (AOR: 1∙01, 95% CI: 0∙82–1∙26).  The programme 
was not associated with reductions in the monthly per person consumption of bidis 
(adjusted coefficient: 0∙07, 95% CI: -0∙13–0∙28) or cigarettes (adjusted coefficient: -
0∙002, 95% CI: -0∙26–0∙26) in bidi/cigarette consuming households. 
 
* Nazar GP, Srivastava S, Chang KC, Pearce N, Karan A, Millett C. Impact of India’s National Tobacco 
Control Programme on bidi and cigarette consumption: a difference-in-differences analysis. Submitted 
in The Lancet Global Health.  
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5.4.1.4.  Interpretation 
There was a decline in bidi and cigarette consumption in India between 1999-2000 and 
2011-12. There was no compelling evidence that NTCP reduced consumption over and 
above the general reduction that occurred in all districts. Strengthening implementation 
and enforcement of tobacco control policies is crucial to reduce the future burden of 
tobacco use in the country.  
 
5.4.2.  Research in context 
 
5.4.2.1.  Evidence before this study 
We conducted a literature search in ‘PubMed’ and ‘Scopus’ to assess existing research 
evidence on the impact of tobacco control programmes/policies on tobacco use. We 
searched for all studies published before November 14, 2016, with no language 
restrictions, using the search terms: ("tobacco control policy"  OR  "tobacco control 
program")  AND  ("evaluation"  OR  "effect"  OR  "impact")  AND  ("smoking"  OR  
"tobacco use"  OR  "prevalence"  OR  "frequency"  OR  "volume"  OR  "intensity"). 
PubMed returned 230 studies and Scopus returned 828 studies. We excluded 
simulation studies which predicted the impact of tobacco control policies/programme, 
school-based or small community-based tobacco control programmes, and studies that 
focused on only one specific tobacco control strategy. We reviewed abstracts of 
remaining studies and further excluded studies which did not specifically report impact of 
tobacco control policies/programmes on tobacco use behaviours. Studies were mostly 
from high income countries such as Spain, US (California, Massachusetts, Arizona, and 
West Virginia) and Australia. These suggest that comprehensive, aggressively 
implemented and well-resourced tobacco control programmes achieved significant 
reductions in tobacco consumption and prevalence. Literature from low- and middle-
income countries (LMICs) was sparse. A small number of studies from Mexico, Uruguay 
and Bangladesh described findings of the International Tobacco Control Policy 
Evaluation Project (ITC Project), a multi-country cohort study (only covering few states 
in the country; not nationally representative), which aims to evaluate the impact of 
specific strategies of the WHO Framework Convention on Tobacco Control (FCTC) e.g. 
smoke-free policy, health warnings, tobacco advertising and promotion, education and 
awareness and price and taxation on tobacco use and its psychosocial correlates. As 
tobacco control policies have been introduced nationwide in these settings, there is 
limited scope to include a suitable comparison group (without existing policies) in these 
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studies. No previous research from LMICs has evaluated the impact of tobacco control 
policies on tobacco use using nationally representative data and a quasi-experimental 
study design.  
 
5.4.2.2.  Added value of this study 
We conducted secondary analyses using a difference-in-differences method (typically 
used in econometrics for programme impact evaluation) on three waves (1999-2000; 
2004-05; 2011-12) of nationally representative Consumer Expenditure Survey data. We 
found that there was a decline in bidi and cigarette consumption in India between 1999-
2000 and 2011-12. There was no compelling evidence that NTCP reduced consumption 
over and above the general reduction that occurred in all districts.  
 
5.4.2.3.  Implications  
Strengthening implementation and enforcement of tobacco control policies is crucial to 
achieving national and international child health and premature NCD mortality reduction 
targets.  
 
5.4.3.  Introduction 
India is home to 275 million tobacco users,48 and faces a substantial associated 
mortality and morbidity burden.8 India ratified the WHO Framework Convention on 
Tobacco Control (FCTC) in 2004 and legislated to implement key tobacco control 
measures through the Cigarettes and Other Tobacco Products Act (COTPA) in 2003.16, 
240 However, implementation of key tobacco control measures has been uneven and 
weak in many parts of the country due to resource constraints, conflicting interests of 
various stakeholders and tobacco industry tactics.233 
 
India launched the National Tobacco Control Programme (NTCP) in 2007-08 to ensure 
more effective implementation and enforcement of tobacco control measures. Initially 
developed as a pilot project in two districts in each of nine Indian states,135 the 
programme was expanded in 2008-09 to cover a total of 42 districts and 21 states 
(Supplementary Table in Appendix D-1). The objectives of the NTCP are to: a) increase 
awareness about the harmful effects of tobacco use and tobacco control laws; and b) 
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facilitate effective implementation of tobacco control laws and policies. The activities of 
the NTCP are distributed and implemented across three Government tiers: national, 
state and district levels, but much of the focus is on strengthening local tobacco control 
efforts at the district level. The NTCP activities include training and capacity building, 
public awareness campaigns, expansion of tobacco cessation facilities, monitoring and 
evaluation and enforcement of COTPA provisions, among others.135, 233 Further details 
about the NTCP are available elsewhere.135  
 
Robust assessment of tobacco control programmes in LMICs is essential given the 
importance of decreasing tobacco use to achieve both child and adult mortality reduction 
targets in the Sustainable Development Goals (SDGs).19, 20 However, robust evaluation 
is often constrained by lack of surveillance to monitor changes in tobacco use over time. 
The objective of our study was to evaluate the impact of the NTCP on bidi† and cigarette 
consumption at the household level.  
 
5.4.4.  Methods  
 
5.4.4.1.  Study design, setting and data 
We used a quasi-experimental difference-in-differences (DID) design to evaluate the 
impact of NTCP on household level consumption of bidis and cigarettes. We used three 
waves (1999-2000, 2004-05 and 2011-12) of the nationally representative, household 
Consumer Expenditure Survey (CES) data conducted by the National Sample Survey 
Organization (NSSO) (Government of India).235, 241, 242 The CES used a stratified 
multistage sampling design covering districts from all states and union territories in 
India. The head of household or equivalent (adult participant aged ≥15 years) of 
randomly selected households were invited to participate in a face-to-face interview, and 
a validated interviewer-administered questionnaire was used to obtain information about 
the household’s consumption and expenditure of over 350 food and non-food items. Full 
details of the CES data are available elsewhere.235, 241, 242 
 
                                                          
† Bidi is made by rolling a dried, rectangular piece of temburni leaf (Diospyros melanoxylon) with 0.15-
0.25 grams of sun-dried, flaked tobacco into a conical shape and securing the roll with a thread.236  
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The sample sizes of the three survey waves varied between 100,000 to 125,000 
households and spread across approximately 12,000 sub-districts (villages or urban 
blocks) in each wave.235, 241, 242 These sum up to 341,975 households included in our 
study after excluding 4,640 households (1.3% of 346,615 households) which had 
no/incomplete data recorded. 
 
5.4.4.2.  Measures 
 
Dependent variables 
We considered four different outcomes: a) proportion of households reporting 
consumption of bidis; b) proportion of households reporting consumption of cigarettes; c) 
number of bidi sticks consumed per person in households reporting bidi use; and d) 
number of cigarette sticks consumed per person in households reporting cigarette use. 
All of the above measures were based on reported consumption in the 30 days before 
the interview. 
 
Independent variables 
Main independent variables were: a) households residing in an NTCP district 
(Supplementary Table in Appendix D-1); b) time indicator; and c) interaction terms 
between households residing in an NTCP district and time.  
 
We created a binary variable to indicate whether the household was from an NTCP 
district (determined by the NTCP operational guidelines).135 We treated the survey year 
1999-2000 as the reference year and created two binary variables to indicate the 
subsequent years of survey data: t2 (1 if 2004-05, 0 otherwise); and t3 (1 if 2011-12, 0 
otherwise). We used two interaction terms: a) an interaction between the indicator of 
households residing in NTCP districts and t2; and b) an interaction between the indicator 
of households residing in NTCP districts and t3. The latter captured the impact of the 
NTCP on bidi and cigarette consumption.  
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We controlled for an array of demographic and socioeconomic status (SES) indicators 
including the household’s area of residence (rural or urban) and wealth quintile (poorest, 
poor, middle, rich, richest); household size (number of household members ≤ 5 or > 5); 
proportion of household members in each age group (0-4 years; 5-14 years; 15-29 
years; 30-59 years; ≥ 60 years); proportion of male and female members of the 
household, proportion of household members at each educational level (illiterate, 
primary, middle, secondary, higher secondary, graduate and above); household religion 
(Hindu, Muslim, Christian, and others); caste‡ (Scheduled Tribe [ST], Scheduled Caste 
[SC], Other Backward Class [OBC], and others); and employment type (self-employed, 
regular labourer, casual labourer, and others).243 Household characteristics of all three 
survey years are presented in a supplementary table in Appendix D-2.  
 
5.4.4.3.  Data analysis 
Quasi-experimental difference-in-differences (DID) is a key econometric approach 
commonly used in policy impact evaluations.244-246 Under a basic set up of DID, the 
impact of an intervention (e.g. the NTCP) is estimated by comparing the average 
changes in outcome from before to after the intervention for the treatment group, and 
subtracting from it, the average changes in outcome over the same time period for the 
control group which is not exposed to the intervention. Thus, an important assumption of 
DID is that in the absence of the intervention, the outcomes for the treated and control 
groups are assumed to follow a parallel trend over time.244  
 
Since the outcomes for the treated group in the absence of the intervention are not 
observed, the parallel time trend assumption cannot be assessed empirically. Therefore, 
in addition to the data we observed for the households residing in an NTCP district or a 
non-NTCP district before and after the implementation of the NTCP (as defined earlier, 
t2 is before and t3 is after NTCP respectively), we included data from another pre-
intervention time period (t1 as defined previously) to test whether the parallel time trend 
assumption holds prior to the introduction of the NTCP.245 
 
                                                          
‡ a system of rigid social stratification characterized by hereditary status, endogamy, and social barriers 
sanctioned by custom, law, or religion  
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We embedded the proposed DID specification into a two-part model (TPM),245, 247, 248 
which captures two dimensions of bidi and cigarette consumption: part I of the TPM 
uses a logit model to estimate the proportion of households reporting consumption of 
bidis/cigarettes; whereas part II uses a semi-log model to estimate the number (log) of 
bidis/cigarettes sticks consumed per person, conditional on the households reporting 
any bidi/cigarette smoking. 
 
The full specification of DID in the TPM framework is described as the following: 
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Where yijt is the outcome variable of interest for household i living in district j during time 
period t, dG is the binary indicator for households living in an NTCP or non-NTCP district. 
td  stands for time indicators for the two later time periods (2004-05 and 2011-12) with t 
varying from 2 to 3. The interaction terms Gt dd .  provide two DID estimators – Gt dd .2  
(DID1) represents the DID from t1 to t2 between households residing in an NTCP or non-
NTCP district before the introduction of the NTCP; and Gt dd .3  (DID2) represents the 
DID from t1 to t3 where households were exposed to the intervention at t3 if they were 
residing in an NTCP district. DID1 is, therefore, the test of parallel time trend pre-
intervention and it is significant if the assumption is violated. If the pre-intervention DID 
remains non-significant, the ratio of DID2 to DID1 (difference [DID2-DID1] in the case of 
part II of the model) would represent the actual effect of the NTCP on the outcome 
measure. We adjusted for the set of independent variables for households (Xijt), state-
level fixed effects ( j and j ), and it and it  are the usual error terms. We used robust 
standard errors that were clustered at the district level and sampling weights provided by 
the CES were applied.  
 
To address the potential for contamination or spill-over of interventions in NTCP to 
neighbouring non-NTCP districts, we ran models with three different sets of control 
groups: a) Model 1 included controls from both NTCP and non-NTCP states; b) Model 2 
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included controls from NTCP states only; and c) Model 3 included controls from non-
NTCP states only.  
 
All statistical analyses were performed using STATA version 13∙1 (StataCorp LP, 
Texas). Exemption from ethics review for using anonymous CES data for secondary 
analyses was obtained from the Research Ethics Committee at the London School of 
Hygiene and Tropical Medicine and the Institutional Ethics Committee at Public Health 
Foundation of India. 
 
5.4.4.4.  Role of the funding source 
The funding bodies had no role in the study design; in the collection, analysis, and 
interpretation of data; in the writing of the report; and in the decision to submit the paper 
for publication. The corresponding author had full access to all the data in the study and 
had final responsibility for the decision to submit for publication. 
 
5.4.5.  Results 
 
5.4.5.1.  Descriptive statistics 
The proportion of households reporting consumption of bidis (31∙9% to 22∙1%) and the 
number of bidis consumed monthly per person (94∙0 to 71∙9 number of bidi sticks) 
declined over the study period (Supplementary figure in Appendix D-3). Similar 
reductions were observed between households in the NTCP and non-NTCP districts 
(Figure 5.3 & Supplementary table in Appendix D-4). The proportion of households 
reporting consumption of bidis was significantly higher in the non-NTCP districts at all 
time points. The proportion of households reporting cigarette consumption increased 
slightly (5∙3% to 6∙3%) over the study period (Supplementary figure in Appendix D-3) 
and was significantly higher in the NTCP districts at all time points (Figure 5.4 & 
Supplementary table in Appendix D-4). The number of cigarettes consumed (28∙4 to 
17∙6 number of cigarette sticks) declined over time (Supplementary figure in Appendix 
D-3) but no significant differences were observed between the NTCP and non-NTCP 
districts at all time points (Figure 5.4 & Supplementary table in Appendix D-4). 
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Figure 5.3: Trends in household consumption of bidis over time (Consumer Expenditure Survey rounds: 1999-2000; 2004-05; 2011-12) in NTCP districts (Intervention) vs. households in 
non-NTCP districts (Control) 
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Figure 5.4: Trends in household consumption of cigarettes over time (Consumer Expenditure Survey rounds: 1999-2000; 2004-05; 2011-12) in NTCP districts (Intervention) vs. 
households in non-NTCP districts (Control) 
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5.4.5.2.  Impact of the NTCP on bidi consumption 
We present in Table 5.3 the adjusted odds ratio (AOR) for the proportion of households 
reporting bidi consumption and the adjusted coefficient for the log of monthly 
consumption of bidi sticks per person. We observed no significant differences in pre-
intervention changes in the proportion reporting consumption or (logged) number of bidi 
sticks consumed between 1999-2000 and 2004-05 (DID1), suggesting the assumption 
of a parallel trend in outcome before the introduction of the NTCP was satisfied.  
 
As shown in Model 1, we found that the NTCP was not associated with a reduction in 
the proportion of households reporting bidi consumption (AOR for the ratio of DID2 to 
DID1: 1∙04, 95% Confidence Interval [CI]:0∙84–1∙28), nor was it associated with a 
reduction in the monthly consumption of bidi sticks per person (coefficient for the 
difference of DID2 subtracts DID1: 0∙07, 95% CI: -0∙13–0∙28). Results of Model 2 and 
Model 3 produced consistent findings, indicating that our Model 1 findings were unlikely 
to be due to contamination or spill over effects of the NTCP into neighbouring districts. 
 
5.4.5.3.  Impact of the NTCP on cigarette consumption 
The AOR for the proportion of households reporting cigarette consumption and the 
adjusted coefficient for the log of monthly consumption of cigarettes per person are 
shown in Table 5.4. The findings suggest that the pre-intervention changes in the 
proportion of consuming households or (logged) number of cigarette sticks consumed 
were not significant between 1999-2000 and 2004-05 (DID1) therefore, the assumption 
of a parallel trend in outcome before the introduction of the NTCP was satisfied.  
 
Our Model 1 shows that the NTCP was not associated with any reduction in the 
proportion of households consuming cigarettes (AOR for the ratio of DID2 to DID1: 1∙01, 
95% CI: 0∙82–1∙26), nor was it associated with any reduction in the monthly 
consumption of cigarettes per person (coefficient for the difference of DID2 subtracts 
DID1: -0∙002, 95% CI: -0∙26–0∙26). The results were consistent for Model 2. In Model 3, 
the NTCP was found to be associated with a borderline significantly higher proportion of 
households reporting cigarette consumption (AOR for the ratio of DID2 to DID1: 1∙32, 
95% CI: 1∙00–1∙73).   
 
162 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Estimates obtained from logistic regression model with state-level fixed effects adjusted for sector (rural/urban); household size (≤5/ >5 members); proportion of 
members in age groups 0-4, 5-14, 15-29, 30-59, ≥60; proportion of females/males in the household; proportion of members in education categories ‘illiterate’, ‘primary’, 
‘middle’, ‘secondary’, ‘higher secondary’, ‘graduate & above’; Religion (Hindu/Muslim/Christian/Others); Caste (ST/SC/OBC/Others); Employment type (Self-
employed/Regular labour/Casual labour/Others); and Wealth quintile (poorest/poor/middle/rich/richest) 
$Estimates obtained from OLS regression model with state-level fixed effects adjusted for the covariates described above for the logistic model 
§Model 1 – Intervention districts from the intervention states and control districts from both, intervention & control states 
†Model 2 – Intervention and control districts only from intervention states 
‡Model 3 – Intervention districts from intervention states and control districts from non-intervention states 
* indicates p-value<0∙05 
 
Table 5.3: Effect of the Indian National Tobacco Control Programme (NTCP) on bidi consumption 
(NSSO 1999-2000; 2004-05; 2011-12 pooled data) 
 Households reporting bidi consumption 
Adjusted Odds Ratio [95% CI]# 
Log of per person monthly consumption of bidi sticks 
Adjusted Beta coefficient [95% CI]$ 
   
 Model 1 (part I)§ 
n=341,975 
Model 2 (part I)† 
n=270,265 
Model 3 (part I)‡ 
n=107,291 
Model 1 (part II) § 
n=86,818 
Model 2 (part II)† 
n=69,366 
Model 3 (part II)‡ 
n=25,767 
Constant 0∙490 
[0∙155, 1∙550] 
0∙397* 
[0∙310, 0∙508] 
0∙590* 
[0∙200, 1∙741] 
4∙248* 
[4∙097, 4∙399] 
3∙245* 
[3∙107, 3∙382] 
4∙178* 
[3∙968, 4∙388] 
NTCP (indicator for intervention districts) 0∙995 
[0∙801, 1∙235] 
1∙004 
[0∙810, 1∙245] 
0∙447 
[0∙165, 1∙212] 
0∙031 
[-0∙103, 0∙167] 
0∙034 
[-0∙100, 0∙169] 
-0∙242* 
[-0∙468, -0∙016] 
t2 (indicator for year 2004-05) 0∙702* 
[0∙659, 0∙748] 
0∙718* 
[0∙670, 0∙769] 
0∙558* 
[0∙493, 0∙631] 
-0∙119* 
[-0∙162, -0∙076] 
-0∙115* 
[-0∙162, -0∙069] 
-0∙150* 
[-0∙241, -0∙058] 
t3 (indicator for year 2011-12) 0∙745* 
[0∙696, 0∙798] 
0∙761* 
[0∙706, 0∙819] 
0∙628* 
[0∙539, 0∙731] 
-0∙378* 
[-0∙445, -0∙311] 
-0∙363* 
[-0∙436, -0∙291] 
-0∙514* 
[-0∙628, -0∙400] 
NTCP x t2 interaction term (DID 1) 0∙991 
[0∙774, 1∙269] 
0∙966 
[0∙753, 1∙238] 
1∙219 
[0∙938, 1∙585] 
-0∙045 
[-0∙231, 0∙139] 
-0∙052 
[-0∙239, 0∙134] 
0∙002 
[-0∙194, 0∙199] 
NTCP x t3 interaction term (DID 2) 1∙031 
[0∙785, 1∙353] 
1∙012 
[0∙768, 1∙333] 
1∙184 
[0∙889, 1∙577] 
0∙029 
[-0∙138, 0∙197] 
0∙020 
[-0∙149, 0∙190] 
0∙103 
[-0∙095, 0∙303] 
Pseudo-R2 / R-squared 0∙170 0∙170 0∙220 0∙295 0∙295 0∙293 
Effect of NTCP (DID 2-DID 1) 1∙039 
[0∙843, 1∙282] 
1∙047 
[0∙847, 1∙3] 
0∙971 
[0∙756, 1∙246] 
0∙075 
[-0∙133, 0∙283] 
0∙073 
[-0∙136, 0∙282] 
0∙101 
[-0∙143, 0∙345] 
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Table 5.4: Effect of the Indian National Tobacco Control Programme (NTCP) on cigarette consumption 
(NSSO 1999-2000; 2004-05; 2011-12 pooled data) 
 Households reporting cigarette consumption  
Adjusted Odds Ratio [95% CI]# 
Log of per person monthly consumption of cigarette sticks 
Adjusted Beta Coefficient [95% CI]$ 
 Model 1 (part I) § 
n=341,975 
Model 2 (part I)† 
n=270,265 
Model 3 (part I)‡ 
n=107,291 
Model 1 (part II) § 
n=28,542 
Model 2 (part II)† 
n=19,076 
Model 3 (part II)‡ 
n=13,162 
Constant 0∙070* 
[0∙048, 0∙103] 
0∙033* 
[0∙03, 0∙047] 
0∙105* 
[0∙056, 0∙198] 
2∙544* 
 [2∙144, 2∙943] 
1∙125* 
[0∙472, 1∙778] 
3∙028* 
[2∙509, 3∙548] 
NTCP (indicator for intervention districts) 1∙233 
[0∙894, 1∙700] 
1∙212 
[0∙877, 1∙677] 
0∙463* 
[0∙324, 0∙662] 
-0∙193 
[-0∙409, 0∙021] 
-0∙212 
[-0∙4, 0∙002] 
-1∙894* 
[-2∙388, -1∙399]  
t2 (indicator for year 2004-05) 1∙011 
[0∙920, 1∙110] 
0∙950 
[0∙851, 1∙060] 
1∙293* 
[1∙117, 1∙496] 
-0∙147* 
[-0∙232, -0∙062] 
-0∙165* 
[-0∙265, -0∙065] 
-0∙060 
[-0∙219, 0∙097] 
t3 (indicator for year 2011-12) 1∙182* 
[1∙064, 1∙312] 
1∙189* 
[1∙054, 1∙343] 
1∙203 
[0∙992, 1∙458] 
-0∙514* 
[-0∙612, -0∙416] 
-0∙579 * 
[-0∙684, -0∙475] 
-0∙300* 
 [-0∙509, -0∙091] 
NTCP x t2 interaction term (DID 1) 0∙852 
[0∙597, 1∙215] 
0∙896 
[0∙625, 1∙284] 
0∙735 
[0∙513, 1∙051] 
0∙192 
[-0∙065, 0∙450] 
0∙197 
[-0∙064, 0∙459] 
0∙090 
[-0∙186, 0∙368] 
NTCP x t3 interaction term (DID 2) 0∙865 
[0∙594, 1∙260] 
0∙857 
[0∙585, 1∙253] 
0∙971 
[0∙647, 1∙457] 
0∙190 
[-0∙082, 0∙462] 
0∙242 
[-0∙028, 0∙513] 
-0∙082 
[-0∙405, 0∙240] 
Pseudo-R2 / R-squared 0∙136 0∙130 0∙125 0∙367 0∙388 0∙322 
Effect of NTCP (DID 2 – DID 1) 1∙015 
[0∙818, 1∙260] 
0∙956 
[0∙763, 1∙198] 
1∙321* 
[1∙007, 1∙733] 
-0∙002 
[-0∙266, 0∙260] 
0∙045 
[-0∙225, 0∙315] 
-0∙173 
[-0∙462, 0∙116] 
# Estimates obtained from logistic regression model with state-level fixed effects adjusted for sector (rural/urban); household size (≤5/>5 members); proportion of members 
in age groups 0-4, 5-14, 15-29, 30-59, ≥60; proportion of females/males in the household; proportion of members in education categories ‘illiterate’, ‘primary’, ‘middle’, 
‘secondary’, ‘higher secondary’, ‘graduate & above’; Religion (Hindu/Muslim/Christian/Others); Caste (ST/SC/OBC/Others); Employment type (Self-employed/Regular 
labour/Casual labour/Others); and Wealth quintile (poorest/poor/middle/rich/richest)   
$Estimates obtained from OLS regression model with state-level fixed effects adjusted for the covariates described above for the logistic model  
§Model 1 – Intervention districts from the intervention states and control districts from both, intervention & control states 
†Model 2 – Intervention and control districts only from intervention states 
‡Model 3 – Intervention districts from intervention states and control districts from non-intervention states 
* indicates p-value<0∙05 
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5.4.6.  Discussion 
Our findings suggest that between 1999-2000 and 2011-12, there was an overall 
reduction in the consumption of bidis and cigarettes in India. However, we did not find 
significant differences in reductions in bidi or cigarette consumption between NTCP and 
non-NTCP districts, four years after the programme implementation. These findings 
indicate that the decline observed in bidi and cigarette consumption in India may not be 
attributable to the NTCP. A possible explanation for our failure to detect a significant 
decline between NTCP and non-NTCP districts could be that COTPA was implemented 
in 2003 and strengthened in 2007-08, through the launch of NTCP. Hence, the control 
districts did not have absolutely no tobacco control intervention, just a less intense 
intervention, compared with the NTCP districts. Nevertheless, the findings are 
suggestive of inadequate implementation of tobacco control activities under the NTCP in 
the country, particularly at state and district levels, reflecting insufficient resource 
allocation and utilization and poor mechanisms for implementation and monitoring.233, 240 
This is reflected in other evidence which suggests that in 2012 only 50% of the 21 NTCP 
states had mechanisms in place to monitor compliance of tobacco control interventions; 
only 50% had collected any penalties for the violation of smoke-free law at public places; 
only 14%  collected penalties for the violation of ban on tobacco advertising; ban on sale 
of tobacco products to and by minors was not enforced in many of the states; and the 
smoking cessation facilities were absent from districts in almost 50% of the states.240 
 
Impact evaluations of tobacco control programmes in high income countries such as the 
US have suggested that only comprehensive, aggressively implemented and well-
resourced tobacco control programmes can achieve significant reductions in tobacco 
consumption and prevalence.249-252 For example, the per person consumption of 
cigarettes in California declined at a rate of 52% during 1989-1993 following the 
implementation of a state-wide comprehensive tobacco control programme,250, 251 with 
similar reductions being observed in Massachusetts.249 However when the funding for 
California’s programme was cut in 1993, the programme suffered a slower rate of 
reduction (28%) during 1994-1996, which was complemented by aggressive tobacco 
industry tactics.251 In a study conducted by Farrelly and colleagues, expenditures on a 
tobacco control programme have been shown to be independently associated with a 
reduction in the prevalence of smoking such that, doubling the expenditure would lead to 
an increased reduction in smoking prevalence by 1% to 1∙7%.253 Evaluation of tobacco 
control programmes in LMIC settings is sparse. However, there are a growing number of 
countries which have been successful in reducing tobacco use such as Brazil, which has 
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reduced the prevalence of smoking by 50% in the past two decades by progressively 
strengthening its tobacco control policies.74   
 
Given this context and the growing burden of tobacco smoking in India,44 the failure of 
the NTCP to deliver an additional reduction in tobacco smoking (over and above the 
decline which would occur without NTCP) and associated magnitude of forgone health 
benefits is concerning. In 2009–2010, one in three employees in India reported being 
exposed to second hand smoke (SHS) at their workplace.48 Simulation of tobacco 
interventions has shown that over one million myocardial infarctions (MI) and stroke 
deaths in India could be averted over the next decade if comprehensive smoke-free 
laws were fully implemented.254 Recent data from England indicate substantial health 
benefits of smoke-free legislation for child health, including reduced infant deaths, other 
birth outcomes and reduced admissions for asthma and respiratory tract infections.122, 
201, 255 These findings indicate that strengthened implementation of tobacco control 
interventions in India and other LMICs could substantially improve child health 
outcomes. These findings highlight the importance of tobacco control to achieve SDG 
targets to improve child health and reduce premature mortality from NCDs.19, 20 
 
5.4.6.1.  Strengths and limitations 
This is the first study to assess the impact of India’s NTCP on consumption of bidis and 
cigarettes using nationally representative, repeated cross-sectional data. Our sample 
sizes for each CES round were very large (100,000 to 125,000) which was a strength of 
the study and ensured that the study was sufficiently powered to detect any significant 
differences in bidi and cigarette consumption between the study groups. Impact 
evaluation studies all share a common challenge when there are differences in the 
observable and/or unobservable characteristics between the intervention and control 
groups.256 We attempted to minimise these biases by implementing the DID design while 
controlling for socio-demographic characteristics of households; state-level fixed effects 
because some activities of the NTCP may have been implemented at the state level; as 
well as extending the analysis to an additional pre-intervention period.244 We additionally 
ran models to test for the potential spill-over effect that may be associated with the 
NTCP on the neighbouring non-NTCP districts, but our findings do not support the 
presence of contamination or spill-over effects. 
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Our study has a number of limitations. First, it was not possible to separate the effect of 
other tobacco control activities (apart from the NTCP intervention) on bidi or cigarette 
consumption particularly at sub-state level (e.g. declaration of smoke-free cities, local 
training sessions for policy enforcers, and local NGO/civil society supported tobacco 
control activities), although we are not aware of other major locally implemented tobacco 
control interventions in our study sites which may have influenced our findings. While 
the focus of the NTCP was to strengthen tobacco control at the district level, some 
activities were undertaken at state and national levels. However, findings from our 
Model 3, which only included controls from non-NTCP states, suggest that a 
combination of district and state level activities did not have a discernible impact on bidi 
and cigarette consumption. Second, we did not include smokeless tobacco (SLT) in our 
analyses restricting the focus to bidi and cigarette consumption. Regulation of SLT 
products has been managed separately in India, for example through the Food Safety 
and Standards (Prohibition and Restriction on Sales) Regulations.257 Further, CES data 
includes a variety of SLT products (although, not all SLT products are captured) and 
reporting of these different products is in different units. Third, the CES provides 
household level data and no individual level information is available. However, previous 
studies have suggested that household level estimates of tobacco consumption may be 
more useful for policy decision making.243 Fourth, some degree of social desirability bias 
would be expected in CES data on questions related to household tobacco consumption 
as it was self-reported. Fifth, it is possible that a four-year follow-up is insufficient and 
that the NTCP has had more recent effects on tobacco consumption. It will be important 
to evaluate how tobacco consumption changes in the future, as further expansion of 
NTCP to other Indian states is currently underway. Finally, although most of the NTCP 
states were high tobacco prevalence states as observed from GATS India 2010,48 
districts for NTCP implementation in each state were not selected randomly. It is 
possible that districts willing to implement NTCP were selected and these districts were 
systematically different compared to the control districts e.g. districts with some pre-
existing tobacco control activities were selected. It may have led to our findings which 
showed no significant differences in decline in bidi and cigarette consumption between 
NTCP and non-NTCP districts. In conclusion, although there was a decline in bidi and 
cigarette consumption in India between 1999-2000 and 2011-12, there was no 
compelling evidence that NTCP reduced consumption over and above the general 
reduction that occurred in all districts. Strengthening implementation and enforcement of 
tobacco control policies is vitally important to achieve national and international child 
health and premature NCD mortality reduction targets.19, 20 
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Chapter 6: Discussion and policy implications  
 
Research evidence from HICs shows that smoking and exposure to SHS are high 
among those belonging to the low SES groups,4, 6, 7 resulting in socioeconomic 
inequalities in smoking-related health outcomes. Implementation of comprehensive SFL 
along with other evidence-based tobacco control measures in HICs has been shown to 
bring about added behavioural, health and economic benefits.6, 21, 27, 31 While some 
tobacco control measures such as taxation have been shown to reduce inequalities in 
smoking (more beneficial to low SES groups vs. the high SES groups), there exists 
mixed evidence with respect to the impact of SFL.155 LMIC settings experience heavy 
health and economic burden due to exposure to tobacco smoke, which is likely to 
escalate in the future as the majority of smokers reside in these settings.2 Moreover, 
implementation, enforcement and monitoring of comprehensive SFL along with other 
WHO FCTC recommended tobacco control measures are lacking in LMICs compared 
with HICs.23 Despite its urgency, research focusing on SHS exposure and the impact of 
SFL is sparse in the LMIC settings. The lack of research evidence, complemented with 
other barriers such as tobacco industry interference, a lack of political will, and poor 
knowledge about the health and economic adverse effects of exposure to tobacco 
smoke as well as the benefits of SFL, impedes effective implementation and 
enforcement of strong tobacco control measures in LMICs. 
 
My thesis, using limited data available in LMICs, including a case study from India, 
assessed whether the health benefits of SFL identified in HICs are likely to accrue in 
LMICs and if so, whether these benefits are evenly distributed between SES groups. 
This goal was addressed through a series of research papers with the following aims: 
1. To study the impact of SFL on socioeconomic inequalities in health outcomes 
related to exposure to tobacco smoke. 
2. To study the association between SFL and exposure to SHS in the home in the 
LMIC settings. 
3. To study socioeconomic inequalities in exposure to SHS at home and in the 
workplace in LMICs. 
4. To assess the impact of its National Tobacco Control Programme (NTCP) in 
India on bidi and cigarette smoking. 
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The other cross-cutting objectives of my thesis were to draw comparisons between the 
findings of this study with those available from the HIC settings and to generate policy 
recommendations to enable better implementation and enforcement of comprehensive 
SFL along with other evidence-based tobacco control measures across LMICs. 
 
In section 6.1 of this chapter, the key results from each research paper are summarised, 
followed by an overall synthesis. The strengths and limitations of this thesis are 
discussed in section 6.2. Each research paper presented in my thesis has its own 
discussion section including its strengths and limitations. Hence, I have attempted to 
limit repetition in this chapter. Relevant recommendations for policy and practice arising 
out of my research findings are discussed in section 6.3; followed by a conclusion in 
section 6.4.  
 
6.1.  Summary and synthesis of the research findings 
In chapter 3, a systematic review was included with the objective of studying the impact 
of SFL on socioeconomic inequalities in health outcomes (morbidity and mortality), by 
assessing the quantity and quality of literature available globally. The results indicated 
that literature exploring this aspect of SFL is sparse. I found only eight studies that could 
be included in the review. All the studies included were from HICs. Further, it was 
observed that only comprehensive SFL (i.e. 100% smoke-free air policy without any 
exemptions, mechanical ventilation or filtration systems or voluntary agreements) is 
likely to be equity positive or more likely to benefit the low SES groups compared with 
the high SES groups; while partial SFL may not reduce socioeconomic inequalities.  The 
review concluded that implementation of comprehensive SFL is important to reduce 
health inequalities and for countries which have implemented no or partial SFL, it is 
important to strengthen existing policies and move towards comprehensive SFL.  
 
In chapter 4, secondary analyses using cross-sectional GATS data from 15 LMICs 
showed that SHS exposure in the LMIC settings at work and at home (most important 
venues where SHS exposure typically occurs) is high and it varies greatly between 
LMICs studied. For example, the prevalence of SHS exposure at home ranged from 
17% in Mexico to 73% in Viet Nam, while at the workplace, the prevalence ranged from 
17% in Uruguay to 66% in Bangladesh.42 These findings are consistent with those 
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observed in an earlier study conducted in these settings.53 The variation reflects the 
differences in the extent and the intensity of implementation of tobacco control policies 
including the SFL in these settings and highlights the steady progress made by some 
Latin American countries in tobacco control (particularly with regard to the 
implementation of SFL) over the last decade.22, 63 In this study, it was observed that SHS 
exposure at home was higher among the poor and the less educated, while at the 
workplace, it was higher among the less educated in the majority of LMICs studied. The 
inequalities in exposure to SHS observed in HICs6, 7 were confirmed to exist in LMICs as 
well (as observed in this study). The need for pro-equity tobacco control interventions 
such as taxation and comprehensive SFL along with targeted awareness campaigns for 
the low SES groups in LMIC settings was highlighted. Such measures would not only 
reduce inequalities in SHS exposure but also reduce overall tobacco smoking, as 
evidenced by previous research.161 
 
In another analysis conducted as part of chapter 4 using the GATS data from 15 LMICs, 
it was observed that those employed in smoke-free workplaces were significantly more 
likely to live in smoke-free homes. This finding was consistent with those from several 
studies conducted in HICs which showed that SFL was associated with increased 
likelihood of living in smoke-free homes32-34 and smoke-free private vehicles.36 It was 
also observed that contrary to popular belief, SFL implementation did not lead to 
increased smoking at homes. To the contrary, it may have produced additional 
protection from exposure to tobacco smoke and associated health benefits, particularly 
among the vulnerable women and children.56 The findings indicated that in LMICs, as 
observed in HICs,32-35 SFL implementation may have led to a change in social norms 
towards protection of non-smokers from exposure to tobacco smoke, thereby 
denormalizing smoking behaviour.  
 
In chapter 5, a case-study from India (an LMIC) was presented wherein the impact of 
NTCP (of which, a major component at district and state level is the implementation and 
enforcement of tobacco control policies including the SFL) on bidi and cigarette 
consumption was studied using the sophisticated difference-in-differences method on 
data from three rounds of NSSO CES (1999-2000; 2004-05 and 2011-12). It was 
observed that although there was a decline in bidi and cigarette consumption in India 
between 1999-2000 and 2011-12, there was no compelling evidence that NTCP 
reduced consumption over and above the general reduction that occurred in all districts. 
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Strengths and weaknesses of the NTCP were discussed, which include a lack of 
capacity and resources, inadequate monitoring and implementation and inadequate 
utilisation of resources.233, 240 A comparison with some of the successful tobacco control 
programmes from the HIC settings revealed that only comprehensive, aggressively 
implemented and enforced, and well-resourced tobacco control programmes are likely to 
be effective.249-252 
 
Findings from all the four research papers, collectively, underscore the observation that 
comprehensive SFL, as a part of a planned, well-resourced and aggressively 
implemented tobacco control programme in LMIC settings may bring about similar 
health benefits, through a reduction in smoking and SHS exposure, as observed in 
HICs. The lack of studies evaluating tobacco control policies such as the SFL from 
LMICs raises concerns due to the heavy health and economic burden associated with 
exposure to tobacco smoke and the poor implementation and enforcement of tobacco 
control policies (including the SFL) in these settings.23 Extending the findings of previous 
reviews which demonstrated the health benefits associated with SFL27, 28 and greater 
benefits with comprehensive SFL vs. partial SFL,27 it was observed in this thesis that 
comprehensive SFL is likely to be pro-equity, through greater reduction in smoking-
related morbidity and mortality among the disadvantaged groups (those most exposed 
to tobacco smoke); while partial SFL may not reduce inequalities. The benefits of SFL 
observed in HICs such as reductions in exposure to tobacco smoke, positive changes in 
social norms with regard to exposing non-smokers to tobacco smoke and the resulting 
likely health benefits are also evident in LMICs (as observed in my thesis). In 
comparison with the comprehensive tobacco control programmes from HICs (such as 
the California’s tobacco control programme),250, 251 those from LMICs such as India 
appear to suffer from drawbacks such as the lack of capacity and resources, monitoring 
and rigour in its implementation, which appear to be the reasons behind the lack of 
impact of these programmes on tobacco smoking. In order to achieve a reduction in 
tobacco smoking, and thereby to achieve UN SDG targets of reduction in inequalities143 
and premature deaths due to NCDs,19, 20 it is important that tobacco control programmes 
in LMICs are comprehensive, aggressively implemented, well-resourced and effectively 
enforced. 
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6.2.  Strengths and limitations 
Each research paper presented in my thesis has its own strengths and limitations, which 
are discussed in respective papers. In this section, I present some of the general 
strengths and limitations for my thesis.  
 
6.2.1. General strengths 
In my thesis, I have used nationally representative GATS datasets from 15 LMICs for 
two research papers presented in chapter 4. GATS utilises uniform survey methodology, 
protocols and questionnaire which enabled broad comparisons to be drawn across 
LMICs. Further, this also ensured that I did not have to restrict myself to one specific 
LMIC and allowed inferences to be drawn, which would be relevant for LMICs globally. I 
have also used three rounds of repeated cross-sectional, nationally representative, 
NSSO CES for evaluation of the impact of India’s NTCP in chapter 5. The case-study 
has been included as India (a representative of LMIC settings) is one of the leading 
producers and consumers of tobacco in the world,3 and has its own tobacco control 
programme135 (consistent with WHO FCTC guidelines16), of which monitoring and 
implementation of SFL is a major component. Evaluation of the impact of NTCP in this 
LMIC has provided some useful insights relevant for tobacco control programmes in 
general, and more specifically for LMICs. I have used a variety of study designs and 
analytic methods in this study rather than being restricted to one specific type e.g. a 
systematic review using the novel ‘Harvest Plot’ for testing competing hypotheses (a 
combination of narrative and graphical method) in chapter 3, regression-based methods 
for cross-sectional data analyses in chapter 4 and a sophisticated difference-in-
differences analysis (typically used in econometrics for programme impact evaluation) 
which was applied using a two-part model in chapter 5. This also shows how diverse 
research methods can be effectively used towards studying issues in tobacco control 
such as SFL in the case of my thesis. In my thesis, I have mainly focused on primary 
outcome indicators relevant for studying SFL such as health effects (socioeconomic 
inequalities therein), SHS exposure (and socioeconomic inequalities therein) and 
tobacco smoking (prevalence and per person sticks consumed), which are deemed to 
be more useful indicators in the long term compared with secondary indicators such as 
knowledge and attitudes, support (for policies), compliance with legislation etc. which 
are more relevant in the short/intermediate term.258  
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6.2.2. General limitations 
In some of the analyses conducted as part of my thesis, I have used cross-sectional 
data (e.g. GATS in 15 LMICs). This limits the ability to assess temporality and therefore, 
to draw causal inferences. The GATS data used in my thesis is from the first round of 
survey conducted between 2008 and 2011. It is possible that there have been more 
recent changes in smoking, SHS exposure and implementation of SFL across GATS 
countries. There has been a recent addition of countries to the list of countries 
implementing GATS, bringing the number of countries implementing GATS to 27.191 
Moreover, some countries have now implemented a second round of GATS. 
Nevertheless, considering the global SFL implementation scenario in LMICs,23 the 
findings of this study are still very much relevant for strengthening SFL implementation 
along with other tobacco control measures in these settings. In both, the GATS and 
NSSO CES data, smoking and exposure to SHS were self-reported (and reported by the 
head of the household in case of NSSO CES), and therefore, likely to be subject to 
recall bias and respondent bias. An important limitation when assessing the impact of 
SFL is that participants are often concurrently exposed to SHS as well as other sources 
of air pollution such as biomass smoke. This seems more relevant in LMICs such as 
India and China, where air pollution has been linked with adverse health outcomes.  
However, it is often difficult to control such external influences in the absence of reliable 
data in studies involving multi-country comparisons and was beyond the scope of this 
study. Across research papers, there was an issue of heterogeneity which was due to 
the inclusion of a number of countries/states with different tobacco use patterns, tobacco 
control policies and demographic characteristics. I have tried to manage the 
heterogeneity in some instances through the use of specific analytic methods (e.g. 
difference-in-differences or adjusted regression models) and at times through the use of 
more generic methods to allow for the heterogeneity (e.g. Harvest Plot). I did not focus 
on secondary outcomes relevant for studying SFL such as air quality (PM2.5 and air 
nicotine concentrations), knowledge/attitudes/support for SFL and compliance with SFL 
implementation which are important short/intermediate term indicators and would be 
more relevant for countries that have newly implemented the SFL.258  
 
6.3.  Policy implications 
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6.3.1.  Strengthen implementation, enforcement and capacity building in LMICs 
Despite the benefits of SFL in both HICs and LMICs as shown by earlier research and 
the findings of my thesis, implementation of SFL remains weak in LMICs with 
considerable forgone health benefits.23 The guidelines for implementation of Article 8 of 
the WHO FCTC recommend that all Parties should take appropriate measures to 
implement and enforce 100% smoke-free policies (without any exemptions) to offer 
complete protection from exposure to tobacco smoke in all indoor workplaces, indoor 
public places, public transport and as appropriate other public places.62 Consistent with 
the WHO FCTC recommendations, the findings of my thesis also suggest that 
comprehensive SFL produces health benefits that may have a greater impact in low 
income groups; while partial SFL may not reduce health inequalities. Likewise, earlier 
research from HICs also demonstrates the health benefits associated with the 
implementation of comprehensive SFL.160 The fact that only 18% of the world’s 
population is covered by comprehensive SFL with a vast majority of LMICs 
implementing partial or no SFL,23 calls for the strengthening of existing SFL in these 
settings. Over the past two decades, some of the Latin American countries (such as 
Brazil and Uruguay) have progressively strengthened their tobacco control policies and 
implemented comprehensive SFL, and have demonstrated: considerable reductions in 
tobacco use and associated health benefits.22, 64 Similarly, other LMICs can follow suit. 
For example, the Government of India is now seeking to amend its tobacco control law, 
which would remove the exemption granted to hotels and restaurants,138 therefore, 
moving one step closer to the implementation of comprehensive SFL.  
 
The WHO FCTC Article 8 guidelines also recommend imposing sufficiently large 
monetary penalties for violation of the SFL by individuals as well as businesses to deter 
smoking.62 The penalties should be increased for offences involving repeated violation 
of SFL including consideration of non-monetary penalties for businesses such as 
cancellation of licenses. For example, in England, the penalty for smoking in a 
designated smoke-free public place is £50 which is reduced to £30 if paid within 15 days 
of being issued or a court fine not exceeding £200.259 For not displaying the appropriate 
no-smoking sign, the penalty is £200 (reduced to £150 if paid within 15 days of being 
issued) or a court fine of up to £1000.259 In case the responsible person fails to prevent 
smoking in a designated non-smoking area, the person is liable to be penalized with a 
maximum amount of £2500 by the court.259 In some LMICs the penalties are not heavy 
enough to deter smoking in designated non-smoking areas. For example, in India, the 
maximum penalty for smoking in public place is INR200 (approximately £2.5) only.232 
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The COTPA amendment bill (2015) seeks to increase the amount of penalty by five 
times to INR1000.138 The case study from India in chapter 5 of my thesis showed that 
one of the issues with NTCP was inadequate implementation including not collecting 
penalties for violation of smoking in public places. However, some of the countries such 
as Israel have in the past imposed heavy penalties on the businesses for violation of 
SFL to the scale of ILS160,000 (approximately £29,000).260 
 
Strengthening tobacco control policies including a comprehensive SFL is not possible 
without an appropriate implementation and enforcement plan, with infrastructure in 
place, and adequate capacity building initiatives.62 The WHO FCTC guidelines 
recommend establishing a national coordinating mechanism/agency for tobacco control 
while the existing personnel under other Government programmes can be used for 
monitoring and enforcement of compliance with SFL. Such monitoring of compliance 
can be accomplished during initial visits for licensing requirements, periodic scheduled 
visits, surprise visits and visits resulting from complaints of consumers.62 It is 
recommended that trained and well-capacitated enforcement agents/squads carry out 
SFL compliance monitoring at the local level, while also educating the businesses in the 
initial phase of the SFL implementation.62 In England, local councils are responsible for 
implementation of the SFL while the responsibility for monitoring compliance rests with 
environment health officers who visit the premises.259 In India, the National Tobacco 
Control Cell (NTCC) under the Ministry of Health and Family Welfare oversees the 
planning and implementation the NTCP.135  The NTCP is implemented at national, state 
and district levels while enforcement squads are based at the district level. These 
enforcement squads consist of a multi-disciplinary team of health department officials, 
customs and excise officials, police department officials, lawyers, and civil society 
members among others.135 Despite the existence of infrastructure, the lack of capacity, 
resources and inadequate implementation was reflected in the failure of NTCP to 
demonstrate an impact on smoking in the Indian context as observed in my thesis; while 
planned, well-resourced, and aggressively implemented tobacco control programmes in 
HICs have been shown to be effective.250 It is essential that enforcement officials are 
well-capacitated and trained, and capable of: immediate action, educating the 
businesses and also penalising the violators on the spot. Periodic training of all team 
members and planning is deemed to be essential for this.  
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6.3.2.   High-level political commitment, leadership and multi-sectoral 
collaboration 
The WHO FCTC recommends that for effective tobacco control, “strong political 
commitment is necessary to develop and support, at the national, regional and 
international levels, comprehensive multi-sectoral measures and coordinated 
responses.”16 For several decades, effective tobacco control has been hampered by a 
lack of political commitment across the globe and in some instances, the tobacco 
industry was also favoured due to such a lack of commitment.261 Often, the conflicting 
priorities of different ministries or departments hamper the multi-sectoral collaboration 
required for effective tobacco control. For example, the department of health is driven by 
the adverse health consequences of tobacco use and the resulting huge economic 
costs, while the finance and agriculture departments and labour groups are driven by the 
economic gains and employment issues related to tobacco business.262 Over the past 
two decades, globally, the tobacco control advocates have managed to find allies within 
the Governments, the WHO and other UN bodies and have worked closely to ensure 
that long-term commitments and collaborations for tobacco control are garnered and 
sustained.261  
 
High-level political commitment has played an important role in strengthening the 
tobacco control policies/programmes and ensuring effective enforcement in HICs as well 
as in LMICs. Successful implementation of comprehensive SFL in some LMICs such as 
Uruguay and Brazil are examples of such high-level political commitment, where the 
presidents of both countries were directly involved.22, 64 Additionally, in Uruguay, the 
National Commission on Tobacco Control, which consisted of members from the 
Government departments and the civil society played a key leadership role and 
collaborated with the University of Waterloo for evaluation and with the media for the 
launch campaign.22, 64 Similarly, in Brazil, two agencies a) the National Commission for 
Tobacco Control and b) the National Agency for Sanitary Surveillance along with the 
Ministry of Finance played a key role in bringing about strong tobacco control policies 
that have helped reduce the smoking rates dramatically over the past two decades.22 In 
India, along with the NTCC there exist the state level coordination committee (SLCC) 
and the district level coordination committee (DLCC) which have a membership of 
officials from various Government departments as well as the civil society and which 
guide implementation of tobacco control activities under the NTCP at these levels.135 A 
major issue with NTCP that was identified and presented in chapter 5 of my thesis was 
that implementation of NTCP rests with the states which do not prioritise tobacco control 
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activities, which may potentially be one of the several issues that prevented the NTCP 
from reducing tobacco smoking. This demonstrates a lack of commitment on part of the 
state Governments and sets a poor example of multi-sectoral collaboration for other 
LMICs. For effective tobacco control, it is important that key stakeholders in all LMICs 
prioritise the issue and resolve to work collaboratively.  
 
WHO FCTC recommends international and national collaboration in terms of sharing 
knowledge, technology and expertise to establish effective tobacco control 
programmes.16 The Governments, policymakers, researchers and advocates from 
LMICs could learn and adopt the best practices in tobacco control from HICs and LMICs 
that have successfully implemented such policies and crossed over into the next stage 
of the tobacco epidemic. For example, countries like Brazil which have successfully 
implemented their tobacco control programme including the comprehensive SFL could 
lead and guide other LMICs adopt, implement and evaluate effective tobacco control 
measures. In some LMICs such as India, despite the existence of NTCP, high-level 
multi-national collaborations for tackling issues such as SFL and tobacco control, in 
general, are seldom observed. For encouraging such multi-national collaborations, the 
role of leading health organisations such as the WHO is important in developing 
standardised protocols for data collection and reporting. This would also enable cross-
country comparisons and sharing of the best practices.  
 
6.3.3.  Strengthen monitoring and surveillance for tobacco control in LMICs 
Despite the fact that WHO recommends monitoring of tobacco use and prevention 
policies, only 30% of the world’s population (representing 65 countries – 37 from HICs, 
27 from middle income countries and one low income country) have recent, 
representative and periodic data for both, adults and youth.23 It was observed in my 
thesis that there was a lack of research from LMICs studying the impact of SFL. A key 
reason for the paucity of research from LMICs is the lack of periodic monitoring data. In 
this thesis, I used the GATS data from 15 LMICs and conducted secondary analyses 
presented in chapter 4 of my thesis. To some extent, surveys such as GATS in some 
LMICs have improved monitoring and surveillance, however, there is still insufficient 
data to conduct a robust evaluation of tobacco control policies. Further, in chapter 5 of 
my thesis, I have used three rounds of NSSO CES data which was used to evaluate the 
NTCP but ultimately the CES was not designed for that purpose and had its own 
limitations (e.g. household level data rather than individual-level data). It is therefore 
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important that all LMICs should become a part of multi-national monitoring and 
surveillance effort. This should include in addition to other tobacco use indicators, 
exposure to SHS at homes/workplaces/other public places, morbidity and mortality 
associated with exposure to tobacco smoke, assessment of air-quality including PM2.5 
and air nicotine concentrations in all indoor public places, knowledge, attitude and 
support for tobacco control policies including SFL, enforcement of and compliance with 
policies including SFL, economic impact of policies and tobacco industry tactics.16 Some 
LMICs have taken positive measures to control tobacco use (e.g. the NTCP in India) 
however, desired results in terms of reduction in tobacco use are not observed which in 
part are attributable to a lack of monitoring and surveillance. It is important that 
implementation and enforcement of tobacco control policies are rigorously and 
periodically monitored along with monitoring of capacity building initiatives so that 
feedback from such monitoring can be effectively utilised for incorporating corrective 
measures and thereby to optimise the tobacco control programme. 
 
Currently, some LMICs do implement the GATS and GYTS every five years yet, several 
of these LMICs lack periodic data. Moreover, GATS and GYTS only capture certain 
aspects such as self-reported tobacco use and SHS exposure, expenditure on buying 
tobacco, exposure to pro- and anti-tobacco media, and knowledge about harms, while 
other key indicators are not included.  Additionally, public health experts/Governments 
should also monitor the industry tactics (including those related to SHS exposure, and 
safety of newer products claimed to be smoke-free e.g. electronic cigarettes). Some of 
the tobacco control policy compliance data are collected through other means such as 
the WHO FCTC country reporting,263 and through independent research studies.39 
However, there is still scope for LMICs to expand their monitoring and surveillance in 
tobacco control. Results from such monitoring and surveillance may also be used to 
influence the public opinion and policymakers with regard to harms associated with 
tobacco use and the need for stronger tobacco control policies.  
 
6.3.4.  Communication and media advocacy 
WHO FCTC as well as tobacco control experts recommend that all Governments should 
implement an ongoing, well-designed and tested public awareness raising media 
campaign in collaboration with the civil society – to inform about the harms of tobacco 
use and exposure to SHS, existing policies and regulations related to tobacco, benefits 
of tobacco-free (including the SFL), and education about the unreliability/harms of newer 
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products such as e-cigarettes which are often claimed to be smoke-free.16, 264 Only when 
the public and the policymakers are aware and convinced about these issues, they will 
support the tobacco control movement. Particularly, when implementing a new tobacco 
control policy such as the SFL, it is necessary to raise awareness about the harms of 
exposure to tobacco smoke, provisions of the SFL with penalties and benefits of SFL to 
overcome the tobacco industry generated rumours about the economic harms to 
businesses due to the SFL, and the health rights of workers employed in hospitality 
venues.62 Countries such as Brazil and Uruguay have effectively used media campaigns 
to raise awareness about the SFL in general masses around the period of 
implementation of comprehensive SFL in respective jurisdictions.22, 64 It was observed in 
my thesis that the low SES groups in LMICs are at higher risk of SHS exposure (vs. the 
high SES) and in need of targeted awareness campaigns. This population is also poorly 
covered by comprehensive SFL.23 In LMICs such as India, it is highly likely that the 
disadvantaged groups are also illiterates or barely literate. TV and radio campaigns in 
local language are likely to appeal to these populations through their visual appeal and 
content and can potentially reach even the rural populations. For example, media 
campaigns through TV and radio for raising awareness about the harms of SLT use 
implemented as a part of the NTCP have been shown to have high reach and recall in 
India.265  Media campaigns have also been shown to be effective in HICs in garnering 
support for SFL among smokers through raising awareness about the harms of 
exposure to tobacco smoke and the benefits of SFL.266 Such media campaigns 
implemented around the time of introduction tobacco control policies such as the SFL in 
LMICs can potentially gain support from the informed masses.  
 
The use of social media in tobacco control advocacy has been increasing and is now 
recognised as an inexpensive alternative for reaching large numbers of users globally 
and even the hard to reach targets such as politicians and celebrities to engage them in 
tobacco control advocacy. Hefler et al., through three case studies from Indonesia 
showed that the social media such as Twitter and Facebook and the online petition 
websites such as Change.org present important opportunities for tobacco control 
advocacy; moreover, Twitter and Facebook could also be vital for tracking industry 
activities.267 Such low-cost approaches would particularly be important for tobacco 
control in LMICs.  
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6.3.5.  Increase funding for tobacco control including smoke-free legislation 
Low prioritisation of tobacco control in LMICs including poor funding for the same is 
reflected in my findings from Chapter 4 which suggests that the percentage of smoke-
free workplaces in several LMICs is still very low. It was observed that less than 65% of 
the participants were employed in smoke-free workplaces in the Russian Federation, 
Turkey, Viet Nam, Egypt, Bangladesh and China.42, 43 Eriksen et al. confirm these 
findings which have also been shown in Figure 2.1 (in Chapter 2) of my thesis.3 They 
additionally show that among workplaces, the percentage of restaurants that are smoke-
free is even lower across LMICs.3 WHO FCTC recommends that Parties should mobilise 
all the available resources at national, regional and local levels to fulfil the objectives of 
the Convention.16 Taxation of tobacco is one of the most effective tobacco control 
measures and also contributes to reducing inequalities in smoking.155 Chaloupka et al. 
suggest that higher tax on tobacco is not harmful to the economy rather, this measure is 
even more effective when a part of the tax imposed on tobacco products is earmarked 
for tobacco control activities.268 In 2015, only 20% of the countries globally had 
dedicated tax revenues for tobacco control.23 A recent WHO report suggests that 
funding for comprehensive tobacco control programmes is often insufficient, 
unsustainable and irregular; while for many LMICs, there is no dedicated funding for 
controlling NCDs (tobacco being one of the most important risk factors for NCDs) and 
earmarked tobacco tax is the only choice for driving tobacco control activities.269 The 
report describes the percentage of earmarked tobacco taxes and the processes involved 
for nine countries (including HICs as well as LMICs): Botswana, Egypt, Iceland, 
Panama, Philippines, Poland, Romania, Thailand and Viet Nam. Although the report 
does not describe the impact of earmarked tobacco taxes on health indicators, the 
experience from these countries indicates that when sufficient revenue is generated 
through this mechanism to be able to fund health promotion programmes, the likely 
impact will be a reduction in tobacco use and the resulting NCDs.269 In my thesis, it was 
observed that there was less than optimal utilisation of funds by the Indian states which 
may have resulted in inadequate implementation NTCP activities (including the SFL) 
and therefore a lack of effect on smoking. Even in states with strong tobacco control 
programmes such as California, a reduction in funding was shown to be associated with 
poor performance of the programme and therefore impact on tobacco use.251 It is 
therefore important that tobacco control activities are well-funded.  
 
Other traditional sources for funding tobacco control activities (including SFL 
implementation, monitoring and evaluation) are philanthropy, added national health 
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budget allocated to tobacco control activities/programmes, and taxes and duties 
imposed upon the tobacco industry. Specifically for the implementation, monitoring and 
evaluation of SFL, sustainable funding sources could include earmarked tobacco taxes, 
business licensing fees and revenues generated from the periodic renewal of licenses or 
earmarked business/professional taxes, and the monetary penalties that are paid to the 
Government for violation of tobacco control laws.62  
 
6.3.6 Tobacco control: a vital investment for achieving global NCD and 
inequality reduction targets 
The World Health Assembly (WHA) in 2012 adopted the Global Monitoring Framework 
for prevention and control of NCDs which outlines nine NCD targets and related 
indicators.18 One of the indicators is 25% relative reduction in premature mortality from 
NCDs by 2025 (25x25). Further, Goal 3 of the UN Sustainable Development Goals 
(SDGs) calls for ensuring healthy lives and promoting well-being for all at all ages.20 A 
reduction in premature mortality from NCDs by one-third till 2030 by prevention and 
treatment and strengthening and implementation of the WHO FCTC across all countries 
are the targets listed for achieving Goal 3 of the UN SDG among other targets.20 
Further, Goal 10 of the UN SDG calls for reducing inequalities.143 Ensuring equal 
opportunity and reducing inequalities of outcome, including by eliminating discriminatory 
laws, policies and practices and promoting appropriate legislation, policies and action is 
one of the targets listed for achieving Goal 10 of the UN SDG.143 The findings of my 
thesis suggest that exposure to tobacco smoke is higher among the low SES groups in 
LMICs (as observed in HICs),42 where implementation of tobacco control measures 
including SFL is poor. This can potentially widen existing health inequalities. Reducing 
tobacco use through the adoption of WHO FCTC and its implementation and 
enforcement has been recommended by experts as critical for the achievement of NCD 
reduction19, 142 and reduction of inequality. In this thesis, it was also observed that 
comprehensive SFL can reduce health inequalities whereas partial SFL may not. SFL 
(due to its demonstrated health benefits) and tobacco control in general, therefore, have 
the potential to be major contributors to the achievement of the WHO 25x25 target for 
NCDs as well as Goal 3 of the UN SDGs.19, 20 While pro-equity tobacco control policies 
such as taxation and comprehensive SFL have the potential to contribute towards 
achievement of Goal 10 of the UN SDGs. As LMICs currently and in the future are likely 
to experience a heavy burden of death and disease due to tobacco smoking, it is 
important that tobacco control policies are strengthened across all LMICs.  
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6.3.7.  Implications for future research  
Most studies assessing the impact of SFL on health outcomes, SHS exposure, smoking 
behaviour and attitudes, air quality, and economic outcomes have been conducted in 
HICs, particularly those from Europe, Americas, or Asia-Pacific (Australia and New 
Zealand). Literature from LMICs assessing the impact of SFL is very limited. Such 
paucity of research from LMICs underscores the need for better monitoring and 
surveillance data, more funding to support evaluation and strengthening collaborations 
between researchers in HICs and LMICs. The GATS and GYTS provide information on 
the prevalence of smoking (in addition to other tobacco products) and SHS exposure at 
home, workplaces and other public places. However, in several LMICs, such data are 
not collected periodically. Moreover, inherent limitations of these types of surveys imply 
that they cannot be effectively used to assess the impact of policies or to guide the 
implementation and enforcement of tobacco control policies. For example, these 
surveys do not capture other indicators such as knowledge and support for policies, air-
nicotine or PM2.5 concentrations to assess the air quality, smoking-related mortality and 
morbidity or other relevant information for economic analyses. So their use in impact 
assessment is limited. Lessons learnt from prior tobacco control research shows that 
just prevalence studies are not sufficient to convince policymakers to bring about the 
desired policy changes.261 Analyses of costs incurred due to tobacco use or smoking 
and the potential costs averted due to lives saved as a result of the implementation of 
tobacco control policies are more likely to receive support from the policymakers.261  
 
Tobacco control policy measures can have an impact on various indicators in the short 
or the long term. For example, SFL is likely to have an immediate impact on air quality in 
hospitality venues or SHS exposure, however, it is less likely to have an immediate 
impact on certain outcomes such as lung cancer which is likely to require several years 
of SFL implementation before any effect is observed. It is also likely that the impact of a 
tobacco control intervention observed immediately after the intervention would get 
diluted in the long term for example in the case of pictorial health warnings on tobacco 
products or tobacco control media campaigns when the messages/pictures are not 
rotated periodically. Therefore, it is necessary to undertake immediate as well as long-
term evaluations of tobacco control policies including the SFL.258  
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As in LMICs, smoking and SHS exposure (as observed in my thesis),42 are higher in the 
low SES groups and variations are also observed across population sub-groups,5, 53 it is 
important that future research should assess the impact of SFL among different sub-
groups such as age groups, gender, urban/rural, national region, and SES indicators, so 
that targeted control measures can be adopted to reduce disparities and inequalities in 
outcomes. Earlier research which has assessed SES differences in the impact of 
tobacco control legislation have mostly relied on the use of SES indicators such as area 
deprivation, income, education, occupation, and health insurance status.155, 161 However, 
all SES indicators may not be relevant for LMICs. A number of surveys including GATS 
in LMIC settings have utilised possession of assets in the households as an indicator of 
SES.192 This information has been utilised to generate an ‘asset index’ which could be a 
more reliable measure of SES in the low SES settings.219, 220 Further, considering the 
multi-dimensional nature of deprivation, World Bank has recommended the use of multi-
dimensional poverty index (MPI) for LMICs which consists of 10 indicators from three 
different dimensions – education, health and standard of living.179 Globardes et al. 
suggest that when SES confounds the relation between a tobacco control intervention 
and the outcomes, it is important to study the association across multiple measures of 
SES rather than focusing only one indicator.182 
 
Specifically, in the LMIC settings, more research is needed on the impact of SFL on: 
o Health outcomes (morbidity and mortality due to cardiovascular, 
respiratory, reproductive and other causes) 
o Exposure to SHS (as assessed from respiratory symptoms, or cotinine 
levels in saliva, urine and hair)  
o Air quality (as assessed from air nicotine and PM2.5 concentrations in 
indoor public places, particularly in the hospitality venues) 
o Economic activity (as assessed from the revenue generated particularly 
in the hospitality industry and the impact on job opportunities in the 
industry) 
o Economic costs averted due to reduced mortality and morbidity 
(associated with smoking-related causes) 
o Smoking behaviours (prevalence, particularly at homes and in private 
vehicles, frequency, cessation, and quit attempts) 
o Public knowledge about and attitudes towards SFL and support for SFL 
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In my thesis, it was observed that there was no compelling evidence that NTCP reduced 
consumption over and above the general reduction that occurred in all districts in India. 
Several implementation issues with the NTCP were identified in Chapter 5 including a 
lack of monitoring, capacity and resources and inadequate utilisation of funds. As 
implementation and monitoring of tobacco control policies are weak in general across 
the LMIC settings compared with HICs,23 operational/implementation research in these 
settings could be useful to study the intervention implementation and compliance, the 
context, and the mechanisms of impact.270 A review of 500 health promotion and 
prevention programmes revealed that the level of implementation influences the 
outcomes.271 The review highlighted that intervention implementation is affected by 
about 23 contextual factors including variables related to the community, the 
environment and the health systems or intervention implementers/providers. Hence, it is 
important to collect process evaluation data which can provide useful feedback to 
strengthen the implementation and enforcement of policies. Fong et al. describe the 
expected mechanisms of impact of various tobacco control policies in the conceptual 
model for the ITC project, wherein they describe the proximal and distal influences 
which mediate the relationship between tobacco control policy implementation and the 
outcomes.272 As wide variations exist across LMICs in terms of types of tobacco used, 
levels of implementation and enforcement of various tobacco control policies and 
activities, it is important that these countries invest in studying the mediating 
mechanisms and processes through which tobacco control policies are expected to 
influence the outcomes.  
 
Modelling studies can be especially helpful in the LMIC settings where limited data 
constrains robust evaluation of tobacco control policies. Levy et al. have used the 
SimSmoke simulation model to study the relative contributions of various tobacco 
control policies towards reducing smoking prevalence and associated premature 
mortality in several countries. In Brazil, it was observed that tobacco pricing and taxation 
explained almost half of the reduction in smoking prevalence while SFL explained 14% 
of the reduction among other tobacco control measures.74 A similar modelling study was 
conducted by Basu et al. to conclude that SFL and raised tobacco taxation would be the 
most effective tobacco control policies to reduce cardiovascular deaths in India.254 Such 
studies would help prioritise and strengthen relevant tobacco control policies in the LMIC 
settings. 
 
184 
 
6.4.  Conclusions 
My thesis has assessed whether similar health benefits of SFL accrue in the context of 
LMIC settings as observed in HICs and whether any benefits are equitably distributed. I 
conclude that exposure to tobacco smoke is high among the low SES groups in LMICs, 
which potentially worsens health inequalities. Furthermore, poor implementation of SFL 
in LMICs is associated with substantial forgone health benefits, especially in these low 
SES groups. Effective implementation and enforcement of comprehensive SFL in the 
LMIC settings may bring about additional health benefits for the vulnerable women and 
children by reducing exposure to tobacco smoke, partly through a positive change in 
social norms about exposing non-smokers to tobacco smoke. Strengthening 
implementation, monitoring mechanisms and collaborative research in tobacco control 
are essential to improve health outcomes and reduce inequalities in LMICs, thereby 
contributing towards the achievement of the UN SDG targets of reducing inequalities 
and premature deaths from NCDs by 2030. 
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Appendix B-1: Systematic Review Protocol 
 
 
 
PROSPERO 
International prospective register of systematic reviews 
 
Review title and timescale 
1. Review title 
Give the working title of the review. This must be in English. Ideally it should state succinctly the 
interventions or exposures being reviewed and the associated health or social problem being 
addressed in the review. 
Smoke free legislation and socioeconomic inequalities in smoking related morbidity and 
mortality among adults: a systematic review and meta-analysis 
 
2. Original language title 
For reviews in languages other than English, this field should be used to enter the title in the 
language of the review. This will be displayed together with the English language title. 
3. Anticipated or actual start date 
Give the date when the systematic review commenced, or is expected to commence.  
11/01/2016 
4. Anticipated completion date 
Give the date by which the review is expected to be completed.  
30/04/2016 
 
5. Stage of review at time of this submission 
Indicate the stage of progress of the review by ticking the relevant boxes. Reviews that have 
progressed beyond the point of completing data extraction at the time of initial registration are not 
eligible for inclusion in PROSPERO. This field should be updated when any amendments are made 
to a published record. 
The review has not yet started × 
 
Review stage Started Completed 
Preliminary searches Yes No 
Piloting of the study selection process Yes No 
Formal screening of search results against eligibility criteria No No 
Data extraction No No 
Risk of bias (quality) assessment No No 
Data analysis 
 
Provide any other relevant information about the stage of the 
review here. 
No No 
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Review team details 
6. Named contact 
The named contact acts as the guarantor for the accuracy of the information presented in the 
register record.  
Dr. Marhazlinda Jamaludin 
 
7. Named contact email 
Enter the electronic mail address of the named contact. 
rmjlja1@ucl.ac.uk 
 
8. Named contact address 
Enter the full postal address for the named contact. 
18. Livingstone Road, E17 9AX, London, UK 
 
9. Named contact phone number 
Enter the telephone number for the named contact, including international dialing code. 
07710483083 
 
10. Organisational affiliation of the review 
Full title of the organisational affiliations for this review, and website address if available. This 
field may be completed as 'None' if the review is not affiliated to any organisation. 
 
1. University of Malaya, Malaysia 2.University College London. UK 3.Imperial College London, 
UK 4. London School Health &Tropical Medicine, UK 5. Public Health Foundation, India 
 
Website address: 
1.www.um.edu.my 2. www.ucl.ac.uk 3.www.imperial.ac.uk 4.www.lshtm.ac.uk 
 
11. Review team members and their organisational affiliations 
Give the title, first name and last name of all members of the team working directly on the 
review. Give the organisational affiliations of each member of the review team. 
 
Title First 
name 
Last 
name 
Affiliation 
Dr Marhazlinda Jam ludin Department of Community Dentistry 
and    Clinical Prevention, University of 
Malaya,    l sia and Department of 
Epidemiology    and Public Health, UCL, London, UK 
Dr Gaurang Nazar Health Promotion Division, Public 
Health    Foundation of India, New Delhi and 
   Department of Non-communicable 
Disease    Epidemiology, Faculty of Epidemiology 
and    Population Health, LSHTM, UK 
Dr Georgios Tsakos Department of Epidemiology and Public 
   Health, UCL, London, UK 
Professor Christopher Millett School of Public Health, Imperial 
College    L ndon, London, UK 
Professor Richard Giddie Watt Department of Epidemiology and Public 
   Health, UCL, London, UK 
 
12. Funding sources/sponsors 
Give details of the individuals, organizations, groups or other legal entities who take 
responsibility for initiating, managing, sponsoring and/or financing the review. Any unique 
identification numbers assigned to the review by the individuals or bodies listed should be 
included. 
Ministry of Higher Education, Malaysia and University of Malaya, Malaysia 
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13. Conflicts of interest 
List any conditions that could lead to actual or perceived undue influence on judgements 
concerning the main topic investigated in the review. 
Are there any actual or potential conflicts of interest?  
None known 
 
14. Collaborators 
Give the name, affiliation and role of any individuals or organisations who are working on the 
review but who are not listed as review team members. 
Title First name Last name Organisation details 
 
 
 
 
 
Review methods 
15. Review question(s) 
State the question(s) to be addressed / review objectives. Please complete a separate box for each 
question. 
RQ: How does smoke-free legislation in public places affect socioeconomic inequalities in 
smoking related morbidity and mortality among adults? 
 
General objective: To systematically investigate the impact of smoke-free legislation in public 
places on socioeconomic differences in, i) smoking related disease specific morbidity and 
mortality (cardiovascular, respiratory and cancer) and ii) all-cause mortality 
 
Specific objectives: 1. To systematically evaluate the impact of smoke-free legislation in public 
places on socioeconomic differences in:- i) smoking related disease specific morbidity (defined 
as a health care attendance or hospital admission): a) acute coronary events (i.e., sudden 
cardiac death and acute myocardial infarction) and other smoking related cardiac diseases 
(i.e., acute coronary syndromes and coronary heart diseases) among adults b) 
cerebrovascular accident (i.e., stroke) and other smoking related cerebrovascular disease (i.e., 
transient ischaemic attack) among adults c) respiratory health (i.e., odor and irritation, 
respiratory symptoms) and other smoking related respiratory diseases (asthma and chronic 
obstructive pulmonary disease (COPD) ) among adults d) lung cancer among adults (ii) cause 
specific and all-cause mortality among adults 
 
16. Searches 
Give details of the sources to be searched, and any restrictions (e.g. language or publication 
period). The full search strategy is not required, but may be supplied as a link or attachment. 
Relevant Mesh phrases and free text will be used as keywords to retrieve eligible published 
studies. We will search the following electronic databases: MEDLINE, EMBASE, Google 
Scholar, ISI Web of Science, SCOPUS, CINAHL Plus, DARE, Global Health (CAB), WHO 
Global Health Library, Cochrane Central Register of Controlled Trials (CENTRAL), Trip, 
IndMed, SciELO, IMEMR, IMSEAR, and KoreaMed from inception to February 2016. We will 
restrict to studies in English language and will screen the references of the retrieved articles, 
conference abstract and proceedings, and citations of articles of interest with Google Scholar 
and ISI Web of Science for additional studies. Where necessary, we will contact the primary 
investigators or authors for details and clarifications. For in-progress and unpublished studies 
we also will consider the following trial registries: WHO International Clinical Trials Registry 
Platform, EU Clinical Trials Register, Australia New Zealand Clinical Trial Registry, Pan African 
Clinical Trials Registry, Clinical Trial Registries India, Brazilian Clinical Trials Registry, Sri 
Lanka Clinical Trial Registry. 
 
17. URL to search strategy 
If you have one, give the link to your search strategy here. Alternatively you can e-mail this to 
PROSPERO and we will store and link to it. 
http://www.crd.york.ac.uk/PROSPEROFILES/35744_STRATEGY_20160124.pdf 
 
I give permission for this file to be made publicly available 
No 
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18. Condition or domain being studied 
Give a short description of the disease, condition or healthcare domain being studied. This 
could include health and wellbeing outcomes. 
Smoking related cardiovascular, respiratory and cancer diseases among adults 
 
 
19. Participants/population 
Give summary criteria for the participants or populations being studied by the review. The 
preferred format includes details of both inclusion and exclusion criteria. 
We will include primary studies with adults aged 18 and above as participants. Studies need to 
report socioeconomic data of the participants to be eligible. 
 
20. Intervention(s), exposure(s) 
Give full and clear descriptions of the nature of the interventions or the exposures to be 
reviewed  
Comprehensive and partial smoke free legislation for public places (bars or restaurants and 
workplaces) either at national, state, city, regional or community level. Comprehensive ban 
referred to 100% smoke-free in any indoor areas while partial ban was when smoking was 
restricted to designated areas. 
 
21. Comparator(s)/control 
Where relevant, give details of the alternatives against which the main subject/topic of the 
review will be compared (e.g. another intervention or a non-exposed control group). 
For non-randomised studies, comparisons may include either a similar population assessed in 
the same time frame in an adjacent area without smoke-free legislation in place or similarly aged 
population or age adjusted population evaluated in the time frame preceding the introduction of 
the smoking ban in the same region of interest. 
 
22. Types of study to be included initially 
Give details of the study designs to be included in the review. If there are no restrictions on the 
types of study design eligible for inclusion, this should be stated. 
We will include studies which investigated the differential effects by socioeconomic position of 
smoke-free legislation in public places on smoking related cardiac and cerebrovascular 
diseases among adults. For studies with multiple estimates of changes in different time periods, 
we will use the estimates from the longest follow up and also the most disaggregated level of 
data for estimates of diseases nested within diagnostic categories. Following the Cochrane 
Effective Practice and Organisation of Care (EPOC) guideline, our main analyses will be 
restricted to randomised controlled trials (RCTs; including cluster RCTS), controlled clinical trials 
(CCTs; including cluster CCTs), quasi experimental studies, interrupted time-series and 
controlled before and after studies. However, it is anticipated that the number of studies that will 
fulfil EPOC criteria will be small. Therefore, we will also consider uncontrolled before and after 
studies, prospective and retrospective cohort, case-control and nested case control studies. We 
will perform sensitivity analysis to explore the effects of including these study types on the effect 
estimates. Cross sectional studies, modelling, cost and qualitative studies will not be included. 
 
23. Context 
Give summary details of the setting and other relevant characteristics which help define the 
inclusion or exclusion criteria. 
Studies will investigate differential effects by socioeconomic position of smoke-free legislation in 
public places on smoking related disease specific morbidity and mortality (cardiovascular, 
respiratory and cancer) and also all-cause mortality among adults. Socioeconomic indicators will 
include either education, income or occupation. As measures of socioeconomic indicators 
depend on social contexts and culture thus may differ across countries, article by Galobardes et 
al (2006a and 2006b) that details out the strengths and limitations of the available measures will 
be referred when interpreting or translating research results. 
 
24. Primary outcome(s) 
Give the most important outcomes. 
Primary outcomes are socioeconomic differences either by education, income or occupation in 
disease specific mortality (ie, sudden cardiac death and death from; i) acute myocardial 
infarction ii) stroke iii) asthma and COPD iv) lung cancer) and all-cause mortality among 
adults. 
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Give information on timing and effect measures, as appropriate. 
Example: Any changes in the incident of death for i) acute myocardial infarction ii) stroke iii) 
asthma and COPD iv) lung cancer) before and after implementation of smoke free legislation 
or any changes in incidence of all-cause mortality before and after legislation by 
socioeconomic status. 
 
25. Secondary outcomes 
List any additional outcomes that will be addressed. If there are no secondary outcomes enter 
None. 
Secondary outcomes are socioeconomic differences in : Hospital admission from acute 
myocardial infarction Hospital admission from stroke Other smoking related cardiac diseases ( 
acute coronary syndromes and coronary heart diseases) Other smoking related cerebrovascular 
disease ( transient ischemic attack) Emergency department visits from respiratory illness (odor & 
irritation, respiratory symptoms, asthma and COPD) Hospital admission from lung cancer 
Intermediate outcomes such as smoking behaviours, second hand smoke exposures and cost 
effectiveness will not be included 
 
Give information on timing and effect measures, as appropriate. 
Example: Any changes in the incident of hospital admissions or emergency visits from i) acute 
myocardial infarction ii) stroke iii) asthma and COPD iv) lung cancer) before and after 
implementation of smoke free legislation by socioeconomic status. 
 
26. Data extraction, (selection and coding) 
Give the procedure for selecting studies for the review and extracting data, including the 
number of researchers involved and how discrepancies will be resolved. List the data to be 
extracted. 
Of those studies retrieved using the search strategies, duplicates will be removed. Two 
reviewers will screen the titles and abstracts for potential eligible studies and will assess the full 
text of selected studies to confirm inclusion. 
Relevant data will be extracted using a standardized and customized form and corresponding 
authors will be contacted for additional information. All stages will be independently conducted 
by two reviewers. Any disagreement in each stage will be resolved through discussion or by 
referral to a third reviewer. Kappa analysis will be performed and reported in the final report. 
We will use EndNote 7 to manage all citations. In a case of duplication, we will retain only the 
largest study to avoid duplication of information. Review articles however will be excluded from 
quantitative statistical analysis (unless the original research cannot be obtained and a summary 
statistical can be reliably obtained from the review). However, they will obviously be the key 
sources for study identification. 
 
27. Risk of bias (quality) assessment 
State whether and how risk of bias will be assessed, how the quality of individual studies will 
be assessed, and whether and how this will influence the planned synthesis. 
Quality of studies and risk of bias will be assessed independently by two reviewers. Risk of bias 
will be evaluated using EPOC guideline and Cochrane risk of bias tool for randomised controlled 
trial, controlled clinical trial and controlled before and after studies, and only EPOC criteria for 
interrupted time series. Quality of observational studies will be checked using the Effective Public 
Health Practice Project (EPHPP) Quality Assessment Toll for Quantitative Studies. Among 
examples of criteria used will include patient selection, comparability at baseline, blinding and 
randomisation, reliability of measurement tools, appropriateness of analysis, attrition rates etc. 
We will grade parameters of trial quality; A. Low risk of bias B. Moderate risk of bias C. High risk 
of bias and will allocate studies according to their quality and risk. Any disagreement will be 
resolved by consensus or referral to a third reviewer. Sensitivity analysis will be conducted to test 
effects of removing poor quality studies. 
 
28. Strategy for data synthesis 
Give the planned general approach to be used, for example whether the data to be used will 
be aggregate or at the level of individual participants, and whether a quantitative or narrative 
(descriptive) synthesis is planned. Where appropriate a brief outline of analytic approach 
should be given. 
If appropriate, we will provide quantitative synthesis and perform meta-analysis for primary and 
secondary outcomes of included studies using a random-effect method to estimate a pooled risk 
ratio with 95% confidence intervals and draw forest plots to display the effect estimates and 
confidence interval for each study and pooled estimates for each health outcome. First, we will 
calculate effect sizes for continuous outcomes and relative risk differences for categorical 
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outcomes for each study to be combined. If the outcomes reported in primary studies are 
continuous outcomes, weighted mean differences (WMD) will be used when all studies used the 
same scale to measure outcomes. 
Otherwise, the standardized mean differences (SMD) will be used as summary estimates. For 
categorical outcomes, we will summarize individual study results as risk ratio/changes. I² statistic 
will be employed to investigate statistical heterogeneity. Values over 50% will be regarded as 
moderate heterogeneity, and values over 75% as high thus meta- analysis will be inappropriate. 
Reporting bias due to publication bias or due to systematic differences between small and large 
studies will be checked by investigating relationship between effect sizes and sample size using 
a funnel plot. 
 
29. Analysis of subgroups or subsets 
Give any planned exploration of subgroups or subsets within the review. ‘None planned’ is 
a valid response if no subgroup analyses are planned. 
We plan to do subgroup analysis by socioeconomic position, age group and type of legislation 
(comprehensive and partial ban). If data permits, subgroup analysis will also be performed for 
high income and low to middle income countries separately. Socioeconomic indicators are 
either education, income or occupation. 
 
Review general information 
30. Type of review 
Select the type of review from the drop down list. 
Intervention, Prevention 
 
31. Language 
Select the language(s) in which the review is being written and will be made available, from 
the drop down list. Use the control key to select more than one language. 
English 
 
Will a summary/abstract be made available in English? 
Yes 
 
32. Country 
Select the country in which the review is being carried out from the drop down list. For multi-
national collaborations select all the countries involved. Use the control key to select more 
than one country. 
India 
 
33. Other registration details 
Give the name of any organisation where the systematic review title or protocol is registered 
together with any unique identification number assigned. If extracted data will be stored and 
made available through a repository such as the Systematic Review Data Repository (SRDR), 
details and a link should be included here. 
The title of this review and the review protocol will only be registered at CRD York. There is 
no plan to register it at other places or organisation. 
 
34. Reference and/or URL for published protocol 
Give the citation for the published protocol, if there is one. 
 
Give the link to the published protocol, if there is one. This may be to an external site or to a 
protocol deposited with CRD in pdf format. 
 
I give permission for this file to be made publicly available  
Yes 
 
35. Dissemination plans 
Give brief details of plans for communicating essential messages from the review to the 
appropriate audiences. 
As a PhD project, a thesis therefore will be produced when review has been completed and a 
report will be submitted to the sponsor of this project. In addition to that, a scientific paper will be 
submitted to a leading journal in this field. 
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Do you intend to publish the review on completion?  
Yes 
 
36. Keywords 
Give words or phrases that best describe the review. (One word per box, create a new box 
for each term) Systematic review inequality, socioeconomic difference, cardiac, 
cerebrovascular, respiratory, cancer, all caused mortality 
 
Meta-analysis 
 
Smoke-free legislation or policy Inequality 
Socioeconomic difference 
cardiac or cardiovascular 
cerebrovascular  
respiratory 
cancer 
 
all-cause mortality 
 
37. Details of any existing review of the same topic by the same authors 
Give details of earlier versions of the systematic review if an update of an existing 
review is being registered, including full bibliographic reference if possible. 
 
38. Current review status 
Review status should be updated when the review is completed and when it is 
published.  
Ongoing 
 
39. Any additional information 
Provide any further information the review team consider relevant to the registration of 
the review. 
 
40. Details of final report/publication(s) 
This field should be left empty until details of the completed review are available. Give 
the full citation for the final report or publication of the systematic review. 
Give the URL where available. 
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Appendix B-2: Systematic Review Search Strategy (Medline and Embase) 
 
1. exp Tobacco Smoke Pollution/ 
2. exp "Tobacco Use"/ 
3. exp Smoking/ 
4. "Environmental tobacco smoke".ti,ab. 
5. (Smok* or Tobacco or Cigar*).tw. 
6. (Smokefree or Smoke-free or "Smoke free").tw. 
7. (Clean air or clean indoor air).tw. 
8. ("Passive smok*" or "Involuntary smoking").mp. 
9. ("Secondhand smoke" or "second-hand smoke" or "second hand smoke" or  
SHS).mp. 
10. or/1-9 [SMOKING CONCEPT] 
11. exp Government Regulation/ 
12. exp Jurisprudence/ 
13. exp Law Enforcement/ 
14. exp Legislation as Topic/ 
15. exp Policy Making/ 
16. exp Health Policy/ 
17. exp Restaurants/lj [Legislation & Jurisprudence] 
18. exp Workplace/lj [Legislation & Jurisprudence] 
19. Tobacco Control Act.mp. 
20. (Law$1 or Legislat* or prohibit* or regulat* or ban$4).tw. 
21. (Ban* or Law* or Restrict* or Prohibit* or Regulate* or Legislat* or 
Polic* or Jurispruden* or Ordinan*).tw. 
22. (Enactment or Act or Injuction or Constitution).tw. 
23. or/11-22 [LAW CONCEPT] 
24. 10 and 23 [SMOKING LAW CONCEPT] 
25. exp Tobacco Smoke Pollution/lj [Legislation & Jurisprudence] 
26. exp Smoking/lj [Legislation & Jurisprudence] 
27. exp Smoke-Free Policy/ 
28. Smokefree Policy.mp. 
29. Smokefree Legislation.mp. 
30. Smoke-Free Legislation.mp. 
31. Smoking Ban.mp. 
32. ((smok$ or anti smok$ or tobacco or cigarette$) adj3 (ban or bans or prohibit$ or 
restrict$ or discourage$0)).ti,ab. 
33. ((smok$ or anti smok$ or tobacco or cigarette$) adj3 (workplace or workplaces 
or work place or work site or worksite or worksites)).ti,ab. 
34. ((smok$ or anti smok$ or tobacco or cigarette$) adj3 (ban or bans or prohibit$ or 
restrict$ or discourage$)).ti,ab. 
35. ((smok$ or anti smok$ or tobacco or cigarette$) adj3 (public place$ or public 
space$ or public area$ or office$ or school$ or institution$)).ti,ab. 
36. ((smok$ or anti smok$ or tobacco or cigarette$) adj3 (legislat$ or 
government$ or authori$ or law or laws or bylaw$ or byelaw$ or bye law$ or 
regulation$)).ti,ab. 
37. ((tobacco free or smoke free) adj3 (hospital or inpatient or institution$)).ti,ab. 
38. ((tobacco free or smoke free) adj3 (facilit$ or zone$ or area$ or site$ or 
places$ or environment$ or air)).ti,ab. 
39. (tobacco control adj3 (program$ or initiative$ or policy or policies or 
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intervention$ or activity or activities or framework)).ti,ab. 
40. ((smok$ or tobacco) adj (policy or policies or program$)).ti,ab. 
41. (tobacco control act or clean air or clean indoor air).ti,ab. 
42. or/25-41 [SMOKEFREE POLICY CONCEPT] 
43. 24 or 42 [SMOKE AND LAW OR SMOKEFREE POLICY] 
44. exp animals/ not humans.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
45. 43 not 44 [SMOKE AND LAW OR SMOKEFREE POLICY] 
46. exp Cardiovascular Diseases/ 
47. exp Heart Diseases/ 
48. exp Myocardial Infarction/ 
49. exp Coronary Disease/ 
50. exp Death, Sudden/ or exp Acute Coronary Syndrome/ or exp Angina, Unstable/ 
or exp Angina Pectoris/ or exp Myocardial Ischemia/ or exp Coronary Artery Disease/ 
51. (Cardiac or heart attack or myocardial or coronary event* or acute coronary 
syndrome or heart disease* or isch$emic heart disease*).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
52. Acute Coronary Event.mp. 
53. or/46-52 [CARDIOVASCULAR DISEASE] 
54. 53 not 44 [CARDIOVASCULAR DISEASE] 
55. 45 and 54 
56. (Socioeconomic or Socio economic or Socio-economic).ti,ab. 
57. inequalit$.ti,ab. 
58. depriv$.ti,ab. 
59. disadvantage$.ti,ab. 
60. educat$.ti,ab. 
61. (social adj (class$ or group$ or grade$ or context$ or status)).ti,ab. 
62. (employ$ or unemploy$).ti,ab. 
63. income.ti,ab. 
64. poverty.ti,ab. 
65. SES.ti,ab. 
66. demographic$.ti,ab. 
67. (uninsur$ or insur$).ti,ab. 
68. minorit$.ti,ab. 
69. poor.ti,ab. 
70. affluen$.ti,ab. 
71. equity.ti,ab. 
72. (underserved or under served or under-served).ti,ab. 
73. occupation$.ti,ab. 
74. (work site or worksite or work-site).ti,ab. 
75. (work place or workplace or work-place).ti,ab. 
76. (work force or workforce or work-force).ti,ab. 
77. (high risk or high-risk or at risk).ti,ab. 
78. (marginalised or marginalized).ti,ab. 
79. (social$ adj (disadvant$ or exclusion or excluded or depriv$)).ti,ab. 
80. exp Socioeconomic Factors/ 
81. exp Public Assistance/ 
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82. exp Social Welfare/ 
83. exp Vulnerable 
Populations/ 84. or/56-83 
85. 84 not 44 [SES CONCEPT] 
86. 45 and 54 and 85 [SMOKEFREE HEART SES] 
87. cerebrovascular disorders/ or brain ischemia/ or "intracranial embolism and 
thrombosis"/ or intracranial hemorrhages/ or stroke/ 
88. cerebrovascular disease.mp. 
89. Stroke/ 
90. Stroke.mp. 
91. exp Brain Ischemia/ 
92. Brain isch$emic.mp. 
93. exp Cerebral Hemorrhage/ 
94. cerebral haemorrhage.mp. 
95. exp Cerebral Infarction/ 
96. cerebrovascular accident$.mp. 
97. cerebral infarction$.mp. 
98. exp Cerebral Arterial Diseases/ 
99. cerebral artery disease$.mp. 
100. exp Ischemic Attack, Transient/ 
101. cerebral 
isch$emic.mp. 102. 
or/87-101 
103. 102 not 44 [STROKE CONCEPT] 
104. 45 and 85 and 103 [SMOKEFREE STROKE SES] 
105. exp Respiration Disorders/ 
106. exp Asthma/ 
107. Pulmonary disease$.mp. or exp lung disease/ [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
108. exp Pulmonary Disease, Chronic Obstructive/ or exp Respiratory Tract Infections/ 
109. (respiratory health or asthma or pulmonary disease or pneumonia or 
respiratory track disease or respiratory track diseases or chronic obstructive 
pulmonary disease or obstructive pulmonary disease or chronic obstructive airways 
disease or COAD or chronic obstructive lung disease).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier] 
110. or/105-109 
111. 110 not 44 [RESPIRATORY CONCEPT] 
112. 45 and 85 and 111 [SMOKEFREE RESPIRATORY SES] 
113. mortality.mp. or exp Hospital Mortality/ or exp Mortality/ 
114. morbidity.mp. or exp Morbidity/ 
115. all cause.mp. 
116. (113 or 114) and 115 
117. (emergency admission$ or ED).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
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118. (116 or 117) not 44 [OTHERS OUTCOMES] 
119. 45 and 85 and 118 [SMOKEFREE OTHERS SES] 
120. 45 and 54 and 85 [SMOKEFREE HEART SES] 
121. 45 and 85 and 103 [SMOKEFREE STROKE SES] 
122. 45 and 85 and 111 [SMOKEFREE RESPIRATORY SES] 
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Appendix B-3: EPOC suggested risk of bias criteria for interrupted time series 
(ITS) studies 
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Appendix B-4: EPHPP quality assessment tool for quantitative studies and rating 
criteria for the study 
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Appendix C-1: Definition of variables used in study presented in section 4.3 
Supplementary Table  
Definition of variables used in study presented in section 4.3  
Sr. 
No. 
Variable Definition 
Dependent variable 
1 Living in Smokefree home Respondents who are living under smoke-free home are defined as those who reported “never” to the following question: How often does “anyone” smoke 
inside your home? Would you say daily, weekly, monthly, less than monthly, or never?  
Independent variables 
2 Employed in Smokefree 
workplace 
Respondents who are employed in smoke-free workplace are defined as those who are not exposed to SHS at workplace. This is among respondents who 
work outside the home and usually work indoors or both indoors and outdoors. 
Respondents who are exposed to SHS at workplace are those who answered ‘yes’ to the following question: during the past 30 days, did anyone smoke in 
indoor areas where you work.  
3 Age Group Age category (in years) to which the respondent belongs i.e. ≥15 to ≤29, ≥30 to ≤44, ≥45 to ≤59, ≥60.  
4 Gender Biological sex of the respondent i.e. Male or Female 
5 Residence Place of residence of respondent i.e. Urban or Rural 
6 Region National region the respondent stays in (National regions differ by country and this variable is present only in case of India, Thailand, China, Brazil, Poland, 
Ukraine and Egypt). 
7 Education The level of education the respondent has completed i.e. primary level; secondary level, tertiary level.  
Primary level includes “no formal education” and “primary education”. Secondary level includes “secondary/higher secondary/ pre college/ 
technical/vocational school”. Tertiary level includes “college/university graduate/ postgraduate, vocational/technical degrees, professional degrees”. 
For Romania, Russian Federation and Ukraine, due to negligible proportion of participants educated up to primary level, those participants were merged in 
the secondary level category. Hence, these countries contained only two categories: secondary level and tertiary level. 
8 Occupation Current occupation of the respondent i.e. Employed or Self-employed. The Government/Non-government employees categories have been merged into 
employed category. Other professions/owners/businesses/employers etc. categories have been merged into self-employed category.  
For China, respondent’s occupation variable is categorised into one of the 5 categories: Agriculture employee; Machine operator, Leader of organizations, 
Medical/Health personnel and Teaching staff as reported by CDC.  
9 Current tobacco smoker A respondent was classified as current tobacco smoker if he/she responded ‘daily’ or ‘less than daily’ to the following question: Do you currently smoke 
tobacco on a daily basis, less than daily, or not at all? 
10 Current smokeless tobacco 
user 
A respondent was classified as current smokeless tobacco user if he/she responded ‘daily’ or ‘less than daily’ to the following question: Do you currently 
use smokeless tobacco on a daily basis, less than daily, or not at all? 
11 Number of people in the 
household 
Indicates how many people live in the household of the respondent. This is the answer to the following question “In total, how many persons are living in 
this household?” 
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Appendix C-2: Missing data for SHS exposure at Home among GATS participants (2008-2011) 
Supplementary Table: Missing data for SHS exposure at Home among GATS participants (2008-2011) 
N (%) 
 SEAR WPR AMR EUR EMR 
 India 
N=67,006 
Bangladesh 
N=9,323 
Thailand 
N=20,437 
China 
N=13,302 
Malaysia 
N=4,091 
Philippines 
N=9,578 
Viet Nam 
N=9,866 
Mexico 
N=13,530 
Uruguay 
N=5,576 
Poland 
N=7,640 
Romania 
N=4,472 
Russian 
Federation 
N=11,321 
Turkey 
N=8,900 
Ukraine 
N=8,092 
Egypt 
N=20,443 
Dependent variable 
SHS 
exposure at 
home* 
2041  
(2.9) 
229 
(2.4) 
84 
(0.4) 
33 
(0.2) 
140 
(3.3) 
121 
(1.2) 
55 
(0.5) 
27 
(0.2) 
2 
(0.03) 
151 
(1.9) 
16 
(0.4) 
69 
(0.6) 
118 
(1.3) 
37 
(0.4) 
470 
(2.2) 
Independent variables 
Age group  - - - - - - - - - - - - - - - 
Gender - - - - - - - - - - - - - - - 
Residence - - - - - - - - - - - - - - - 
Education 137 
(0.2) 
64 
(0.7) 
40 
(0.2) 
5 
(0.04) 
17 
(0.4) 
1 
(0.01) 
4 
(0.04) 
26 
(0.2) 
- 22 
(0.3) 
25 
(0.5) 
3 
(0.03) 
12 
(0.1) 
16 
(0.2) 
6 
(0.03) 
Wealth 
Quintile 
1 
(0.001) 
1 
(0.01) 
- - - - - 18 
(0.1) 
3 
(0.05) 
- - - - - 1 
(0.0) 
Occupation 111 
(0.2) 
12 
(0.1) 
5 
(0.02) 
14 
(0.1) 
2 
(0.05) 
1 
(0.01) 
- 16 
(0.1) 
- 27 
(0.3) 
4 
(0.1) 
13 
(0.1) 
0 13 
(0.2) 
(0.02) 
Total 
missing 
cases 
2290  
(3.3) 
306 
(3.2) 
129 
(0.6) 
52 
(0.4) 
159 
(3.7) 
123 
(1.3) 
59 
(0.6) 
87 
(0.6) 
5 
(0.1) 
200 
(2.5) 
45 
(1.0) 
85 
(0.7) 
130 
(1.4) 
66 
(0.8) 
481 
(2.3) 
*Participants who responded “Don’t know” or “Refused to answer” for the question “How often does anyone smoke inside your home?” were dropped from the analysis.  
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Appendix C-3: Missing data for SHS exposure at Workplace among GATS participants (2008-2011) 
Supplementary Table: Missing data for SHS exposure at Workplace among GATS participants (2008-2011) 
N (%) 
 SEAR WPR AMR EUR EMR 
 India 
N=12,852 
Bangladesh 
N=1,704 
Thailand 
N=5,021 
China 
N=1,859 
Malaysia 
N=996 
Philippines 
N=2,152 
Viet 
Nam 
N=2,419 
Mexico 
N=2,082 
Uruguay 
N=1,796 
Poland 
N=3,030 
Romania 
N=1,175 
Russian 
Federation 
N=5,464 
Turkey 
N=2,160 
Ukraine 
N=2,761 
Egypt 
N=4,490 
Dependent variable 
SHS exposure at 
workplace* 
667 
(4.9) 
104 
(5.7) 
51 
(1.0) 
10 
(0.5) 
122 
(10.9) 
17 
(0.8) 
21 
(0.9) 
17 
(0.8) 
2 
(0.1) 
70 
(2.3) 
16 
(1.3) 
114 
(2.0) 
11 
(0.5) 
52 
(1.8) 
26 
(0.6) 
Independent variables 
Age group  - - - - - - - - - - - - - - - 
Gender - - - - - - - - - - - - - - - 
Residence - - - - - - - - - - - - - - - 
Education 3 
(0.02) 
4 
(0.2) 
10 
(0.2) 
2 
(0.1) 
6 
(0.5) 
- 1 
(0.04) 
2 
(0.1) 
 
- 4 
(0.1) 
1 
(0.1) 
1 
(0.01) 
- 1 
(0.03) 
- 
Wealth Quintile - - - - - - - - 1 
(0.05) 
- - - - - - 
Occupation - - - - - - - - - - - - - - - 
Total missing 
cases 
670 
(4.9) 
108 
(6.0) 
61 
(1.2) 
12 
(0.6) 
128 
(11.4) 
17 
(0.8) 
22 
(0.9) 
19 
(0.9) 
3 
(0.2) 
74 
(2.4) 
17 
(1.4) 
115 
(2.1) 
11 
(0.5) 
53 
(1.9) 
26 
(0.6) 
*Participants who responded “Don’t know” or “Refused to answer” for the question “During the past 30 days, did anyone smoke in the indoor areas where you work?” were dropped from the analysis.  
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Appendix C-4: Adjusted Odds Ratio estimates showing secondhand smoke (SHS) exposure at home 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure: Adjusted Odds Ratio estimates showing secondhand smoke (SHS) exposure at home [highest wealth quintile vs. lowest 
(ref.) and highest education level vs. lowest (ref.)] 
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Appendix C-5: Adjusted Odds Ratio estimates showing secondhand smoke (SHS) exposure at workplace 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure: Adjusted Odds Ratio estimates showing secondhand smoke (SHS) exposure at workplace [highest wealth 
quintile vs. lowest (ref.) and highest education level vs. lowest (ref.)] 
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Appendix C-6: Socioeconomic inequality in secondhand smoke (SHS) exposure at home 
Supplementary Figure: Socioeconomic inequality in secondhand smoke (SHS) exposure at home --- a) RII estimates of wealth inequality in SHS exposure at home; b) SII estimates of wealth inequality 
in SHS exposure at home; c) RII estimates of education inequality in SHS exposure at home; and d) SII estimates of education inequality in SHS exposure at home 
a
. 
b
. 
c
. 
d
. 
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Appendix C-7: Socioeconomic inequality in secondhand smoke (SHS) exposure at workplace 
Supplementary Figure: Socioeconomic inequality in secondhand smoke (SHS) exposure at workplace --- a) RII estimates of wealth inequality in SHS exposure at work; b) SII estimates of wealth 
inequality in SHS exposure at work; c) RII estimates of education inequality in SHS exposure at work; and d) SII estimates of education inequality in SHS exposure at work 
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Appendix D-1: States and Districts in India covered under the National Tobacco 
Control Programme (NTCP) 
 
Supplementary Table: States and Districts in India covered under the 
National Tobacco Control Programme (NTCP) 
Sr. No. Name of State Name of Districts 
Phase 1 (2007-2008) 
1 Assam Kamrup and Johrat 
2 Delhi New Delhi and East Delhi 
3 Gujarat Vadodara and Sabarkantha 
4 Karnataka Bangalore and Gulbarga 
5 Madhya Pradesh Khandwa and Gwalior 
6 Rajasthan Jaipur and Jhunjhunu 
7 Tamil Nadu Kancheepuram and Villupuram 
8 Uttar Pradesh Lucknow and Kanpur 
9 West Bengal Cooch Behar and 
Murshidabad 
Phase 2 (2008-2009) 
10 Andhra Pradesh Guntur and Hyderabad 
11 Arunachal Pradesh West Kameng and East Siang 
12 Bihar Patna and Munger 
13 Goa North Goa and South Goa 
14 Jharkhand Dhanbad and Jamshedpur 
15 Maharashtra Thane and Aurangabad 
16 Mizoram Aizawl and Lunglei 
17 Nagaland Kohima and Dimapur 
18 Odisha Cuttack and Khurda 
19 Sikkim East Sikkim and South Sikkim 
20 Tripura West Tripura and Dhalai 
District 
21 Uttarakhand Dehradun and Tehri Gadhwal 
(Source: Ministry of Health and Family Welfare. Operational Guidelines: National 
Tobacco Control Programme.  2012. URL: 
http://mohfw.nic.in/WriteReadData/l892s/2945310979Operational%20Guidelines.
pdf. accessed: July 24, 2016) 
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Appendix D-2: Description of household characteristics in NTCP and non-NTCP districts 
Supplementary Table: Description of household characteristics in NTCP and non-NTCP districts (N=341,975) 
 Intervention* 
(n=35,581) 
Control 
(n=306,394) 
 1999-2000 
(n=12,281) 
2004-05 
(n=13,001) 
2011-12 
(n=10,299) 
1999-2000 
(n=107,259) 
2004-05 
(n=110,742) 
2011-12 
(n=88,393) 
Sector (% [95% CI]) 
Rural 56∙2 
[54∙6, 57∙9] 
54∙0 
[52∙5, 55∙6] 
46∙0 
[43∙9, 47∙9] 
74∙3 
[73∙9, 74∙6] 
75∙3 
[74∙9, 75∙7] 
71∙2 
[70∙7, 71∙7] 
Urban 43∙8 
[42∙1, 45∙4] 
46∙0 
[44∙4, 47∙5] 
54∙0 
[52∙0, 56∙0] 
25∙7 
[25∙4, 26∙0] 
24∙7 
[24∙3, 25∙1] 
28∙8 
[28∙3, 29∙3] 
Household size (% [95% CI]) 
Number of residents ≤ 5 68∙8 
[67∙4, 70∙1] 
71∙8 
[70∙5, 73∙1] 
77∙0 
[75∙3, 78∙6] 
66∙1 
[65∙7, 66∙5] 
68∙8 
[68∙4, 69∙2] 
74∙0 
[73∙5, 74∙6] 
Number of residents > 5 31∙2 
[29∙9, 32∙6] 
28∙2 
[26∙9, 29∙5] 
23∙0 
[21∙4, 24∙7] 
33∙9 
[33∙5, 34∙3] 
31∙2 
[30∙8, 31∙6] 
26∙0 
[25∙4, 26∙5] 
Religion (% [95% CI]) 
Hindu 81∙5 
[80∙4, 82∙6] 
81∙8 
[80∙6, 82∙8] 
82∙0 
[80∙5, 83∙4] 
83∙5 
[83∙2, 83∙8] 
83∙5 
[83∙2, 83∙9] 
83∙4 
[83∙0, 83∙8] 
Muslim 14∙3 
[13∙3, 15∙3] 
14∙0 
[13∙1, 15∙0] 
14∙1 
[12∙8, 15∙5] 
10∙6 
[10∙3, 10∙9] 
11∙0 
[10∙7, 11∙2] 
11∙6 
[11∙2, 12∙0] 
Christian 2∙6 
[2∙3, 3∙0] 
2∙8 
[2∙3, 3∙3] 
2∙8 
[2∙3, 3∙2] 
2∙7 
[2∙6, 2∙9] 
2∙4 
[2∙3, 2∙5] 
2∙4 
[2∙3, 2∙6] 
Others 1∙6 
[1∙3, 1∙8] 
1∙4 
[1∙1, 1∙8] 
1∙1 
[0∙9, 1∙4] 
3∙2 
[3∙0, 3∙3] 
3∙1 
[3∙0, 3∙2] 
2∙6 
[2∙5, 2∙8] 
Caste (% [95% CI]) 
Scheduled Tribe (ST) 7∙7 
[7∙0, 8∙3] 
7∙2 
[6∙5, 7∙9] 
8∙3 
[7∙4, 9∙3] 
9∙0 
[8∙8, 9∙2] 
9∙0 
[8∙8, 9∙3] 
8∙8 
[8∙5, 9∙2] 
Scheduled Caste (SC) 18∙1 
[17∙0, 19∙2] 
19∙0 
[17∙7, 20∙3] 
16∙0 
[14∙6, 17∙5] 
19∙3 
[18∙9, 19∙6] 
19∙7 
[19∙4, 20∙1] 
19∙5 
[19∙0, 20∙0] 
Other Backward Class (OBC) 24∙7 
[23∙5, 25∙9] 
31∙7 
[30∙3, 33∙2] 
39∙3 
[37∙4, 41∙3] 
36∙1 
[35∙7, 36∙5] 
41∙4 
[40∙9, 41∙8] 
43∙7 
[43∙1, 44∙4] 
Others 49∙5 
[47∙9, 51∙2] 
42∙1 
[40∙6, 43∙6] 
36∙4 
[34∙4, 38∙4] 
35∙6 
[35∙2, 36∙0] 
29∙9 
[29∙5, 30∙3] 
28∙0 
[27∙4, 28∙5] 
Employment type (of the head of the household) (% [95% CI]) 
Self-employed 38∙4 
[36∙9, 39∙9] 
42∙3 
[40∙8, 43∙8] 
39∙0 
[37∙2, 41∙0] 
43∙7 
[43∙3, 44∙1] 
48∙1 
[47∙6, 48∙5] 
46∙1 
[45∙4, 46∙7] 
Regular Labour 21∙0 
[19∙5, 22∙6] 
21∙4 
[20∙2, 22∙7] 
31∙3 
[29∙5, 33∙2] 
10∙4 
[10∙1, 10∙6] 
9∙6 
[9∙4, 9∙9] 
17∙7 
[17∙3, 18∙2] 
Casual_labour 29∙5 
[28∙1, 30∙9] 
24∙4 
[23∙1, 25∙7] 
20∙4 
[18∙8, 22∙0] 
34∙1 
[33∙7, 34∙5] 
31∙3 
[30∙8, 31∙7] 
28∙6 
[28∙0, 29∙2] 
Others 11∙1 
[10∙3, 11∙9] 
11∙9 
[10∙8, 13∙0] 
9∙3 
[8∙0, 10∙7] 
11∙8 
[11∙5, 12∙1] 
11∙0 
[10∙7, 11∙3] 
7∙6 
[7∙2, 8∙0] 
Wealth quintile (% [95% CI]) 
Poorest 19∙2 
[17∙8, 20∙7] 
16∙9 
[15∙8, 18∙0] 
16∙9 
[15∙5, 18∙4] 
20∙3 
[20∙0, 20∙6] 
20∙5 
[20∙1, 20∙9] 
20∙4 
[19∙9, 20∙9] 
Poor 20∙2 
[18∙8, 21∙6] 
19∙3 
[18∙1, 20∙5] 
20∙7 
[19∙2, 22∙3] 
19∙9 
[19∙5, 20∙2] 
20∙1 
[19∙8, 20∙5] 
19∙9 
[19∙4, 20∙4] 
Middle 20∙1 
[18∙9, 21∙4] 
21∙4 
[20∙2, 22∙8] 
20∙2 
[18∙7, 21∙8] 
20∙0 
[19∙6, 20∙3] 
19∙8 
[19∙5, 20∙2] 
20∙0 
[19∙5, 20∙5] 
Rich  21∙0 
[19∙9, 22∙1] 
20∙9 
[19∙7, 22∙1] 
21∙1 
[19∙5, 22∙7] 
19∙8 
[19∙5, 20∙2] 
19∙9 
[19∙5, 20∙2] 
19∙9 
[19∙3, 20∙4] 
Richest 19∙5 
[18∙4, 20∙7] 
21∙5 
[20∙2, 22∙9] 
21∙1 
[19∙4, 23∙0] 
20∙0 
[19∙7, 20∙4] 
19∙7 
[19∙3, 20∙0] 
19∙8 
[19∙3, 20∙3] 
Proportion of household members in each age groups [95% CI]# 
0-4 years 0∙09  
[0∙08, 0∙09] 
0∙08  
[0∙07, 0∙08] 
0∙07  
[0∙06, 0∙07] 
0∙09 
 [0∙09, 0∙09] 
0∙09  
[0∙09, 0∙09] 
0∙07  
[0∙07, 0∙07] 
5-14 years 0∙20  
[0∙19, 0∙21] 
0∙19  
[0∙18, 0∙19] 
0∙16  
[0∙16, 0∙17] 
0∙22  
[0∙21, 0∙22] 
0∙20  
[0∙20, 0∙21] 
0∙19  
[0∙18, 0∙19] 
15-29 years 0∙28  
[0∙27, 0∙29] 
0∙30  
[0∙29, 0∙31] 
0∙32  
[0∙30, 0∙33] 
0∙27  
[0∙27, 0∙27] 
0∙27  
[0∙26, 0∙27] 
0∙27  
[0∙27, 0∙28] 
30-59 year 0∙35  
[0∙34, 0∙35] 
0∙35  
[0∙34, 0∙36] 
0∙36  
[0∙35, 0∙37] 
0∙33  
[0∙33, 0∙33] 
0∙35  
[0∙34, 0∙35] 
0∙37  
[0∙37, 0∙37] 
≥60 years 0∙08  
[0∙07, 0∙08] 
0∙08  
[0∙08, 0∙09] 
0∙09  
[0∙08, 0∙09] 
0∙09  
[0∙09, 0∙09] 
0∙09  
[0∙09, 0∙09] 
0∙10  
[0∙10, 0∙10] 
Proportion of household members who are males or females [95% CI]# 
Females 0∙47  
[0∙46, 0∙47] 
0∙47  
[0∙46, 0∙48] 
0∙45  
[0∙44, 0∙46] 
0∙48  
[0∙47, 0∙48] 
0∙48  
[0∙48, 0∙48] 
0∙48  
[0∙47, 0∙48] 
Males 0∙53  
[0∙53, 0∙54] 
0∙53  
[0∙52, 0∙53] 
0∙55  
[0∙53, 0∙55] 
0∙52  
[0∙52, 0∙52] 
0∙52  
[0∙52, 0∙52] 
0∙52  
[0∙52, 0∙52] 
Proportion of household members in each of the educational categories [95% CI]# 
Illiterates 0∙56  
[0∙55, 0∙58] 
0∙75  
[0∙73, 0∙76] 
0∙40  
[0∙38, 0∙41] 
0∙62  
[0∙62, 0∙63] 
0∙83  
[0∙83, 0∙84] 
0∙49  
[0∙48, 0∙49] 
Primary 0∙11  
[0∙10, 0∙12] 
0∙09  
[0∙09, 0∙10] 
0∙12  
[0∙11, 0∙13] 
0∙11  
[0∙11, 0∙12] 
0∙08  
[0∙07, 0∙08] 
0∙13  
[0∙13, 0∙13] 
Middle 0∙11  
[0∙11, 0∙12] 
0∙07  
[0∙06, 0∙07] 
0∙14  
[0∙13, 0∙15] 
0∙11  
[0∙11, 0∙11] 
0∙04  
[0∙04, 0∙04] 
0∙14  
[0∙14, 0∙14] 
Secondary 0∙09  
[0∙08, 0∙10] 
0∙01  
[0∙01, 0∙01] 
0∙12  
[0∙11, 0∙13] 
0∙07  
[0∙07, 0∙07] 
0∙01  
[0∙01, 0∙01] 
0∙10  
[0∙10, 0∙11] 
Higher Secondary 0∙01  
[0∙01, 0∙01] 
0∙08  
[0∙07, 0∙09] 
0∙10  
[0∙09, 0∙11] 
0∙004  
[0∙004, 0∙005] 
0∙04 
 [0∙04, 0∙04] 
0∙08  
[0∙08, 0∙08] 
Graduate and above 0∙05  
[0∙05, 0∙06] 
- 0∙12  
[0∙11, 0∙13] 
0∙03  
[0∙03, 0∙03] 
- 0∙06  
[0∙06, 0∙06] 
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Appendix D-3: Trends in household consumption of bidis and cigarettes over time in India (Consumer Expenditure Survey rounds: 1999-
2000; 2004-05; 2011-12) 
  
Supplementary Figure: Trends in household consumption of bidis and cigarettes over time in India (Consumer Expenditure Survey rounds: 1999-2000; 2004-05; 2011-12) 
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Appendix D-4: Household consumption of bidis and cigarettes across 
intervention (NTCP) and control groups 
 
Supplementary Table: Household consumption of bidis and cigarettes across intervention (NTCP)  and 
control groups 
Percentage of households reporting bidi consumption in the past month [95% CI] 
 1999-2000 
n=119,540 
2004-2005 
n=123,743 
2011-2012 
n=98,692 
Intervention (NTCP) 30∙6 
[29∙2, 31∙9] 
25∙9 
[24∙6, 27∙2] 
18∙8 
[17∙3, 20∙4] 
Control  32∙0 
[31∙6, 32∙4] 
29∙1 
[28∙7, 29∙5] 
22∙5 
[22∙0, 23∙1] 
Difference# -1∙4* 
[-2∙9,  -0∙02] 
-3∙2* 
[-4∙6, -1∙8] 
-3∙7* 
[-5∙3, -2∙1] 
Percentage of households reporting cigarette consumption in the past month [95% CI] 
 1999-2000 
n=119,540 
2004-2005 
n=123,743 
2011-2012 
n=98,692 
Intervention (NTCP) 6∙9 
[5∙9, 8∙1] 
6∙1 
[5∙4, 6∙8] 
8∙6 
[7∙3, 9∙9] 
Control  5∙1 
[4∙9, 5∙3] 
4∙7 
[4∙5, 4∙8] 
6∙0 
[5∙7, 6∙2] 
Difference# 1∙8* 
[0∙7, 2∙9] 
1∙4* 
[0∙7, 2∙1] 
2∙6* 
[1∙3, 3∙9] 
Monthly consumption of bidi sticks in numbers per person [95% CI] 
 1999-2000 
n=34,196 
2004-2005 
n=33,476 
2011-2012 
n=19,146 
Intervention (NTCP) 95∙8  
[92∙4, 99∙2] 
89∙3 
[85∙8, 92∙7] 
72∙3  
[67∙4, 77∙2] 
Control  93∙9 
[92∙7, 95∙0] 
87∙9 
[86∙8, 89∙0] 
71∙9 
[70∙1, 73∙7] 
Difference$ 1∙9  
[-1∙6, 5∙5] 
1∙3 
[-2∙3, 4∙9] 
0∙4 
[-4∙8, 5∙6] 
Monthly consumption of cigarette sticks in numbers per person [95% CI] 
 1999-2000 
n=9,349 
2004-2005 
n=9,310 
2011-2012 
n=9,883 
Intervention (NTCP) 25∙9 
[22∙4, 29∙4] 
23∙3  
[20∙4, 26∙1] 
20∙4 
[16∙8, 23∙9] 
Control  28∙7 
[27∙6, 29∙7] 
25∙1 
[24∙1, 26∙1] 
17∙2 
[16∙3, 18∙1] 
Difference$ -2∙8 
[-6∙4, 0∙9] 
-1∙8 
[-4∙8, 1∙2] 
3∙1 
[-0∙5, 6∙8] 
# test for difference in proportions between intervention and control groups 
$ test for difference in means between intervention and control groups 
* indicates p<0∙05 
 
 
